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The HIV Cost and Services Utilization Study and HIV Research Network (HIVRN) 
clinical studies showed disparities among HIV-positive men and women in outpatient 
care use in the U.S.   Formal social support provided by case managers may help patients 
access outpatient care.  The primary purpose of this study was to determine if having case 
managers is associated with levels of outpatient care visits among 797 individuals living 
with HIV/AIDS, and whether this association varies by patient sex.  Other aims were to 
determine if the number of in-person case management visits and the type of formal 
social support are associated with these same outcomes.  Outpatient visit levels were 
defined as 2-5 (average) or 6+ (high).  Based on Andersen’s (1995) Behavioral Model of 
Health Services Use, a conceptual model was developed as a framework for examining 
the study’s hypothesized relationships.  
 
Methods 
The HIVRN is a convenience sample of 17 U.S. clinical sites serving more than 15,000 
people living with HIV/AIDS.  In 2003, interviews were conducted with a stratified 
sample of 951 clients at 14 HIVRN sites.  The current study sample consisted of 797 
adult respondents (543 males and 254 females).  Logistic regression was used to identify 
significant predictors of outpatient care visit levels. 
 
Results 
Patients who had one or two case managers versus no case managers were significantly 
more likely to have 6+ outpatient visits, while patients who were employed and had 
higher self-reported perceptions of their health were significantly less likely to have 6+ 
  
outpatient visits.  These relationships did not vary by patient sex.  Level of outpatient 
visits also did not vary by patient sex.  No significant associations were found between 
the number of in-person case management visits or the type of formal social support and 
level of outpatient visits.  In sub-analyses that separated patients with one case manager 
from those with two case managers, no new predictors emerged.   
  
Conclusion 
Case management was associated with higher levels of outpatient visits for both male and 
female patients in this study.  This finding suggests that utilization of HIV-related 
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Chapter 1: Introduction 
 
Eliminating disparities in health care access and service utilization has become a national 
priority over the past decade.  As documented in Healthy People 2010, the nation’s 
roadmap for health promotion and disease prevention, the elimination of health 
disparities is a central goal essential to improving health for all Americans  (DHHS, 
2000; Institute of Medicine, 2001).  For persons in the United States (U.S.) living with 
Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS), 
persistent disparities in health care access and service utilization demonstrate that there is 
a challenge in realizing this goal.  The hallmark of HIV is its ability to invade and destroy 
white blood cells, the cells that make up humans’ immune response to disease.  As HIV 
gradually ravages these critical cells, particularly the infection-fighting white blood cells 
known as CD4 + T cells, the immune system becomes vulnerable to opportunistic 
illnesses.  The manifestation of these illnesses is one marker of the transition from HIV 
infection to AIDS.  The development of highly active antiretroviral therapies (HAART) 
in the mid-1990s has altered the natural course of HIV disease by greatly increasing 
survival times (Cunningham et al., 2000).  Still, disparities in access to HAART exist, as 
can be seen in survival time differentials in various subgroups that are affected by 
HIV/AIDS. 
 
To be clear, HIV/AIDS is an unprecedented modern-day pandemic.  The prevalence of 
HIV/AIDS worldwide is close to 45 million cases (Centers for Disease Control and 
Prevention [CDC], 2002).  Of these estimated 45 million people living with HIV/AIDS 
worldwide, 36.3 million are adults.  Nearly 50% of this seropositive adult population are 
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women, with the majority of infected women living in sub-Saharan Africa (CDC, 2002).  
Worldwide, more than three million children under the age of 15 are also living with 
HIV/AIDS.  In the U.S., approximately 40,000 new HIV infections occur annually; 30% 
of these new infections are among women, particularly African American and Hispanic 
women (CDC, 2002).  HIV/AIDS is now in the top 10 leading causes of death in the U.S 
for all women aged 25 to 44 and the leading cause of death among African American 
women aged 25-34.  Nearly 468,000 deaths can be attributed to AIDS through 2001 
(CDC, 2003).   
 
As the HIV/AIDS epidemic evolved in the early 1980s from an unknown disease 
affecting relatively few individuals into a pandemic affecting millions around the world 
(Beaudin & Chambré; Fee & Fox, 1992), researchers have sought to identify individual, 
social, and organizational factors to better understand health care and service utilization 
differences, and to reduce treatment costs and human suffering (Kenagy et al., 2003; 
Shapiro et al., 1999).  For example, in a number of studies to date, including the national 
HIV Cost and Services Utilization Study (HCSUS), researchers have documented 
reduced access to and use of HIV-related health care services for women as compared to 
men (Burke et al., 2003; Hellinger, 1993; Palacio, Kahn, Richards, and Morin (1999).  
HIV- positive men and women who are poor may also postpone seeking care, given other 
competing day-to-day survival challenges such as food, clothing, or shelter (Cunningham 
et al., 1999; Ward, 1993).  HIV-positive women may be particularly prone to delaying 
care, given their concerns for children and other family members’ well-being above their 
own health (Raveis, Siegel, & Gorey, 1998).    
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 Reframing HIV/AIDS as a manageable chronic illness similar to many long-term 
progressive conditions that may be accompanied by periods of disability as well as 
periods of relative remission from symptoms has significantly changed how care is 
planned and evaluated in the clinical setting.  A continuum of care services that include 
physical, mental, and social components and that also involve inter-relationships among 
patients, provider networks, case managers, and community-based organizations has 
become one best practice model (Conviser & Pounds, 2002).  Moreover, the advent of 
HAART in 1996 as the standard of clinical care has led to significant decreases in the 
progression of HIV infection to AIDS and death.  Approaching HIV/AIDS as a chronic 
rather than an acute illness, however, raises a number of major challenges and questions, 
not the least of which is how to effectively manage an illness that continues 
disproportionately to affect those who are members of disempowered and minority 
groups, who often have lower social and economic status, and who are likely to lack 
access to ongoing health care services.  Underlying and inter-connected social and 
economic forces -- namely stigma, discrimination, gender inequality, and poverty -- 
contribute to increased HIV infection among certain subgroups, as well as the timing of 
subsequent entry into and maintenance into health care (Devine, Plant, & Harrison, 1999; 
Farmer, Lindenbaum, & Good, 1993; Goldstein, 1997; Ward, 1993).  The lived 
experience of HIV/AIDS from a chronic illness perspective is not gender-neutral; it is 
often very different for women than men, as a result of many factors including pre-
existing inequality in society, later entry into the health care system, and the expectation 
that women will continue to fulfill traditional familial caretaking roles, such as mother, 
daughter, spouse, and partner, when they may be ill themselves (Heath & Rodway, 1999; 
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Thorne, McCormick, & Carty, 1997).  Women living with other chronic illnesses besides 
HIV/AIDS, such as diabetes and arthritis, have similar challenges as well (Kralik, 2002; 
O’Neill & Morrow, 2001). 
 
Finally, organizational and health care system barriers, such as provider bias, high health 
care costs, and lack of insurance coverage can impede access to quality HIV care and 
treatment.  According to Kahn and colleagues (2001), the average cost per patient per 
year for HIV-related medical care is between $10,000 and $12,000, with higher costs on 
the order of $25,000 for persons with more advanced HIV-related symptoms.  According 
to Schackman and colleagues (2006), the estimated undiscounted lifetime cost of medical 
care for HIV-positive adults could be as high as $618,900.  This figure does not include 
costs for mental health and substance abuse treatment or for case management services.  
Other data suggests that direct medical costs per case vary by race/ethnic background, 
with the highest costs for Whites ($180,900) and the lowest cost for Blacks ($160,400) 
(Hutchinson et al., 2006).  The cost of HAART is thought to account for one-half to 
three-fourths of these costs.  Although Federal Medicaid and Medicare programs cover a 
large portion of the uninsured and underinsured, eligibility for and access to HIV/AIDS 
services vary considerably from state to state, leaving a sizable number of people out of 
care completely or moving sporadically in and out of care.  Often, the lengthy waiting 
periods and restrictive criteria for program enrollment preclude early treatment that could 
halt the progression of disease and disability, including an increased number of 
opportunistic infections and hospitalizations, and poorer quality of life (Bright, Arnett, 
Blair, & Bayona, 1996; Buchanan & Chakravorty, 1999; McDonnell, Gielen, Wu, 
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O’Campo, & Faden, 2000; Tsasis, 2000).  Other safety net programs, including services 
provided under Title XXVI of the Public Health Service Act (PHS) Act as amended by 
the Ryan White HIV/AIDS Treatment Modernization Act of 2006 [formerly called the 
Ryan White Comprehensive AIDS Resources Emergency (CARE) Act], and at public 
hospitals and community clinics, are also sources of limited care for uninsured or 
underinsured HIV-positive persons; still, these programs have not been given the 
financial capacity to provide care to all who are in need. 
  
One of the challenges of retaining individuals in care is the co-occurrence of mental 
illness and substance abuse with HIV/AIDS.  A number of studies have found HIV 
prevalence rates ranging from 4-18% among the mentally ill population, as compared 
with 1% in the general population (American Psychiatric Association, 2002).  Encandela 
and colleagues (2003) also note the high prevalence and incidence of HIV among persons 
with mental illness and substance abuse problems.  CDC surveillance figures show 
injection drug use (IDU) was associated with more than 25% of newly-reported 
HIV/AIDS cases between 1999 and 2002 among both men and women.  Women with 
mental health and substance abuse issues may be at an even greater risk, with an 
estimated 5% HIV infection rate as compared to 0.17% in the general population (Carey, 
Carey, & Kalichman, 1997; Rosenberg et al., 2001).  Women who have mental health 
and substance abuse issues may be less likely to practice condom use and safe sex 
behaviors, in addition to having poor overall coping skills. 
  
Of particular interest to the present work is how HIV/AIDS-related outpatient care can be 
better understood when formal social support systems are in place.  Such systems and 
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models of care have been successful with a number of other chronic conditions, including 
heart disease, asthma, depression, and arthritis (Chernesky & Grube, 1999; Lorig, 1996; 
Rapp & Chamberlain, 1985).  A distinguishing feature of chronic illness management is 
an active patient-provider partnership, which shifts patients’ attention away from a 
reactive position to one of proactive collaboration.  A proactive stance features two-way 
dialogue and shared goal-setting for health maintenance and improvement (Lorig, 1996).  
One way to operationalize coordination of care is through a case management model, 
where formal social support is obtained from a health care professional who can connect 
patients to an array of services in a particular community.  Social support researchers 
have made a strong case for the benefits of social support during times of stress and 
personal/family illness (Hupcey, 1998; Thoits, 1982).  These benefits include improved 
coping with adverse conditions and less distress with managing a difficult situation.   
Social support for HIV-positive patients has become increasingly recognized as an 
important element in maximizing quality of life and better health outcomes; patients 
accessing regular care can potentially live for many years (Chernesky & Grube, 1999; 
Indyk, Belville, Lachalle, Gordon, & Dewart, 1993; Kucera, 1998).   
 
The definition of case management varies widely from setting to setting.  For illustrative 
purposes, one definition is proposed below:   
 
[a] collaborative process that assesses, plans, implements, coordinates, monitors, 
and evaluates the options and services required to meet an individual’s health 
needs, using communication and available resources to promote quality and cost-




Given the myriad of medical and social services needed by HIV-positive persons, case 
management has become one promising strategy to assist patients in obtaining supportive 
community services (Chernesky & Grube, 1999; Parish, Burry, & Pabst, 2003; Piette, 
Fleishman, Mor, & Thompson, 1991; Katz et al., 2001; Katz, et al., 2000; Kucera, 1998).  
Patients who are connected to clinical and social services are hypothesized to have less 
unmet need and to have consistent outpatient care visits.  They may also be less likely to 
need costly emergency room (ER) services and inpatient hospitalizations.   
 
HIV/AIDS case managers are often tasked with having knowledge of social service 
benefits as well as Federal, state and local entitlement programs, and they may serve as 
one of several groups of formal social support advocates for clients.  Sonsel and 
colleagues (1988) described one of the first concepts of HIV/AIDS case management as a 
way to increase clients’ contact with services.  Early work by Piette and colleagues 
(1991) established one view on case management goals for individuals living with 
HIV/AIDS. These goals were coordination of services, increased access to care, and 
decreased costs associated with inpatient care. Work by Chachkes (1993) clarified case 
management for HIV-positive patients as a combination of in-person contacts to ensure 
coordinated medical and social services in the best interest of the client.  In the early 
1990s, case managers were utilized less often for stabilized patients and more often for 
patients in crisis and those needing palliative care.  Also, HIV-positive women were often 
less likely to have case managers than HIV-positive men, in part because of a failure to 
recognize women as an at-risk group, as well as longstanding gender-based inequality of 
care (Fleishman, Mor, & Piette, 1991).  As HIV/AIDS was recast as a chronic illness 
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with the advent of HAART in the mid-1990s, the role of case managers also shifted, with 
a greater emphasis on assisting patients to improve their health rather than preparing for 
death.  Increased numbers of HIV-positive women in the past two decades has also led to 
the need to address gender-specific case management interventions.  Clarifying the 
specific benefit of case management for HIV-positive men and women in an era in which 
patients can be expected to live is a new direction addressed in this dissertation.  
 
The recent Institute of Medicine (IOM, 2005) report, “The Public Financing and Delivery 
of HIV Care: Securing the Legacy of Ryan White” addresses the importance of a 
comprehensive and continuous primary care package of services for uninsured and 
underinsured persons living with HIV/AIDS.  Recommended Federally-funded services 
include case management and treatment for mental health and substance abuse problems 
in an effort to stabilize patient care and contribute to overall treatment plans.  At the same 
time, such a standardized benefits package would be aligned with current science-based 
evidence on HIV/AIDS treatment, theoretically enroll patients earlier after the initial HIV 
diagnosis, and reduce costly inpatient care and emergency service needs.  In the absence 
of implementation of the IOM recommendations, however, continued attention is needed 
to address differences in HIV/AIDS health services utilization and to seek innovative 










Purpose of the Study 
 
The primary purpose of this study was to determine if formal social support predicts 
levels of HIV/AIDS-related outpatient care visits among a subset of 797 individuals 
living with HIV/AIDS in the U.S., and whether this association varies by patient sex.  
The study sample is derived from a larger stratified random sample of 951 individuals 
living with HIV/AIDS.  For the purposes of this study, formal social support was defined 
as having up to two case managers in the last six months.  The dependent variable – 
number of outpatient care visits in the last six months - can vary across a wide 
continuum.  For the purposes of this study, and to narrow the interpretability of outpatient 
visits in a manageable way, the number of outpatient visits was categorized as follows:  
2-5 visits (average use); and 6+ visits (high use).  The number of patients with 0-1 visits 
(n=67, rare use) in this sample was too low to run meaningful bivariate and multivariate 
analyses; however, this is an important subgroup to address in other research.  
 
The aforementioned categorization should not be interpreted as a standard of care, or a 
judgment on appropriateness of care, but rather as one schema for examining ranges of 
outpatient visits that may provide other information about the context of living with 
HIV/AIDS (personal communication, V. Cargill-Swiren, M.D., M.S.C.E.,  
July 3, 2006).  Patients with rare use of outpatient visits may have unaddressed mental 
health, substance abuse, and other social health issues that interfere with both case 
management contact and outpatient care appointment keeping.  Similarly, patients with 
high use of outpatient visits may have medication side effects or other illnesses besides 
HIV/AIDS that may require more clinical oversight.  Thus, the important question for 
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this research was whether the number of in-person case management contacts and type of 
support was sex/gender-specific in predicting levels of outpatient care visits.  A better 
understanding of these relationships may lead to targeted case management and other 
enabling services for HIV-positive men and women to help them strengthen therapeutic 
alliances and connect to outpatient care.    
 
For the purposes of this study, the terms “sex” and “gender” were used interchangeably, 
given that the study data source used the term “gender” to assess an individual’s 
biological male- or female-ness.  However, it is important to recognize that the IOM 
(2001) has established distinct definitions of the two terms.  Specifically, sex refers to 
being male or female according to reproductive organs and chromosomal make-up, while 
gender defines one’s sense of self as male or female in society.    
 
Previous research efforts have established that there are significant differences in receipt 
of HIV-related care and HAART by sex/gender as well as other factors, such as 
race/ethnicity and injection drug use, with more frequent use of outpatient care among 
White males and non-injection drug users, and more frequent use of emergency room 
care for women and substance-abusing persons (Andersen et al., 2000; Cunningham et 
al., 2000; Fleishman & Hellinger, 2003;  Masson, Sorensen, Phibbs, & Okin, 2004; 
Mauskopf et al. 1994;  Menke, Giordano, & Rabeneck, 2003; Mor, Fleishman, Dresser & 
Piette, 1992; Schoenbaum & Webber, 1993; Sorenson et al., 2003).  A recent study by 
Gebo and colleagues (2005) also found significant differences by race/ethnicity and 
gender in the receipt of HAART among a sub-sample of 6,192 patients seen at nine HIV 
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Research Network sites, with significant disparities evident among women, African 
Americans, and injection drug users (IDUs).  Providers may be less likely to prescribe 
medications to IDUs when they have concerns about adherence to treatment (Escaffre et 
al., 2000); at the same time, IDUs may be less likely to seek regular care.   
 
The supporting aims of the present research were to determine if the intensity and type of 
formal social support, respectively, predicted levels of HIV/AIDS-related outpatient care 
visits, and whether this association varies by patient sex.   For the  purposes of this study, 
intensity was defined as the number of in-person contacts across a maximum of two case 
managers in the last six months; while type of formal social support was defined as either 
informational or instrumental.  In the only nationally representative sample of HIV-
positive patients’ health services utilization, patients who had at least one case 
management contact in person or by phone over the six month study period had less 
unmet need for support services (Katz, 2000).  In other studies that were done among 
patients engaged with HIV/AIDS safety net providers, case management was associated 
with entry into appropriate medical care (Messeri, Abramson, Aidala, Lee, & Lee, 2002; 
Sherer et al., 2002).  Magnus and colleagues (2001) found that receiving help with 
transportation –a form of instrumental support – and having more than one contact with a 
case manager were both significantly related to improved retention in primary care 
among a sample of 198 HIV-positive women.  Data were collected for that study between 
January 1, 1997 and December 31, 1998, which is after HAART had become the standard 
of care.  Establishing a clearer picture of the role of case managers as one category of 
formal social support for men and women living with HIV/AIDS in the post-HAART era, 
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and whether the type of support can influence outpatient care utilization were important 
goals of the present work. 
 
The overall conceptual model behind this study came from research and analysis of 
health services use first developed by Andersen (1968) and further explored in later years 
(Andersen, 1995; Phillips, Morrison, Andersen, & Aday, 1998).  The core model (see 
Figure 1) suggests that health services utilization is a function of an individual’s 
predisposition to use services, factors that enable or impede use, and his/her need for 
care.   
 
Predisposing   →    Enabling Resources    →    Need    →   Use of Health Services 
         │  │      │ 
Demographic   Personal/Family  Perceived 
         │  │      │ 
Social Structure Community   (Evaluated) 
         │ 
Health Beliefs 
Figure 1. Behavioral Model of Health Services Use, Andersen, R.M. (1968). 
 
These three components – Predisposing Characteristics, Enabling Resources, and Need – 
include several sub-components.  For example, demographics such as age and sex fall 
under Predisposing Characteristics.  Education, employment status and race/ethnicity 
were originally conceived under the Social Structure sub-component, whereas  
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attitudes, values, and knowledge about health services were subsumed under the Health 
Beliefs sub-component.   Andersen (1995) purported that personal/family and community 
resources were both important sub-components under the Enabling Resources 
component.  From his point of view, people needed the means and information to access 
and use health services; at the same time, health care professionals and clinics needed to 
be located in the same neighborhoods in which people carry on with their daily lives.  
Proxies for these variables include income, health insurance, and having a regular source 
of care.  Andersen (1995) contended that individual social ties could be put under the 
Enabling Resources component, as compared to wider social networks –or groups of 
interactions—that are better accommodated under the Social Structure component.  
  
When explaining the Need component, Andersen (1995) noted that this refers to two 
parts: first, the perception of health status from the individual’s point of view, and 
second, the health professional’s objective evaluation of an individual’s health.  In some 
cases, patient perception may be the catalyst for seeking care, whereby a professional’s 
judgment can have a positive or negative impact on what kind of and how much care is 
provided.   The definition of “care” in Andersen’s model was not specifically defined; 
however, Andersen believed that predicting ambulatory health services use was different 
than predicting inpatient care, and that application to different diseases may change how 
the model is operationalized.  Notwithstanding, the intention of the model is to better 




The current study took an in-depth look at the Enabling Resources component of 
Andersen’s model, as described above, and its relationship to use of HIV/AIDS-related 
outpatient care.  Thus, it focused in on that part of the model that may predict health 
services use for a group of people whose health prognosis depends on using the health 
care system on a regular basis.  At the same time, the present study put a greater 
emphasis on understanding how a demographic factor– patient sex – may interact with a 
specific enabling resource – formal social support -- which has implications for 
improving connections to care, establishing stronger therapeutic relationships, targeting 
case management services, and improving HIV/AIDS patient outcomes.  Currently, little 
is known about the variation of case management services by sex/gender and their 
possible connection to HIV/AIDS-related outpatient care.  As compared to Andersen’s 
original conceptualization, the present study considered education and employment as 
well as the presence of others in the household as possible Enabling Resources, in that 
they may contribute to patients’ knowledge of and access to outpatient care; in the 
original model, education and employment were labeled under the Social Structure sub-
component, with the idea that they represented a person’s position in the community.  
Adaptations of the Andersen model for different health issues allows for flexibility to 
better understand health services use.  
 
For the purposes of this study, formal social support provided by one or two case 
managers served as the primary independent variable; further contextual information 
came from intensity of formal support and type of support.  Given the study’s focus on 
potential sex/gender differences in predicting levels of HIV/AIDS-related outpatient 
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visits as influenced by formal social support, patient sex was the primary Predisposing 
covariate of interest.  Also, as adapted to the HIV/AIDS case, other covariates including 
race/ethnicity, age, education, employment, perceived health status, change in health 
status, illicit drug use, availability of informal support, and stage of illness (CD4 nadir), 
were measured and adjusted for in multivariate analyses, as appropriate.  More details 
and definitions of the covariates can be found in Chapter 3.  
 
An Analytic Model (See Figure 2, Chapter 3) was developed to inform the study’s 
primary research question and secondary research questions.   
 
Primary Research Question- Does the scope of formal social support predict levels of 
HIV/AIDS-related outpatient care visits?  Does this association vary by patient sex? 
 
Secondary Research Question- Does the intensity of formal social support predict 
levels of HIV/AIDS-related outpatient care visits?  Does this association vary by patient 
sex? 
 
Secondary Research Question - Does the type of formal social support predict levels of 
HIV/AIDS-related outpatient care visits?  Does this association vary by patient sex? 
 
 
The dependent outcome examined was level of HIV/AIDS-related outpatient care visits, 
which was operationalized in this study as 2-5 visits (average use) and 6+ visits (high 
use).  The primary covariate of interest was patient sex.  The primary independent 
variable was formal social support.  Other covariates were grouped under three major 
headings:  1) Other Predisposing Characteristics; 2) Other Enabling Resources; 3) Other 
Need for Services.  Further details on specific variables under each of these groups are 
given in Chapter 3.   
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HCSUS studies based on data collected in the mid-1990s suggest that both HIV-positive 
men and women need case management services; however, Katz and colleagues (2001) 
did not find a significant relationship between case management receipt and having one 
outpatient visit during a three month study period.  However, newer studies are beginning 
to revisit the possible relationships among case management receipt, retention in primary 
care, and outpatient care use, as well as the importance of looking at specific types of 
social support needed for HIV-positive men and women, given other physical and social 
demands on their time (Knowlton, Hua, & Latkin, 2005; Magnus et al., 2001).   
 
The following hypotheses were put forth, taking into account what is known to date on 
the connection of case management to outpatient care for HIV-positive men and women, 
in addition to the larger literature base on health care utilization.  These hypotheses were 
also informed by studies that illustrate how HIV-positive women may need additional 
personalized attention in the form of instrumental support to take care of their own needs 
above those of other family members (Cunningham et al., 1999; Magnus et al., 2001; 
Raveis, Siegel, & Gorey, 1998; Ward, 1993).  Still, because of the lack of previous 
research on the impact of informational support and the impact of frequency of 
HIV/AIDS case management contacts, two of the hypotheses were null hypotheses.  
 
Hypothesis 1 - Patients with formal social support will have more HIV/AIDS-related 
outpatient care visits as compared to patients without formal social support. 
 
Hypothesis 2 - Level of HIV/AIDS-related outpatient care visits will not be associated 




Hypothesis 3a - Increased instrumental formal social support will be associated with 
increased levels of HIV/AIDS-related outpatient care visits.  
 
Hypothesis 3b - Increased informational formal social support will not be associated with 
increased levels of HIV/AIDS-related outpatient care visits.  
 
If patient sex was shown to be a significant covariate in tests of any of the above 
hypotheses, the cross-product of the variables “patient sex” and “social support” would  
be created and added to the multivariate models to determine if there was an interaction 
between these variables in predicting levels of HIV-related outpatient visits.  An 
interaction was expected for Hypotheses 1 and 3a.  Finally, one additional sub-analysis, 
which is further explained in Chapter 3, was conducted.  This sub-analysis addressed 
whether any significant relationships found with the entire study sample remained when 
HIV-positive patients with two case managers were excluded.   
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Chapter 2: Literature Review 
 
Disparities in health care access and treatment are well documented across a wide 
number of medical conditions and for a number of different populations, including 
women and racial/ethnic minorities (AHRQ, 2004; AHRQ, 2002; Alliance for Health 
Reform, 2003; Pearcy & Keppel, 2002; Satcher, 2001; Wong, Shapiro, Boscardin, & 
Ettner, 2002), both in the U.S. and around the world (Casas-Zamora & Ibrahim, 2004).   
In the 2004 National Healthcare Disparities Report (AHRQ, 2004), three key themes 
emerged: 
• Disparities are pervasive. 
• Improvement is possible. 
• Gaps in information exist, especially for specific conditions and  
populations. (p. 1)  
 
The American Public Health Association (2004) defines health disparities as “differences 
that occur by gender, race and ethnicity, education level, income level, disability, 
geographic location and/or sexual orientation.”  In the context of health care, the term 
“differences” suggests inequitable access to, availability of, and distribution of needed 
services.  Across virtually all medical conditions, persons with lower income levels have 
reduced access to and choice of health care providers and services (Mayberry, Mili, & 
Ofili, 2000).  However, health care disparities are not fully explained by income 
variation, stage or severity of illness, co-morbidities, or health insurance coverage; other 
factors, such as historical biases in access to medical care, may be at play (Kaiser 
Commission on Medicaid and the Uninsured, 2005; Mayberry, Mili, & Ofili, 2000).  In 
addition, patient sex and race/ethnicity can be synergistic disparity factors.  In a landmark 
study controlling for symptom presentation and other factors, Schulman and colleagues 
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(1999) found that physicians were significantly less likely to refer African American 
women for cardiac catheterization than White males, Black males, and White female 
patients.   
 
To put these disparities in context, one model of health services utilization that has been 
useful to researchers and that is adapted for the current study is Andersen’s (1968, 1995) 
Behavioral Model of Health Services Use.  As described in Chapter 1, this model 
includes a number of factors that are presumed to predict and explain the use of health 
services.  These factors included Predisposing Characteristics, including demographic, 
social structure, and health beliefs; Enabling Resources, which include personal/family 
and community variables; and Need, which includes both perceived and evaluated 
requirements.  Over time, the model has been modified and adapted by others to focus 
more on system or organizational characteristics such as insurance, provider type and 
training, and geographic location of health facilities (Andersen & Newman, 1973), as 
well as the mutability of the model components in predicting health service use.  Other 
additions to the model in the 1980s and 1990s have encompassed perceived health status 
and consumer satisfaction as important components (Andersen, 1995).  Access to health 
insurance has become more important as the model developed over the last three decades.   
 
Lack of health insurance is one of the most significant contributors to health care 
disparities.  Reasons for lack of insurance include but are not limited to the high costs of 
insurance premiums, lack of appropriate employer-based health plans, geographic 
location, poverty, and pre-existing health conditions.  Women are more likely than men 
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to lack employer-sponsored insurance and to rely on public systems of care (Kaiser 
Family Foundation, 2004a).  Moreover, women living with HIV/AIDS are more likely 
than men living with HIV/AIDS to be Medicaid beneficiaries, given the potential for 
pregnancy and responsibility for dependent children (Bozzette et al., 1998).   Having a 
regular source of care significantly increases the chance that men and women receive 
sufficient preventive care, health education messages, and other important health 
services.  Lack of a regular source of health care is a problem for all, but it is particularly 
devastating to those living with chronic illnesses, given their elevated need for costly 
health care services (Kinney & Steinmetz, 1994; Stroupe, Kinney, & Kniesner, 2000).   
 
More than 90 million Americans live with visible and non-visible chronic illnesses 
(CDC, 2005a).  Chronic conditions can be characterized by fluctuating and often 
unpredictable periods of disability and improvement.  Diseases that once were 
immediately life threatening, such as heart disease, can now be managed over time with 
appropriate chronic disease management care plans.  Many chronic illnesses are a result 
of advanced age, but an increasing number of these conditions are related to a 
combination of lifestyle choices; as a result, the diagnosis of a chronic illness must be 
seen within the context of other life experiences.  Some chronic illnesses 
disproportionately affect women, such as osteoporosis, while men are more likely to be 
obese.   It is not uncommon for people to be living with more than one chronic illness 




For both men and women, living with an ongoing health challenge involves a 
reorganization of one’s life plan.  Chronic disease management is a strategy for patients 
and providers to work together to maintain or improve health and functional status while 
postponing or preventing functional decline (Bierman & Clancy, 1999; Lorig, 1996).  
New medications to manage symptoms and support active living can help patients 
continue with day-to-day activities rather than become housebound.  Support groups and 
other social outlets can help persons living with chronic conditions find others who can 
provide encouragement during stressful times.  As with many aspects of health care 
delivery in the U.S., however, there are challenges for chronic disease management at 
personal, social, and economic levels.  Some research suggests that women living with 
chronic illnesses report more symptoms and worse physical health than their male 
counterparts, as a result of differences in symptom interpretation, health-seeking 
behavior, and access to resources (O’Neill & Morrow, 2001).  Access to chronic care 
providers may also be different for men and women with the need to afford health care 
and child care options placing women at a disadvantage.  Thorne and colleagues (1997) 
have also noted that some men and women living with chronic illnesses may focus on 
different priorities according to socialized roles of paid work for men and family 
caretaking for women.  Additional research is also needed to fully understand how 
acculturation affects chronic disease management for men and women as well as how 
individuals learn to live with more than one chronic illness. 
 
Chronically ill persons often lack adequate health insurance coverage and pay more out-
of-pocket for care (Hwang, Weller, Ireys, & Anderson, 2001; Stroupe, Kinney, & 
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Kniesner, 2000).   One study by Reed and Tu (2002) found that nearly 63% of the 
uninsured with chronic health conditions have family incomes below 200 percent of the 
Federal poverty level; many of these families rely on publicly funded health insurance 
programs such as Medicaid.  However, providers may limit the number of Medicaid-
dependent patients in their caseloads or may refuse to see Medicaid-dependent patients 
altogether.   
 
HIV/AIDS-related services paid by Medicaid cover the care of nearly 50% of all persons 
in the U.S. with AIDS and 90% of children living with AIDS (Graydon, 2000).   In 
HCSUS, the only nationally representative study of 2,864 persons living with HIV/AIDS 
in care, 61% of women were covered by Medicaid as compared to 39% of men (Bozette 
et al., 1998).  Indeed, public sector insurance programs, including Medicaid and 
Medicare, have become two of the largest sources of financing for HIV/AIDS care in the 
U.S.  In fiscal year 2004, the Federal share of Medicaid HIV/AIDS-related spending was 
$5.4 billion; for Medicare, it was $2.6 billion (Kates & Leggoe, 2005).  The President’s 
fiscal year 2007 budget request for these same programs was $6.8 billion for the Federal 
share of Medicaid and $3.5 billion for Medicare.  Still, it is important to keep in mind that 
the number of people in need of these benefits is constantly growing, given that there are 
more than 40,000 new HIV diagnoses each year in the U.S., and fewer than 16,000 HIV-
related deaths (CDC, 2005b).  The potential per capita increase in public funding is thus 
relatively small.  Private insurance provides coverage for some 30% of all individuals 
with HIV/AIDS; of those with private insurance, only 26% who are covered have full-
22  
 
blown AIDS.  One reason for this latter figure is that many individuals with AIDS no 
longer work and don’t qualify for private employer-based health insurance coverage.  
 
Differences in healthcare-seeking behavior have been shown to vary by health insurance 
status, patient sex, race/ethnicity, income level, and perception of illness (Adamson, Ben-
Shlomo, Chaturvedi, & Donovan, 2003; Park & Buechner, 1997; Puentes-Markides, 
1992; Xu & Borders, 2003).  For example, a Kaiser Family Foundation Report by 
Salganicoff, Beckerman, and Wyn (2002) revealed that women often delayed seeking 
health care as a result of affordability concerns, logistical barriers, including lack of 
transportation; and competing needs of family members.  Several years later, in a 
separate issue brief, the Kaiser Family Foundation (2004b) noted that health disparities 
for women exist across several areas, including health status, health insurance, access to 
culturally competent health professionals, and access to ancillary services such as child 
care and transportation.  Women may have less access to purchasing coverage as a result 
of their own or their spouse’s work situation.  As a result of these disparities, some 
female workers are unable to access primary care services when illness progression is 
less advanced and treatment may be less costly. 
  
Given the increasingly disquieting statistics about disparate health care access and 
treatment, in 1999, the Congress charged the National Institute of Medicine (IOM) with 
addressing this issue through a careful review of the literature.  Review parameters 
included gender, insurance status, and individuals’ ability to pay for health care.  IOM 
experts were also requested to ponder explicit or subtle biases by healthcare providers 
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that might affect quality of care.  The resulting report, “Unequal Treatment: Confronting 
Racial and Ethnic Disparities in Healthcare,” uncovered consistent evidence of health 
care disparities across more than 100 studies in a number of disease areas and across a 
range of clinical settings, including public and private hospitals (IOM, 2002).   Although 
the present study is not directly addressing system-level disparities nor focusing primarily 
on race/ethnicity, the reader is reminded of their potential presence in the overall context 
of unequal care for HIV/AIDS patients. 
 
Historical Context of HIV/AIDS in the United States 
 
The first cases of what would later become known as AIDS were reported in the U.S. in a 
June 1981 Morbidity and Mortality Weekly Review brief (MMWR; CDC, 1981).  As with 
other scourges that had wide impact on social and political discourse, such as leprosy and 
tuberculosis, CDC scientists were tasked with understanding the epidemiology of the 
growing number of AIDS cases while trying to limit spread of new infections.  In the 
early 1980s, CDC scientists identified four at-risk groups that came to be known 
colloquially as the “4-H Club”: homosexuals, heroin users, hemophiliacs, and Haitians 
(Goldstein, 1997; Rodriguez, 1997).  In this classification system, women were not 
considered at risk.  The earliest group of women identified as being at risk was labeled 
with yet another “H” word - hookers.  The first heterosexual woman with AIDS was 
actually noted in the 1981 MMWR brief, while the first descriptions of 
immunosuppression in heterosexual injection drug users (IDUs) were published later that 
year.   Increasing evidence suggested that an infectious agent carried in the blood might 
be involved and that certain behaviors, including unprotected sex and injection drug use, 
24  
 
placed people at higher risk.  The isolation of HIV in a laboratory setting was eventually 
completed in 1984.   
 
Over the next ten years, HIV/AIDS increasingly spread from gay and more affluent 
populations into marginalized and impoverished sectors of society that almost always 
included some groups of women (Tiamson, 2002).  Still, for many years, HIV-positive 
women were typecast as vessels of contagion to innocent babies and male partners 
(Patton, 1993; Rodriguez, 1997; Smeltzer & Whipple, 1991; Zivi, 1998).  Other typecasts 
divided women based on their work as prostitutes; their lesbian orientation; or their 
substance-abusing behaviors (Patton, 1993).  The social construction of HIV/AIDS as a 
gendered epidemic has led some researchers to express outrage over the lack of 
recognition of symptom-specific conditions for women (Zierler & Krieger, 1997).  
During the first decade of the epidemic, the CDC did not change its AIDS definition to 
include any female-specific, HIV-related condition, despite growing evidence of 
increased incidence of vaginal candidiasis and cervical cancer among infected women.   
 
HIV-positive men were also stigmatized based on public fear around homosexual 
behavior, the practice of anonymous sexual encounters at bathhouses, and simultaneous 
use of drugs.  Misunderstandings about HIV transmission; disbelief about high profile 
celebrities who became HIV-positive, such as Rock Hudson and Magic Johnson; and 
mass media stereotyping led to confusion and, in some cases, the emergence of hate 
crimes.  Over time, mass media outlets altered their coverage of HIV/AIDS from a 
human-interest story among a small stigmatized group to one of hyped alarm among the 
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general population (Cook & Colby, 1992).  Political leaders were forced to address the 
epidemic, but not before social and grassroots advocates demanded answers for the lack 
of Federal attention and funds for research, education, and treatment.  In part, the Federal 
government’s slow response to the epidemic relied on scientists to present evidence-
based information that could be translated into programmatic action.  Policymakers’ 
unwillingness to change opinions about disease patterns, at-risk populations, and 
eligibility criteria for publicly financed early treatment also contributed to a delayed 
response (Rodriguez, 1997). 
 
The historiography of HIV/AIDS - from its early classification in 1981 as a twentieth 
century plague to its current classification as a manageable, chronic condition comparable 
to diabetes or heart disease - offers a compelling view of how social, political, and 
personal agendas influence public policy and public response.  The social contexts of 
HIV/AIDS transmission – sexual behavior and intravenous drug use – have both 
contributed to the shaping of HIV/AIDS history, as have intersections of gender, 
race/ethnicity, class, and culture (Goldstein, 1997).  Berger (2004) labels this 
phenomenon “intersectional stigma,” arguing that multiple layers of oppression and 
marginalization, particularly for women, may adversely affect access to care and basic 
survival.   Stigma notwithstanding, it is also possible for new ways of political and 
collective activism to emerge. 
 
It is clear from historical accounts that the changing conceptualization of HIV/AIDS care 
from an acute medical paradigm to a chronic illness model was motivated by a number of 
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heated debates around cost containment and HIV/AIDS-specific drug development (Fox, 
1992).   For example, when a number of NIH-funded drug trials were beginning to show 
promising results for slowing the progression of HIV infection, policymakers changed 
their statements about the duration of time from HIV infection to full-blown AIDS.  At 
the same time, HIV/AIDS was moving more quickly into disadvantaged populations, the 
same groups that had the lowest rates of health insurance coverage to pay for drugs that 
would slow the rate of disease progression.  Thus, the burden on policymakers was not 
only to support a more positive outlook, given new life-sustaining drugs for HIV- 
positive persons, but to reconcile this position with existing disparities in health care 
access and treatment.  This task has proved to be difficult and politically charged, with no 
easy solution.  In sum, although the biomedical construction of HIV/AIDS explains how 
the disease is transmitted from person to person, it is limited in its ability to defend 
unequal rates of access to early, comprehensive and coordinated treatment.  Given the 
history of longstanding inequalities, Fox (1992) argued that uncertainty in future funding 
for HIV/AIDS treatment, prevention, and research would continue for the foreseeable 
future.  Since Fox’s prediction in the early 1990s, funding for services through the Ryan 
White CARE Act has increased dramatically; however, access to care is still limited as a 
result of divergent eligibility policies, non-standard drug formularies across states, and 
relatively fewer dollars per capita to cover costly HIV-related medications through 
discretionary Ryan White CARE Act-funded AIDS Drug Assistance Programs 





HIV/AIDS and Disparities 
From incidence to prevalence and diagnosis to treatment, disparities are well-documented 
for persons affected by HIV/AIDS.  It is important to remember that sex/gender, 
race/ethnicity, and social class all intersect to affect HIV risk.  Women of color, 
particularly African American and Hispanic females, have been particularly affected; 
they comprise the majority of new AIDS cases among women.  The rate of reported 
AIDS cases among African American women is 25 times higher than among White 
women; for African American men, it is eight times higher than among White men.  
Among Hispanic women, the reported rate of AIDS cases is six times higher than among 
White women of non-Hispanic origin; among Hispanic men, it is three times higher than 
among White men (NIH, 2005). 
 
In 1985, women represented an estimated 8% of AIDS cases; by 2004, women made up 
27% of new HIV infections.  According to the most recent (2003) reports from CDC on 
the leading causes of death (National Center for Injury Prevention and Control, 2006), 
HIV/AIDS was the sixth leading cause of death among all women ages 25 to 34 and the 
fourth among all women ages 35 to 44.  In comparison, HIV/AIDS was the fifth leading 
cause of death among all men ages 35 to 44.  Among men of all races, ages 25 to 34, 
HIV/AIDS was also the sixth leading cause of death.  
 
Research suggests that there are sex/gender-based differences in HIV/AIDS vulnerability 
(Cohen, 1997).  These differences are both physiologically and socially grounded.  For 
example, experts acknowledge that women are physiologically at greater risk than men 
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for acquiring HIV from heterosexual intercourse (Ickovics & Rodin, 1992; National 
Institutes of Health, [NIH], 2003; Ward, 1993), while the practice of anal intercourse 
places men who have sex with men at an increased risk (Gross, 2003).  Social and 
cultural influences also place men and women at risk for HIV infection to different 
degrees (NIH, 2003; Rao Gupta, 2000; Zierler & Krieger, 1997).  Many clinicians and 
social researchers now understand that women are at increased risk for HIV infection if 
they lack empowerment to make self-protective health decisions, including those that 
affect sexual health and HIV risk reduction (Campbell, 1995; Monti-Catania, 1997; North 
& Rothenberg, 1993; Quina et al., 1997; Stevens, 1995; Stevens & Richards, 1998; 
Zierler, 1997; Zierler & Krieger, 1997).  For example, socio-economic constraints and 
gender inequality can play a role in women’s inability to negotiate safe sexual practices 
with their male partners (Bunting, 1996; Rao Gupta, 2000; Zierler & Krieger, 1997), as 
well as increasing the potential for engaging in illicit drug use and sex work, both of 
which have implications for HIV transmission.  Lichenstein, Laska, and Clair (2002), and 
others (Semple et al., 1993; Wiener, 1991) have observed that the lived experience of 
HIV/AIDS is different for women than for men, as shaped by social status and sexual 
norms (Schieman, 1998), and that these contexts affect access to care.  In male-
dominated hierarchies (often found in Hispanic cultures), women may feel unable to 
discuss self-protection before sexual encounters (Flaskerud & Calvillo, 1991; Kline, 
Kline, & Oken, 1992).  Ironically, many HIV prevention messages targeted to women 
assume that there is open and honest communication with sexual partners and that these 
women have substantial personal power in deciding self-protection and the timing of 
sexual activity.  In reality, these may be remote options.   
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AIDS Cost and Services Utilization Survey (ACSUS) and HIV Cost and Services 
Utilization Study (HCSUS) 
Much of what is known about HIV/AIDS health services utilization in the contiguous 
U.S. comes from two forerunner studies – the AIDS Cost and Services Utilization Survey 
(ACSUS) and the HIV Cost and Services Utilization Study (HCSUS).  ACSUS included 
data collected from 1991-1992 on a wide range of demographic, health, and economic 
variables for a sample of HIV-infected persons in care.  Purposive sampling was carried 
out in ten cities in the U.S. with high AIDS prevalence; the final number of patients 
included in ACSUS was 1,949.  ACSUS is an important pre-HAART source of 
information on health services utilization for HIV-positive individuals.  For example, 
using ACSUS data, Pezzin and Fleishman (2003) analyzed the association of inpatient 
and emergency department care with outpatient care and noted several key findings 
among a sub-sample of 1,243 ACSUS respondents.  First, patients with diagnosed AIDS 
had higher health services utilization rates than persons who had not developed advanced 
illness.  Also, individuals with drug abuse histories (24% of the sample) were more likely 
to have inpatient admissions than persons who were not injection drug users.  Significant 
differences by gender were not observed in the results; this may be because women were 
not oversampled in the study design and comprised less than 20% of the cohort.  This 
limitation is not an issue for the current study, as female adults comprise 30% of the 
patients in the HIV Research Network interview sample.   
 
In an ACSUS study addressing patterns of contact with health services over a 17- month 
time period from March 1991 to August 1992, Niemcryk and colleagues (1998) found 
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that utilization of a particular service – emergency room visit, hospital admission, 
outpatient care, dental care, substance abuse treatment, and counseling - was a strong 
predictor of subsequent use of that service.  Service utilization at time 2 (approximately 
three months after time 1 baseline) was the best predictor of service over the full study 
period for all services, except for dental care.  Again, women comprised less than 20% of 
the sample, making it impossible to run meaningful gender analyses.  The historically 
low numbers of women enrolled in general HIV-related studies limit understanding of 
sex/gender differences in study outcomes.  Among another sample of 1,449 ACSUS 
respondents, Fleishman, Hsia, and Hellinger (1994) also found that the experience of pain 
or functional limitations associated with HIV/AIDS can motivate patients to seek health 
services, particularly at emergency rooms.  
 
Since ACSUS, a great deal of knowledge about utilization of HIV/AIDS services has 
come from HCSUS.  Funded by a public-private partnership of Federal agencies and 
corporations, HCSUS examined a number of variables associated with HIV-related care, 
including cost, access, quality of care, unmet need, and knowledge of HIV therapies.  The 
core sample of the study consisted of 2,864 HIV-positive adults (age 18+), who came 
from 28 urban areas and 24 clusters of rural counties in the contiguous U.S, and made at 
least one visit for regular or ongoing care to a non-military, non-prison clinician other 
than an emergency room during the first two months of 1996 (note: one site had a study 
period that began in March 1996).  All data were collected using computer-assisted 
personal interviewing beginning in January 1996 and ending 15 months later, in April 
1997.  Data were weighted to correct for unequal probabilities of selection into the study 
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across patient and provider respondents, with oversampling for women and minorities.  
HCSUS was comprised of a core study and seven supplemental studies.  The core study 
addressed the following domains: cost, use, and quality of care; access to care; unmet 
needs for care; quality of life; social support; knowledge of HIV; clinical outcomes; 
mental health; and the relationship of these variables to provider type and patient 
demographics.  The supplemental analyses used data from the core study to look at HIV 
in rural areas; prevalence of mental illness and substance abuse, oral health, and issues 
related to HIV-positive individuals over age 50.  A baseline and two follow-up interviews 
at 6 months and 12 months after the baseline were completed.  Researchers continue to 
draw upon the HCSUS core study to understand health services use among HIV-positive 
persons and to use this dataset to answer questions about health services utilization 
among HIV-positive persons; however, reliability and validity tests of the survey 
instruments have not been carried out or published on the HCSUS core study (personal 
communication, J. Fleishman, Ph.D., June 20, 2006). 
 
Given the importance of HCSUS in learning about HIV/AIDS service utilization and 
trends, researchers developed several policy briefs early on to characterize findings from 
the data; numerous subsequent studies have been carried out, addressing specific research 
questions using HCSUS data.  Early findings illustrated many significant issues.  For 
example, almost 90 percent of the HCSUS sample was less than 50 years of age; 75% 
were male; 25% were female; nearly half were non-Hispanic White, and one third were 
African American.  Forty six percent had annual household incomes less than $10,000 
(RAND, 1999).  A subsequent HCSUS policy brief demonstrated systematic socio-
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economic differences in access to HIV-related care across the U.S.   For example, as 
early as 1996, 15% of HCSUS respondents had fewer than two outpatient visits during a 
6-month period.  Persons with private insurance or Medicare fared better than those with 
Medicaid or no health insurance (RAND, 2000).  Follow-up interview data at six and 
twelve months showed modest progress on some measures; however, the percentage of 
persons who had fewer than two outpatient visits per 6-month interval remained 
unchanged.   
 
Numerous articles have been published in peer-reviewed journals based on the HCSUS 
core study and follow-up datasets.  A seminal article by Shapiro and colleagues (1999) 
provided a comprehensive look at the disparities in care for HIV-positive adults based on 
HCSUS data.  Outcome measures included outpatient visits, emergency room visits, 
hospitalizations, and medication usage (receipt of antiretroviral therapy and prophylactic 
drugs for Pneumocystis carinii pneumonia [PCP], an opportunistic infection associated 
with AIDS).  Analyses were run with and without adjustment for CD4 counts.  Patients 
who had fewer than twelve years of education and who were uninsured or on public 
health insurance had poorer health outcomes at both baseline and follow-up.  Even with 
adjustment for CD4 counts, female patients, Black patients, and Hispanic patients were 
more likely than White male patients to have had at least one emergency department visit 
and less likely to have received antiretroviral therapy or prophylactic medication for PCP.   
Female HCSUS patients also had less routine patterns of care, though covariate 




Studies to date suggest that there are significant differences between HIV-positive 
women and men in care.  Shapiro and colleagues (1999) found that in data collected from 
the HCSUS sample of 2,864 HIV-positive men and women, the women were more likely 
to have visited the emergency department at least once and to have been hospitalized at 
least once during the preceding six months.  They were also less likely than men to have 
begun HAART therapy by the end of 1996 or to have taken prophylactic medication for 
PCP.  Another study based on the HCSUS sample found that HIV-positive women were 
less likely to receive HAART than HIV-positive men, when controlling for other 
demographics (Cunningham et al., 2000).  A third study by Andersen and colleagues 
(2000) based on HCSUS patients corroborated differences in early access to HAART by 
gender, race/ethnicity, and education level, with women, African Americans, and persons 
with less education facing greater challenges in getting early access to HAART.   In 
contrast, Turner and colleagues (2000) found significant differences by race/ethnicity but 
not by patient sex in delay of medical care following HIV diagnosis among two cohorts 
of HCSUS participants.  For purposes of this study, Turner and her colleagues divided 
HCSUS participants by time of diagnosis and integration into care: Cohort A (N=1540) 
was diagnosed by February 1993 and was in care within 3 years; cohort B  (N=1960) was 
diagnosed by February 1995 and was in care within a year of an HIV-positive diagnosis.  
This latter finding may reflect, in part, an increased understanding among clinicians of 
the necessity to move newly diagnosed patients into care as soon as possible.  
One important limitation of HCSUS is that data was collected between 1996-1998 and 
are now outdated, given changes in treatment guidelines for HIV/AIDS clinical care.  The 
cost of replicating the design of HCSUS with a new representative sample would be 
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prohibitive.  Instead, one alternative has been the creation of the Federally-funded HIV 
Research Network (HIVRN).  The HIVRN was created in 1998; following a pilot phase 
of development that included 15 sites, the Network now coordinates data from 17 U.S. 
clinical care sites serving more than 15,000 people living with HIV/AIDS.  The goal of 
the HIVRN is to provide timely information on health services utilization by persons in 
HIV care.  Information learned from studies using the HIVRN data is essential to 
understanding patient use of services in the post-HAART era.  The HIVRN adult patient 
interview dataset was the source of data for this dissertation.  More information about the 
HIVRN is provided in Chapter 3.    
 
There are mixed findings in the literature concerning disparities in HIV-related inpatient 
and outpatient utilization in non-HCSUS samples.  Mor and colleagues (1992) found that 
among 939 HIV-positive persons, there was a significant difference between men and 
women in the rate of outpatient health service use over a three-month period, with men 
having higher rates of outpatient use than women.  In contrast, researchers using now-
retired HIVRN data from calendar year 1999 found that women (24% of the sample, 
N=5,266) had higher rates of both outpatient and inpatient utilization than men at nine 
primary care sites across the U.S (HIV Research Network, 2002).  Finally, in a recent 
paper analyzing trends in HIV-related inpatient admissions from 1996-2000 across seven 
states, Fleishman and Hellinger (2003) noted that the proportion of inpatient admissions 
to total admissions was highest for Black men and lowest for White women, and that 
admissions for White males and for privately insured patients showed the largest decline 
over the 4-year study period.   
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Delays in seeking timely health care can have a negative impact on HIV-related health 
outcomes, including an increased number of opportunistic infections and hospitalizations 
and poorer quality of life (Bright, Arnett, Blair, & Bayona, 1996; McDonnell et al., 2000; 
Tsasis, 2000).  Moreover, lack of adherence to prescribed HAART regimens can lead to 
drug resistance and fewer options for alternative treatment courses (Cunningham et al., 
2000; Paterson et al., 2000).   Patients who do not adhere to their medication at least 80% 
of the time may experience less clinical benefit than patients who are adherent (Eldred, 
Wu, Chaisson, & Moore, 1998; Friedland & Williams, 1999).  Some evidence suggests 
that women seek care at later disease stages than men, yet they may encounter the same 
general barriers to care, such as lack of transportation and child care, as non-HIV-positive 
women (Butz et al., 1993; Mocroft, Gill, Davidson, & Phillips, 2000; Palacio, Shiboski, 
Yelin, Hessol, & Greenblatt, 1999; Raveis, Siegel, & Gorey, 1998; Stein et al., 2000).  
However, other studies suggest that with equal access to health care services, HIV-
positive women do not experience a difference in prognosis relative to men (Brettle & 
Leen, 1991).  Rather, the course of illness and length of survival appear to be 
significantly influenced by co-morbid illnesses and socio-economic conditions (Cohen, 
1997; Eldred & Chaisson, 1996).  More research is needed to understand health care 
accessibility and utilization patterns among HIV-positive men and women so as to 
minimize barriers that may impede entry into early treatment.   
 
The next section of this literature review addresses important aspects of the evolution of 
HIV/AIDS standards of care and treatment options, which continue to be unavailable to 
all patients in need. 
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HHS Treatment Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected 
Adults and Adolescents 
 
Early diagnosis of HIV infection is critical for appropriate treatment plans to be 
developed and implemented.  As previously noted, persons living with HIV/AIDS often 
have numerous medical, psychological, and social needs which can affect early access to 
and continuity of care.  Initial treatment options for persons infected with HIV included 
single drug regimens, such as the nucleoside reverse transcriptase inhibitor zidovudine 
(AZT), which quickly proved to be ineffective against the mutating nature of HIV.  Drug 
resistance was also an issue if and when patients failed to follow dosage 
recommendations consistently.  With the introduction of combination therapy (HAART) 
in 1996, clinicians had improved treatment options in their medical arsenal for HIV-
positive patients.  Currently, there are several recommended HAART regimens, with 
combinations drawn from four classes of antiretroviral drugs.  From a medical 
perspective, the Department of Health and Human Services’ “Guidelines for the Use of 
Antiretroviral Agents in HIV-1-Infected Adults and Adolescents” is considered one of 
the most reputable sources of current clinical knowledge for treating HIV-positive adults 
and adolescents.  The purpose of the Guidelines is to answer several core clinical 
questions about when to start treatment, what treatment combinations to use, and how to 
advise clinicians on optimal treatment goals for patients and special subpopulations.  
Recommendations are based on scientific evidence and experts’ opinion; this information 
is updated often on the HHS AIDSInfo website, http://aidsinfo.nih.gov/.    
 
In gauging when to start treatment, clinicians rely on two surrogate markers of viral 
activity – CD4 + T cells and viral load.  CD4 + T cells (the measure of which is referred to 
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in this document as “CD4 count”) are a type of white blood cell involved with the 
normally functioning human immune system.  A normal adult’s CD4 count is on the order 
of 1000 cells/mm3.   A CD4 count below 200 cells/mm3  is indicative of the substantial 
degree of immunocompromisation that is called AIDS; however, people with counts 
higher than 200 cells/mm3 may also experience AIDS-defining opportunistic infections.  
Viral load or plasma HIV RNA is an indicator of treatment response and signifies the 
number of viral copies/mL of blood, with a higher number of copies indicating more 
advanced illness.    
 
Some data indicate sex-specific differences in viral loads and CD4 counts.  Women may 
have lower levels of viral load at the time of infection and may progress to full-blown 
AIDS with lower viral load levels than men.  Other sex-specific clinical differences 
suggest that women are infected by multiple variants of HIV while men are not (NIH, 
2005).  HIV-positive women also exhibit a high risk for gynecological malignancies, 
including invasive cervical cancer and human papillomavirus infection (NIH, 2005).  
These factors notwithstanding, differences in treatment by sex are currently not supported 
by scientific evidence (nor were they in 2003 when the HIVRN adult patient interview 
data were collected); however, clinicians are advised to consider potential future 
pregnancy in women (HHS, 2005).  Some antiretroviral drugs can interact with oral 
contraceptives, increasing the chance of unplanned pregnancy, while other antiretroviral 
drugs can interfere with fetal development.  A primary clinical goal is avoidance of 
perinatal transmission, which has a greater chance of success with appropriate clinical 
intervention early in the pregnancy.    
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Although gender differences in HIV-related morbidity and mortality are well-
documented, many if not all of these differences can be attributed to co-occurring social 
and economic disparities and higher rates of co-morbidities such as hepatitis C 
(associated with injection drug use) and tuberculosis.  In addition, it is important to 
remember that both client and clinician characteristics can play a role in the initiation of 
and adherence to HAART regimens (Bird, Bogart, & Delahanty; 2004; Friedland & 
Williams, 1999; Malcolm, Ng, Rosen, & Stone, 2003; Palacio et al., 2000; Paterson et al., 
2000; Power et al., 2003; Roberts, 2002).  Clinicians who are more familiar with HAART 
regimens and potential side effects, and who are seen as trustworthy, can help patients 
adhere to medications.  In the meantime, clinicians and patients can benefit from 
coordination of care models, including those models built upon case management which 
have demonstrated promise to improve the quality of HIV/AIDS care.  These models are 
built around social support theory, which is described next.  
 
Social Support Theory 
Social support theory suggests that persons with established connections to others in a 
personal or professional network may be better able to cope with life changes and 
stressful situations, and they may have improved health outcomes (Thoits, 1982).  The 
conceptualization of social support varies extensively, with numerous multi-dimensional 
definitions provided in the peer-reviewed literature.  Cobb (1976) defines social support 
as information leading a person to believe that he or she is cared about; loved, esteemed 




Kaplan (1977) defined social support as the degree to which an individual’s basic social 
needs are met through interaction with others.   House (1981) suggests social support is 
an interpersonal transaction encompassing one or more of the following types of 
assistance: emotional concern, instrumental aid, information, or appraisal relevant to self-
evaluation.  This latter definition was adapted for the present study.  
 
Work by Vaux (1988) has delved into the theoretical definition of social support by 
looking at the constructs of networks, supportive behaviors, and subjective appraisal of 
support.  Networks focus on an individual’s social integration into a group, the number of 
people in that group, the frequency of contact among group members, and the kinds of 
relationships that members have with other members.  Social support networks are likely 
to evolve and go through some change over time (Kimberly & Serovich, 1996).  The type 
of support provided by a network may be emotional, instrumental, informational, 
financial, or a combination of any of these types.  Definitions of support types often vary 
from one research study to another.  In general, emotional support can be thought of as 
behaviors such as listening, caring, or offering companionship.  Instrumental support 
includes practical help such as assistance with obtaining services or other practical 
benefits.  Informational support is akin to advice or feedback that helps with decision-
making and may overlap with emotional support, whereas financial support encompasses 
the provision of funds (Schwarzer, Dunkel-Schetter, & Kemeny, 1994).   
 
Subjective appraisal connotes how persons perceive social support and their willingness 
to receive it from a particular source.  It is possible that support may be perceived 
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negatively in the context of social network demands and expectations (Coyne & 
DeLongis, 1986).  Some of these demands can be detrimental to health; for example, in 
active substance use circles, individuals may be “supported” by those who engage in drug 
use behaviors and encouraged to continue with these behaviors as part of group 
membership.  For some individuals, the cost of asking for and receiving support can be 
difficult; reaching out to others may be associated with a fear of rejection.   
 
Cohen and Syme (1985) note the importance of matching support to a specific need, the 
appropriate timing of support, positive and negative support features, and linking 
recipient and provider characteristics.  Social support provided by professional helpers, 
such as counselors and health care providers, may be characterized as non-reciprocal in 
nature, as compared to personal contacts in which informal support may follow a give 
and take pattern.  Research has shown that in many cases, the quality of social support is 
more important than its quantity (Hupcey, 1998).  Providers’ understanding of a patient’s 
health needs, previous experiences, culture, and other factors can influence whether a 
patient can benefit from a given type of support.  Patients who have a trusting ongoing 
relationship with their health care providers may be more likely to engage in health care 
decision-making and follow prescribed treatment (Friedland & Williams, 1999; Whetten 
et al., 2006).   For chronic illnesses, such as HIV/AIDS, the presence of formal social 
support through case managers can be particularly important for maintaining residence in 
the community and receiving services that meet the myriad of social and medical needs 
associated with chronic illnesses. 
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The next section of this literature review provides further background on the importance 
of social support for HIV-positive men and women.  The studies examined have a broad 
range of sample characteristics and findings. 
 
Social Support and HIV/AIDS 
Many researchers have noted that patients at every stage of HIV infection can benefit 
from social support to help deal with and adjust to the disease (Ciambrone, 2002; Hays, 
Chauncey, & Tobey, 1990; Kimberly & Serovich, 1996; Knowlton, Hua, & Latkin, 2005; 
Tsasis, 2000).  Social support may help reduce depression and anxiety, improve overall 
quality of life, and help with HIV-related medication adherence (Cox, 2002; Knowlton, 
Hua, & Latkin, 2005; Jia et al., 2004).  Immediate family and friends may be the first 
networks of social support that HIV-positive patients turn to; however, for some 
individuals, these sources are not available.  Patients may live far away from their 
families; moreover, family members and friends may be fearful about the social stigma 
associated with HIV/AIDS and keep their distance (Hays, Chauncey, & Tobey, 1990; 
Servovich, Brucker, & Kimberly, 2000; Turner-Cobb et al., 2002).  Some research 
suggests that sex/gender and mode of contracting HIV are predictive of social support 
networks that are most helpful, with family members being most supportive for women, 
male IDUs, and heterosexual men, and friends being most supportive for men who have 
sex with men (Smith & Rapkin, 1996) and lesbians (Kurdek & Schmitt, 1987).  HIV-
positive men and women who are IDUs have complex social support needs.  Family 
member ties may have been severed, and fellow drug users may comprise the primary 
support network.  Skepticism and mistrust of assistance available through formal sources 
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of support can be formidable hurdles to engaging HIV-positive injection drug users in 
care (Sorenson et al., 2003).     
 
Other studies have suggested that support systems can vary by age (Scrimshaw & Siegel, 
2003); culture (Ciambrone, 2002); and self-acceptance of sexual orientation (Gant & 
Ostrow, 1995).  Timing of different types of support is also important.  Tsasis (2000) has 
noted that informational support is helpful to all patients, particularly in the days 
following HIV diagnosis.  As HIV disease progresses, some evidence suggests that 
formal social support helpers, including hospice care workers and home health nurses, 
may be of greater importance to those who are infected (Tsasis, 2000).  Emotional 
support may be particularly needed for AIDS patients near death (Zich & Temoshok, 
1987).   
 
Given the focus in the present study on sex/gender differences, the following synopses 
address research findings from studies that have looked at the role of informal and formal 
social support in the lives of HIV-positive men and women.  Many of these studies draw 
upon social support provided by family members and friends.  More detailed findings 
from studies that address formal social support provided by professional helpers, 
including the association of case management with the use of clinical health care 
services, will be addressed later in this literature review in the Coordination of Care and 





Social Support and HIV-Positive Men 
A large body of social support research conducted in the early 1990s focused on HIV- 
positive men who had sex with men.  Many researchers utilized qualitative one-on-one 
interviews to learn about the breadth and depth of social support networks in small 
samples.  For example, among a sample of 25 gay men living with AIDS, Hays and 
colleagues (1990) found that social support networks were comprised primarily of other 
gay male friends, including persons who were also living with HIV/AIDS.  Friends most 
often provided emotional support, guidance, and shared experiences with other network 
members, whereas professional helpers provided limited informational support.   Only 
therapists and physicians were specifically named as sources of formal social support.  In 
a study by White and Cant (2003) looking at social networks among a sample of 30 HIV-
positive gay men, results indicated that emotional and instrumental support were most 
often provided by partners, ex-partners, friends, and family members; in this study, health 
care providers were not listed.  There are few studies that have addressed social support 
among HIV-positive heterosexual men; one study among a sample of 219 HIV-positive 
persons stratified by gender and mode of contraction found that heterosexual men 
perceived family members as more supportive than friends (Smith & Rapkin, 1996).  
 
Other social support research studies have included both male and female persons living 
with HIV/AIDS.  Kimberly and Serovich (1996) explored perceived availability of social 
support among 77 individuals living with HIV/AIDS in the Southwestern U.S.  These 
researchers hypothesized that friends would be perceived as more supportive than family 
members.  This was not found to be the case: both support systems provided comparable 
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levels of support.  The researchers also looked at whether the presence of a significant 
other would be positively associated with the perception of social support, as compared 
with HIV-positive persons who did not have an intimate relationship with a spouse or 
partner.  No significant association was found.  Of note, the number of women in this 
study was too low to carry out sex/gender analyses.  In contrast, Burgoyne and Saunders 
(2000) found that having partners and friends was associated with higher ratings of 
functional support (i.e., material aid), and emotional-informational support (i.e. 
expressions of understanding and caring) among a sample of 114 newly-registered 
outpatients at an urban HIV/AIDS clinic.  Generalization of study results was also limited 
by the low number of females who participated in the study.   
 
Social Support and HIV-Positive Women 
Several studies have examined the role of social support exclusively among HIV-positive 
women.  Many researchers note that HIV-positive women’s needs for social support may 
be different than those for HIV-positive men, given that women are often fulfilling other 
gendered roles as mothers and caretakers, and may be putting their own needs last 
(Andrews, 1995; Ciambrone, 2002; Gurung, Taylor, Kemeny, & Myers, 2004;  Heath & 
Rodway, 1999; Raveis, Siegel, & Gorey, 1998; Solomon & Cohn, 1996).  Serovich & 
colleagues (2001) studied perceptions of perceived and actual social support provided by 
friends and family members of 24 HIV-positive women.  Results showed that perceived 
social support, as opposed to actual social support, was negatively correlated with mental 
health indicators such as depression and loneliness.  Both family and friends were 
important sources of social support.  Perceived family support explained 56% of the 
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variance for depressive symptoms and 47% of the variance for loneliness in the past year.  
Although more information is needed on family structure and individual relationships 
within the family, these results suggest that the perception of family support may be 
critical to HIV-positive women’s mental health and well-being.    
 
In another study, Hudson and colleagues (2001) examined social support and level of 
distress among a sample of 104 ethnically diverse HIV-positive women in the San 
Francisco area.  Results revealed that race/ethnicity was not a significant predictor of 
perceived social support, and that friends were significantly more supportive than family 
members in reducing distress as measured on the Brief Symptom Inventory, a 53-item 
instrument designed to measure psychological symptoms across nine dimensions.  Of 
relevance to the present study, Hudson and colleagues (2001) note that the extremely 
high levels of perceived stigma among some HIV-positive women may affect their ability 
to reach out for the social support they need and cause delayed entry into medical care 
(Leenerts, 1998).  Health care providers, including case managers, may be in a position to 
fill some of the gaps in a non-judgmental setting to help HIV-positive women obtain 
services and follow treatment regimens.  Andrews (1995), a certified nurse-midwife, also 
documented the role of formal social support networks during interviews with three of 
her female HIV-positive clients.  Social support sources included doctors and nurses as 
well as 12-step group facilitators; the type of support provided ranged from emotional to 
informational.  Finally, in an exploratory study examining psychosocial needs of 12 HIV-
positive women living in Alberta, Canada, Heath and Rodway (1999) identified several 
important themes, including the need for informational support at the time of diagnosis; 
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the need for ongoing emotional support from family, friends, and health care providers, 
including counseling; and the need for practical (instrumental) support with child care.   
 
In almost all studies that address HIV-positive women’s social support needs, 
instrumental support issues, including child care and transportation, are noted.  These 
social support issues are not as prominently mentioned in studies to date addressing the 
needs of HIV-positive men.  Although study findings cannot be generalized until more 
research is completed, these early studies suggest that instrumental support may be 
particularly needed by HIV-positive women.  The next section of this literature review 
focuses on formal social support provided by case managers through the coordination of 
care model, and its potential link to outpatient care. 
 
Coordination of Care Model 
Levi and Kates (2000) state that “…HIV is a lens through which the underlying problems 
of the United States health care system can be examined.” (p. 1033)  Lack of coordinated 
systems, expensive drugs, and long delays in receiving care are some examples of how 
the current health care system is flawed.  For HIV-positive individuals, the need for 
coordinated systems of medical and ancillary services, also known as integrated HIV 
care, is especially critical to ensure that patients stay as healthy as possible (Soto, Bell, & 
Pillen, 2004).  Because HIV/AIDS was first characterized as a short-term illness, systems 
of care were based upon a crisis-oriented medical model with palliative care as the 
backbone of supportive services.  As previously noted, with the availability of HAART 
since 1996, the management of HIV/AIDS has evolved to follow a chronic illness 
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paradigm, with more outpatient management in the primary care setting.  In addition, the 
prevalence of HIV among women has continued to rise, with close to 30% of new 
infections now occurring among women.  Thus, sex/gender-specific targeted coordinated 
care models have become increasingly important.  These models are designed around 
services to provide supportive systems for patients and their families and the sharing of 
data to optimize coordinated services.  Health care provider training and support are 
important components of these models. 
 
In 2002, the Health Resources and Services Administration (HRSA), HIV/AIDS Bureau 
funded a project that looked at how collaborative systems of care could make a marked 
difference in care delivery, clinical outcomes, and cost containment (HRSA, 2002).   
Project findings focused on several models, including one promising framework that 
came to be known as the “Care Model.”  The components of this model included self-
management and adherence, decision support, clinical information system, delivery 
system design, organization of health care, and community.  All of these elements are 
accompanied by several strategies for their integration into the care setting that would 
support a holistic approach to patient care and support providers in their roles to deliver 
timely services based on current clinical guidelines.  Involving patients in developing 
their care plans provides an opportunity for empowerment and providing a voice in 
selecting services that best meet their changing needs.  Also of critical importance is the 
establishment of a clinical information system to keep track of patient characteristics, 
care planning and delivery, and connections with community resources, including case 
managers and mental health providers.   Leadership commitment to collaborative models 
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of care plays an important role in ensuring that improvements in health care delivery take 
hold and thrive while linkages with community groups serve to connect patients with a 
broader array of supportive and ancillary services.   
 
Other coordination of care models funded by the HRSA project included a “Learning 
Model,” which focused on bringing together hospital teams for 12 to 15 months for 
rigorous training on HIV/AIDS care within a coordinated system, and an “Improvement 
Model,” which defines how to test and implement changes in a clinic setting in a rapid 
and efficient manner.  Changes are then studied carefully and refined before they are 
broadly implemented into patient care delivery.  These latter two models focus more on 
developing innovations in the system of care, while the “Care Model” focuses more on 
identifying the interactive elements that should become part of a coordinated system. 
 
Coordinated systems of care are important to consider when policy and legislative 
decisions are being discussed.  In its second five-year reauthorization of the Ryan White 
CARE Act in 2000, Congress directed HRSA to commission a study by the Institute of 
Medicine (IOM, 2005) addressing current and future challenges of providing care and 
health-related support services for low income, uninsured, and underinsured persons 
living with HIV/AIDS.  To guide its work, the Committee on Financing and Delivery of 
HIV Care, which the IOM formed to conduct the study, put forth as its goal “…to 
improve the quality and duration of life for those with HIV and promote the effective 
management of the epidemic by providing access to comprehensive care to the greatest 
number of low-income individuals with HIV infection.” (p. 10) 
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After reviewing the literature and considering a variety of alternative strategies, the 
Committee recommended the establishment of a new entitlement program that would be 
fully funded by the Federal government but administered at the state level.  This program 
would be called the HIV Comprehensive Care Program (HIV-CCP – “the Program”) and 
would be available for persons whose incomes were below 250% of the Federal poverty 
limit.  Persons with higher incomes would be able to qualify through spend-down 
provisions, allowing them to deduct medical expenses from their incomes, while others 
would be able to participate by making premium payments.  Benefits through the 
Program would include HAART, obstetric and reproductive health services for women, 
mental health and substance abuse inpatient and outpatient treatment, case management 
services, HIV prevention services, and primary care services.  The Committee recognized 
the need to include coverage of ancillary services for co-occurring conditions – substance 
abuse and mental health – that are frequently associated with HIV/AIDS.  As previously 
noted, these co-morbidities can affect physicians’ decisions whether to prescribe HAART 
and patients’ adherence with treatment plans.  Interruptions in treatment can lead to the 
development of strains of HIV that are resistant to drugs.  Thus, care for co-morbidities is 
essential for the successful medical management of HIV/AIDS.  Further, case managers 
are specifically noted in the Committee’s report as a component of the move toward a 
comprehensive standard of care package for HIV/AIDS-affected patients.  The 
comprehensiveness of the Program would support continuity of care, the development of 
consistent access to treatment across the U.S., and a reduction of the public burden on 
Medicaid and CARE Act programs.1  
 
                                                 
1 These Program recommendations have not been adopted by the current Administration. 
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Case Management Model 
In addition to coordination of care models, many health services researchers and social 
service advocates believe in the value of a specific type of coordination framework, the 
case management model.  This model, as described earlier in this literature review, 
employs case management professionals to connect patients to medical and social 
services in the community.  The coordination of care tailored to each patient is believed 
to reduce costs, help patients receive needed services, and improve health outcomes 
(Kucera, 1998; Piette et al., 1992).  In this way, case managers can be seen as sources of 
formal social support that help patients remain in the community rather than in hospitals 
or other acute care facilities (Fleishman, Mor, & Piette, 1991; Piette et al., 1990).  To 
date, a number of research teams have published on the definitions and roles of case 
management in the HIV/AIDS health arena, while other groups have conducted studies 
looking at the association of case management with health outcomes.  These studies will 
be discussed below.  Some research has been done to examine the impact of case 
management on reducing unmet needs among HIV-positive persons (Ashman, Conviser 
& Pounds, 2002; Emlet & Gusz, 1998; Grube & Chernesky, 2001; Katz et al., 2001; Katz 
et al., 2000; Kucera, 1998; Messeri, Abramson, Lee, & Lee; 2002; Parish, Burry &  
Pabst, 2003).  An assessment of unresolved issues in HIV-related case management is 
provided to further support the focus of this dissertation. 
 
Case management models for HIV/AIDS have borrowed from similar models developed 
for other populations needing a continuum of coordinated services, including patients 
with mental health needs and geriatric populations (Corson, Grannemann & Holden, 
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1988; Rapp & Chamberlain, 1985).  Case management includes planning, arrangement, 
and delivery of services that are tailored to patient needs in cost-effective ways (Emlet & 
Gusz, 1998; Fleishman, Mor, & Piette, 1991; Kucera, 1998; Riley, 1992).  Often, case 
managers are part of multi-disciplinary community-based teams that ensure patients 
receive services such as transportation assistance, child services, home meal delivery, 
counseling, and preventive services (Fleishman, Mor, & Piette, 1991; Kirton, Ferri, & 
Eleftherakis, 1999; Piette et al., 1991).  Case managers may also encourage patients to 
adhere to drug regimens (Chernesky & Grube, 2000; Cox, 2002).  Case managers may be 
functioning either exclusively in these roles or in other formal roles in the health care 
system as nurses, clinical nurse specialists, or social workers.   
 
One set of HIV/AIDS case management clinical practice guidelines was developed by St. 
Coeur (1996).  Case managers can use these guidelines to develop care plans that fit 
patients’ needs over time.  These guidelines include the following: 
• Promotion of independence 
• Empowerment leading to informed decision-making 
• Prevention of HIV transmission to others 
• Nutritional status maintenance and improvement 
• Avoidance of hospitalizations 
 
• Utilization of community resources 
• Lessening of stress and feelings of isolation 
 
Chernesky & Grube (1999) have also done considerable work describing thematic 
statements and strategies behind the work of HIV/AIDS case managers and the types of 
activities they perform.  In their qualitative work describing the HIV/AIDS case 
management process, these researchers note that many case managers actively see 
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themselves as part of a client’s support system.  Helpful strategies include assisting 
clients with managing personal health, obtaining and maintaining entitlements and 
services, developing skills and support systems, and improving quality of life.   Other 
case management support functions include teaching clients about self-advocacy and 
behavior change, and empowering clients to find solutions to daily problems. 
 
Early studies addressing the role of case management with HIV/AIDS patients included 
work done by both Federal and non-Federal researchers.   In the late 1980s and early 
1990s, CDC and HRSA partnered to address how HIV prevention and early intervention 
services could be integrated into primary care settings at three community health centers 
located in cities in which the prevalence of HIV infection was particularly high: Miami, 
Florida; New York City, New York; and Newark, New Jersey.  Results of this small 
study that used a pre-post study design with 50 persons suggested that ongoing case 
management could assist clients in maintaining healthier lifestyles (CDC, 1993).  Since 
this early interest in case management in HIV/AIDS care, numerous other studies have 
been conducted; they will be summarized below. 
 
The proliferation of case management for HIV-positive individuals can be attributed in 
part to Ryan White CARE Act legislation and funding, which requires each state and 
Title I-funded (Part A) metropolitan area to design its own service delivery system 
(Chernesky & Grube, 2000).   Early work by Emlet and Gusz (1998) examined service 
use patterns among a group of HIV-positive patients receiving case management services 
between 1990-91 and 1994-95 in California.  During the study period, HIV care focused 
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primarily upon palliative services since few effective medical options were available.  
Services provided by case managers included attendant care, mental health counseling, 
in-home supportive services, and skilled nursing care.  For each service type, the mean 
number of hours of use per year increased across the five-year study period.  Results 
suggest that health and social service needs among HIV-positive patients can be 
particularly high when there is symptom deterioration and/or new symptom presentation.  
This study was carried out before the introduction of HAART in 1996.   
 
Fleishman, Mor, and Piette (1991) were pioneers in demonstrating that clients with case 
managers were more likely to have service needs met than those without case managers.  
In their study, patients who were unemployed, diagnosed with AIDS, and covered by 
public insurance were more likely to have case managers than patients who were 
employed, asymptomatic, and privately insured.  In addition, women were less likely than 
men to have case managers, as were patients with substance abuse problems relative to 
those without drug problems.  Race/ethnicity was not associated with having a case 
manager.  Moreover, the authors noted that more frequent contact with case managers– 
three or more times per month – resulted in more social service needs being met except 
for substance abuse treatment referrals and legal/financial assistance.  These services may 
require additional specialized interventions. 
 
Given differences in the services needed for women and men, several research teams 
have examined how case management can specifically help HIV-positive women and 
their families.  Magnus and colleagues (2001) evaluated the association between receipt 
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of ancillary services, including case management, and clinical and behavioral outcomes 
among a sample of 198 HIV-positive women in the New Orleans area between January 1, 
1997 and December 31, 1998.  After adjusting for age, CD4 count, substance abuse 
status, and other clinical indicators, researchers found that more than one case 
management contact per month was significantly related with improved retention in 
primary care (OR 2.63, 95% CI, 1.60-4.32), defined in the study as at least one clinic visit 
in the past six months.  Study participants who received more than one transportation 
service – a form of instrumental support – were also significantly more likely to be 
retained in primary care (OR 2.70; 95% CI 1.56-4.76).  Magnus and colleagues (2001) 
suggest that outpatient care for HIV-positive women must take into account their multiple 
social roles as well as the greater childcare demands on their time that can interfere with 
keeping scheduled medical appointments.  
 
In another study, Riley (1992) published a case review about an HIV-positive woman 
who received case management assistance in transitioning from jail into the community 
setting.  Case managers were instrumental in providing linkages to mental health care and 
reproductive health services.  In another descriptive study, Indyk and co-workers (1993) 
presented a chronology of a young HIV- positive Hispanic woman from the time of her 
case management intake to the time of her death.  The challenges she faced included 
communication barriers, child care needs, and confrontations with the health care system.  
Continuity of care and respect for cultural differences helped case managers make strides 
in meeting her needs.  Finally, Parrish and colleagues (2003) noted the particular 
challenges faced by a group of 200 HIV-positive African American women in finding job 
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training, housing, and food for themselves and their children.  Distrust of the health care 
system was one of the primary barriers to care. 
 
The role of case management services has also been examined in the HCSUS sample.  
Using this sample, Katz and colleagues (2000) assessed need and unmet need for 
supportive services and the impact of case management on unmet need.  Supportive 
services included benefits assistance, housing, home health care, emotional counseling, 
and substance abuse treatment.  With controls for demographics, results showed that 
clients who had had at least one contact with a case manager in the previous six months 
had less unmet need for all supportive services.  There was a dose-response relationship 
between the level of contact and unmet need, with more intensive contact being 
associated with less unmet need for home health care, emotional counseling and all needs 
taken together.  In a later study also using the HCSUS sample, Katz and colleagues 
(2001) looked at the association of case management with unmet needs and utilization of 
health services.  Women, persons from minority groups, IDUs, those with less education, 
those on public or with no insurance, and those with lower CD4 counts were more likely 
to have contact with a case manager.  They found that contact with a case manager was 
strongly associated with decreased unmet need for supportive services such as home care, 
emotional counseling, and financial aid.  HCSUS respondents who had contact with case 
managers were also more likely to have taken some specific two- and three-antiretroviral 
medication combinations between baseline and follow-up interviews; this finding 
suggests that case managers may play a role in helping patients overcome anxiety about 
drug treatment.  However, similar associations were not found between case management 
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and ambulatory care, hospital, or emergency department visit usage.  It is possible that 
case managers are effective in helping patients connect to short-term needs and to 
supportive services, but that receipt of certain optimal clinical services within the context 
of already challenging environments requires different interventions.  Also, patient and 
provider distrust, communication barriers, and limited clinical hours of operation may 
influence receipt of quality care (IOM, 2003).  The number of case managers was not 
addressed in this latter study.  One of the major limitations of the study is that the authors 
fail to draw attention to the finding that women, among other vulnerable groups, were 
more likely than men to have had a case management contact in the last six months.  That 
more women than men had contact with a case manager, while controlling for lowest 
CD4 count, suggests that case management involvement continues to change over time.  
Still, the benefit of case management as a predictor of outpatient care for both sexes was 
not seen, leaving this question open for further study.   
 
One recent study that looked at the association between sources of social support and 
clinical services use was conducted by Knowlton and colleagues (2005).  They found that 
among a sample of 295 African American HIV-positive persons (34% female) with 
injection drug use histories, access to the same medical care provider was associated with 
having greater numbers of females in one’s social support network and a larger number 
of network sources of emotional, financial and instrumental support.   Any use of 
outpatient services was significantly associated with having more female support network 
members and more sources of instrumental and emotional support.  The mean number of 
female support network members for this sample was 2.58 (SD= 1.61).  The researchers 
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controlled for several confounders, including patient sex, AIDS diagnosis, health 
insurance, and drug use.  Future studies should attempt to replicate the finding that there 
is a connection between outpatient service use and having more female members in one’s 
social support network, which may be indicative of social patterns of female caretaking. 
 
Other research teams have looked at the role that case management can play for 
individuals living with HIV/AIDS who have mental health and substance abuse issues.   
The co-occurrence of mental health and substance abuse behaviors with HIV/AIDS is 
well-documented.  Based on the national HCSUS sample of 2,864 adults, Bing and 
colleagues (2001) discovered that nearly half of the sample screened positive for a 
psychiatric disorder, 42% reported drug use other than marijuana, and more than 12% 
screened positive for drug dependence during the previous 12 months.  Case management 
for IDUs with HIV/AIDS may be particularly challenging, given that IDUs may not 
follow through on medical and social service appointments on a consistent basis.  
Sorenson and colleagues (2003) found that case management had a minimal effect among 
a sample of 98 HIV-positive patients with a history of substance abuse relative to a 
control group (n=92) that received a brief one-time educational and referral contact.  
Snyder and colleagues (1996) documented a unique approach to the case management of 
HIV-positive patients with substance abuse and mental health issues, whereby primary 
care, case management, and local/regional community experts were integrated into teams 
overseen by a physician.  This approach was based on the idea that innovative models are 
needed to attend to the primary diagnoses of mental health and substance abuse issues 
that may get overlooked in conventional care plans.    
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The contribution of case management and other ancillary services, including mental 
health treatment and substance abuse counseling to improving access to primary care, 
was the focus of a special 2002 supplement to the journal AIDS Care.  Articles in this 
supplemental issue focused on data collected at eight Ryan White CARE Act-funded sites 
beginning in fiscal year 1998.  Investigators were asked to address two primary questions 
of interest: whether clients’ receipt of ancillary services was associated with their entry 
into primary care in non-emergency room venues, and whether clients’ receipt of such 
services correlated with their retention in primary care.  Retention was operationalized as 
having at least one primary care visit every six months.  In addressing the study 
questions, authors were asked to include controls for client demographics such as 
race/ethnicity, gender, age, insurance, risk factor, and CD4 count at entry into care.   A 
summary of findings from several of these articles follows. 
 
Messeri and colleagues (2002) examined longitudinal data from 577 HIV-positive adults 
in New York City to identify the effect of ancillary services on entry into and retention in 
medical care.  Thirty nine percent of the sample was female; more than fifty percent of all 
clients were African American.  Among the findings were that case management, drug 
treatment, and mental health services exerted the strongest impact of any services studied 
on entry into medical care.  Medical care was operationalized in several ways – entry into 
care with any medical provider, entry into appropriate medical care (clinical services 
reflecting a set of preferred practice guidelines), continuity with any medical provider, 
and continuity in appropriate medical care.  The authors note that the potential to meet 
one type of need, i.e., housing, can exert further benefit on other needs, such as retention 
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in appropriate medical care.  Messeri and colleagues (2002) were able to see effects over 
time with their study with their longitudinal dataset. 
 
Another study by Sherer and colleagues (2002) in the AIDS Care supplement focused on 
HIV-positive clients receiving services between 1997 and 1998 at a Chicago primary care 
site.  Thirty two percent of clients were female; more than 70% of the total sample was 
African American.  Patients who received case management services (n=2,043) were 
more likely to be in regular care over a two-year period than patients not receiving case 
management in both years.  Women in this study were significantly more likely than men 
to need case management, transportation, mental health and substance abuse services.  
Receiving mental health services was significantly associated with receipt of regular care.  
However, patients who received substance abuse counseling were less likely to receive 
regular care in this study.  This finding raises the issue of matching needs to services, 
which can change unpredictably for HIV/AIDS patients.  It is possible that patients in 
crisis require more services than are available at any given time.  It is also interesting to 
note that gender and racial/ethnic disparities continued to exist in this study despite the 
availability of free services.  
 
A third study by Ashman, Conviser, and Pounds (2002) in the AIDS Care supplement 
addressed the association of ancillary services with receipt of primary care at six 
geographically diverse Ryan White CARE Act-funded sites.  Results showed that 73% of 
clients overall received case management services, while fewer than 20% received 
substance abuse counseling.  Mental health treatment/counseling was received by 28% of 
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clients.  Controlling for demographic variables, the receipt of ancillary services was 
associated with the receipt of any primary medical care from a safety net provider.  
Among clients with provider-identified mental health needs, those who received case 
management were 1.8 times more likely to receive mental health services than those not 
receiving case management.  Also, clients with provider-identified substance abuse needs 
were 2.3 times more likely to receive substance abuse treatment if they had also received 
case management services.  Of note, receipt of mental health and substance abuse 
counseling and treatment was significantly associated with patients’ retention in primary 
care.  
    
Coordinated HIV/AIDS services continue to evolve and change within and across 
communities (Conviser & Pounds, 2002).  The reduction in fragmented services and 
retention in primary care through a coordination of care model that includes case 
management and other ancillary services has shown promise and has been endorsed by 
the IOM (2005); however, many of these services are vulnerable to funding cuts during 
periods of budget constraints, leaving behind a rationing of services that limits benefits to 
persons in need.  As a result, researchers continue to be tasked with documenting all 
findings and explaining in great detail how specific cost-saving coordinated services save 
lives.   
 
Summary  
The aforementioned synopses of HIV-related case management research illustrate several 
weaknesses in the literature.  Of critical importance is the lack of consensus on a standard 
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definition of HIV-related case management that can be used as a basis for practice and 
reimbursement (Chernesky & Grube, 1999; Snyder, Kaempfer, & Ries, 1996).  
Additional information is also lacking on those specialized functions and referral systems 
that may be needed to best assist clients at varying stages of HIV infection (Piette, 
Fleishman, & Mor, 1992).  Patients in later stages of HIV/AIDS may require more 
emotional and instrumental types of social support than newly diagnosed HIV-positive 
patients who may need more basic informational types of support (Heath & Rodway, 
1999).  A definitive recommendation on which types of support are most needed at 
different stages along the HIV/AIDS trajectory, and whether the recommended services 
vary by patient sex has yet to be published; at the same time, there are few studies in the 
literature that address this topic in the post-HAART era.  Moreover, the likelihood of 
having a case manager continues to evolve alongside the changing demographics of the 
HIV/AIDS epidemic.  Early studies suggested that patients who had more advanced 
illness were more likely to seek out or be referred to case managers (Emlet & Gusz, 
1998; Fleishman, Mor, & Piette, 1991).  In contrast, some case managers today are more 
involved with patients at earlier stages of illness to assist with disease self-management, 
prevention, and other chronic care issues (Chernesky & Grube, 2000; Mitchell & Linsk, 
2001).  It is not clear whether all asymptomatic HIV-positive patients are more likely to 
have case managers now, or whether patient sex plays a defined role in this picture 
(Indyk et al. 1993; Parrish, Burry, & Pabst, 2003).  Kenagy and colleagues (2003) found 
that among a sample of 161 HIV-positive men and women, 81% had someone 
coordinating their care; of this number, a slightly higher percentage of women (72.7%) 
than men (69.3%) had a case manager.  There may be times when patients are more 
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connected to other individuals in their social support networks and may not need case 
manager assistance.  Among those without a case manager, two possibilities emerge:  
some clients need a case manager but do not have one, while others do not need a case 
manager and don’t have one.  The latter scenario may represent patients who are healthier 
or have other stable support systems in place to help them navigate medical and social 
service care.  In the present study, several variables that serve as proxies for health status 
were controlled in an effort to see whether “healthier” patients had more or less access to 
formal social support through a case manager.   
 
Across numerous studies, cultural sensitivity training provided for case managers and the 
types of services offered vary significantly.  Some assume that case managers are 
providing administrative, linkage, and referral services, whereas some studies have 
shown that a greater proportion of time is spent in a formal social support/counseling role 
(Grube & Chernesky, 2001).  Although the administrative side of a case manager’s job is 
important, it is the interpersonal interaction that can help patients feel less alone and 
isolated, and consequently more likely to follow through with outpatient visit 
appointments.  This formal social support component of a case manager’s job was a key 
focus of this study.    
 
Another important factor to understand regarding case management as a source of formal 
social support concerns the characterization of HIV/AIDS as a chronic illness requiring 
an array of medical, psychological, and social interventions.  This comprehensive 
approach to HIV care has not been fully integrated into policy and practice in all parts of 
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the U.S.  This may be a result of outdated perceptions of case managers as providing only 
palliative care for HIV-positive patients, as well as a shortage of funds and expertise to 
implement coordinated systems of care.  Even within clinic settings in which case 
management exists, the activities of a case manager are determined largely by the 
structure and mission of the site as well as caseload distribution (Indyk et al., 1993; 
Piette, Fleishman, & Mor, 1992).  Moreover, extended periods of case management 
inactivity are common in both metropolitan and rural cities.  Patients may be entitled to 
and have the need for services that are beyond the scope and reach of a particular 
geographic or service site.   
 
The relationship between case management as a source of formal social support and 
utilization of outpatient care and other clinical care services in general remains 
undetermined.  Some studies have found that case management is associated with use of 
some clinical care services, while other studies have shown no association.  Nationally 
representative data from HCSUS failed to show a significant association between receipt 
of case management services and clinical care (Katz et al., 2001), whereas smaller studies 
with local data have shown some promising associations with retention in primary care 
(Ashman, Conviser, & Pounds, 2002; Chan, Absher & Sabatier, 2002; Magnus et al., 
2001; Messeri et al., 2002 ).  In theory, the supportive and referral services provided by 
case managers should assist patients with managing their illnesses outside of acute care 
facilities.  Other factors may interfere with this scenario; for example, many HIV-positive 
female patients often have multiple other responsibilities, such as the unpredictable needs 
of children and partners that may take priority on any given day (Raveis, Siegel, & 
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Gorey, 1998).  Patients may also encounter system barriers and provider bias, both of 
which affect access to equal treatment (IOM, 2003).  Further studies are needed to learn 
more about the relationship between case managers as a source of formal social support 
and the use of outpatient care by HIV-positive men and women.  This study contributed 
to this goal. 
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Chapter 3: Data and Methods 
The purpose of the present study was three-fold:  1) to determine if the receipt of formal 
social support predicts the level of HIV/AIDS-related outpatient care visits among a 
subset of 797 individuals living with HIV/AIDS in the U.S.; 2) to determine if the 
intensity of formal social support (number of in-person contacts) predicts the level of 
HIV/AIDS-related outpatient care visits; and 3) to determine if the type of formal social 
support predicts the level of HIV/AIDS-related outpatient care visits.  Because of the 
student researcher’s particular interest in sex/gender differences, if patient sex was shown 
to be a significant covariate when testing any of the above three study goals, the cross-
product of the variables “patient sex” and “social support” would be created and added to 
the multivariate models to determine if there was an interaction between these variables 
that was associated with levels of HIV/AIDS-related outpatient visits.  As previously 
noted, an Analytic Model (see Figure 2) was developed as a framework for examining the 
hypothesized relationships between the study’s independent variables and the primary 
outcome variable.  The outcome to be examined was HIV/AIDS-related outpatient care 
visits, which was operationalized in this study as follows: 2-5 visits (average use) and 6+ 
visits (high use).  The primary independent variable (Enabling Resource) examined was 






For purposes of this study, formal social support was defined as having up to two case 
managers in the last six months.  The primary covariate of interest to be examined was 












Figure 2.   Analytic Model [Based on Behavioral Model of Health Services Use, Andersen, R.M. 
(1968, 1995)]. 
 
For the purposes of this study, and as adapted to the HIVRN sample, other Predisposing 
covariates included race/ethnicity and age; other Enabling Resources covariates  
included access to health resources (education, insurance, employment), availability of 
informal support (living arrangement); and other Need for Services covariates included 
stage of illness (CD4 nadir, change in health status); health-related quality of life 
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Specifically, it was hypothesized that:  
Hypothesis 1- Patients with formal social support will have more HIV/AIDS-related 
outpatient care visits as compared to patients without formal social support. 
 
Hypothesis 2 - Level of HIV/AIDS-related outpatient care visits will not be associated 
with levels of intensity of formal social support.  
 
Hypothesis 3a - Increased instrumental formal social support will be associated with 
increased levels of HIV/AIDS-related outpatient care visits.  
 
Hypothesis 3b - Increased informational formal social support will not be associated with 
increased levels of HIV/AIDS-related outpatient care visits.  
 
If patient sex was shown to be a significant covariate in tests of any of the above three 
study goals, the cross-product of the variables “patient sex” and “social support” would 
be created and added to the multivariate models to determine if there was an interaction 
between these variables that is associated with levels of HIV-related outpatient visits.  An 
interaction was expected for Hypotheses 1 and 3a.   
 
This chapter describes the sample and the HIVRN adult patient self-report interview 
instrument.  The majority of the items in the HIVRN adult patient interview ask  
patients to use the immediate past six months as a reference period for providing 
responses.  Data in this study came from interviews conducted in 2003 with a stratified 
random sample of 951 individuals receiving HIV/AIDS-related care at a convenience 
sample of fourteen clinics in the U.S.  Study protocol and data analysis procedures are 






Data Source – The HIV Research Network (HIVRN) 
At the time of the interviews, the HIVRN was funded by four entities within the U.S. 
Department of Health and Human Services: the Agency for Healthcare Research and 
Quality, the Health Resources and Services Administration, the Substance Abuse and 
Mental Health Services Administration, and the Office of AIDS Research at the National 
Institutes of Health.  The principal goal of the HIVRN is to offer timely information on 
utilization of health services by HIV-positive individuals and to study disparities in health 
care service receipt and trends in usage over time.  The HIVRN has some similarities 
with HCSUS, but unlike HCSUS, its patient sample is not nationally representative of 
persons living with HIV/AIDS.  For the HIVRN, client-level data, including clinical and 
patient demographics; medications prescribed; and inpatient, outpatient, and emergency 
room services are abstracted from the records of 17 high volume providers of HIV 
treatment across the U.S. and submitted to a Data Collection Center at Johns Hopkins 
University Medical Center (JHU) in Baltimore, Maryland.  JHU has been the Data 
Coordinating Center since the HIVRN was founded in 1998.  Data are sent from 
participating sites to JHU approximately every six months, lagged 9-12 months behind 
the half-year for which data are being submitted.  JHU staff review and enter 
standardized clinical data from the HIVRN sites into a uniform database.  While the 
complete dataset is not available for public use, some of the data are available on the 
AHRQ website.  Although the HIVRN dataset is not representative of HIV care provided 
across the U.S., early analyses have shown similarities between its findings and those 





Table 1: Comparison of HCSUS and HIVRN Populations 










%  N % 
Age4                 
18-34 67,035,178  23.8 987 34.0 79,100 34.0  79 8.0 
35-49 65,240,931  23.2 1,591 55.0 125,900 54.0 596 63.0 
>= 50 76,851,985  27.3 286 10.0 26,400 11.0 269 28.0 
Missing        7   
Sex5                 
Male 100,994,367  35.9 2,017 70.0 179,200 77.0 648 68.0 
Female 108,133,727  38.4 847 30.0 52,200 23.0 303 28.0 
Race/Ethnicity
1                 
White 211,460,626  75.1 1,399 49.0 114,000 49.0 294 31.0 
Black, not 
Hispanic 3,458,190  1.2 959 33.0 75,800 33.0 491 52.0 
Hispanic or 
Latino 35,305,818  12.5 415 14.0 34,200 15.0 130 14.0 
Other   91 3.0 7,400 3.0 36 4.0 
Marital Status4                 
Married 115,796,000  41.1 39 1.0  N/A N/A 95 10.0 
Separated 4,547,000 1.6 106 4.0  N/A N/A 70 7.0 
Divorced 20,895,000  7.4 281 10.0  N/A N/A 142 15.0 
Widowed 14,036,000  5 102 4.0  N/A N/A 34 4.0 
Never Married 51,143,000  18.2 1,135 40.0  N/A N/A 553 58.0 
Missing  N/A   1,201 42.0  N/A N/A 54 6.0 
Education6                  
Less than HS 28,794,775  10.2 724 25.0 57,700 25.0 244 26.0 
HS Diploma or 
GED 59,906,752  21.3 805 28.0 63,500 27.0 569 60.0 
AA Degree, 
Junior, 2 year 
college 
35,847,343  12.7 809 28.0 65,600 28.0  N/A N/A 
Bachelors or 
higher 46,577,126  16.6 526 18.0 44,600  19.0 127 13.0 
Missing   N/A   1       
                                                 
1 Census 2000 Summary File 1 - Total Pop 281,421,906. 
2 HCSUS Baseline Public Use Dataset does not include age to protect privacy. Numbers have been copied from seminal 
article by Shapiro et al (1999). Variations in the Care of HIV-Infected Adults in the United States; N for HCSUS Baseline is 
2864. 
3 Age categories used in Shapiro et al, 1999. 
4 March 2002 CPS. 




Table 1: Comparison of HCSUS and HIVRN Populations (cont.) 










%  N % 
Insurance 
Status8                  
None 43,574,000  15.5 597 21.0 45,700 20.0  35 4.0 
Medicaid 33,246,000  11.8 858 30.0 67,600 29.0 435 46.0 
Medicare 38,448,000  13.7 544 19.0 44,300  19.0 319 34.0 
Private 
insurance 198,973,000  70.7 391 14.0 38,200 15.0 162 17.0 
Private HMO  N/A    474 17.0 35,500 17.0  N/A N/A 
 
In the pilot phase of the HIVRN, data on HIV-positive patients’ resource use was 
collected for the first six months of 1998 and for calendar year 1999 among 15 sites.  
Remuneration to the sites was low ($5,000 to $10,000 per site per year), leading to 
insufficient resources at some sites to provide complete data.  This pilot database has 
been retired.  Site interest, location, management information, and system capacity were 
key to the selection of additional HIVRN sites in 2001.  Under a new contract, payments 
to sites increased to a minimum of $50,000 per year, and data submission requirements 
were better defined.  Each potential site provided an overview of what data elements 
could be abstracted; these overviews were ranked as “A,” “B,” or “C.”  Most 
participating sites were ranked "A" or "B" by JHU (the Data Collection Center).  No 
other formal proposal was required, although the sites were and continue to be visited to 
ensure they remain capable of providing the data agreed to in their contracts with the 
Data Collection Center.  Sites are located across the contiguous U.S. and include urban 
and rural settings at both academic and community-based centers. 
                                                 
6 Census 2000 Summary File 1 - Total Pop 281,421,906. 
7 HCSUS Baseline Public Use Dataset does not include age to protect privacy. Numbers have been copied from seminal 
article by Shapiro et al (1999). Variations in the Care of HIV-Infected Adults in the United States; N for HCSUS Baseline is 
2864. 
8 CPS 2002-2003 Annual Social and Economic Supplements. 
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An HIVRN patient interview component was explored beginning in 2001.  This 
component was important because if patients had been obtaining any of their care at  
sites outside the HIVRN, information about that care would not have been in the 
HIVRN’s clinical data set.  Also, patient-level interview data provides a more 
comprehensive picture than is available through clinical data of patients’ use of HIV 
medications and other services.  Other important variables in the patient interview (but 
not in the clinical data set) address satisfaction with care, health-related quality of life, 
and receipt of home health services.    
 
Sampling Frame 
In 2003, JHU subcontracted with Battelle, a survey research company, to conduct patient 
interviews with a sample of HIVRN adult patients, stratified by provider site, ethnicity, 
and sex, with intentional oversampling of Hispanics and women.  At the outset, random 
samples from de-identified patient lists at 14 sites were drawn.  All provider sites in the 
HIVRN able to receive local IRB approval contributed proportionally to the interview 
sample; a minimum of 25 patients was sampled from each patient care site.  In the 
process of patient recruitment, several challenges were encountered including general 
privacy regulations around collecting sensitive information.  After patients were selected 
from this randomization process, contact information was linked to each patient, and 
study staff sent out 5,363 invitation letters.  Non-response was a significant issue as were 
incorrect addresses.   See Figure 3 for more details about the sampling for the HIVRN 
adult patient interview.  All patients, regardless of whether they were recruited by mail or 
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from waiting rooms, were interviewed face-to-face at the HIVRN site at which they 












951 HIV-positive Adult  
Patient Interviews 
4,412 no response  
717 interviews from mailing 
234 interviews from patient 
intercept in waiting rooms 
14 HIVRN U.S. Adult  
Care Sites 
5,363 letters mailed  
Figure 3. HIVRN Adult Patient Interview Sampling, JHU Original Data Collection. 
 
The patient interview was pilot-tested on a random sample of ten patients at the Johns 
Hopkins HIV/AIDS Clinic, Baltimore, Maryland.  Pilot test questions were created by 
Federal partners based on HCSUS questions.  Patients were recruited from clinic waiting 
rooms and received $30 each for their participation.  Patients under 18 years of age and 
those who were intoxicated at the time of the interview were ineligible.  (A subsequent 
interview tool was developed for pediatric and adolescent patients, and/or their 
caregivers; interviews were conducted in 2004 at the four HIVRN sites whose patients 
were largely or exclusively in younger age cohorts).  The HIVRN adult patient interview 
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instrument did not change significantly from the pilot test version.  Following the pilot 
test period, informed consent was given in writing by each patient before interviews took 
place.  Battelle followed an approved protocol for collecting patient-level data.  Similar 
to the pilot test participants, patients had to be at least 18 years of age and sober at the 
time of the interview to be included.  Interviews were conducted one-on-one with 
patients, and answers were recorded on interview forms.  Interviews with each patient 
were completed in one session.  Patients could refuse to answer any question and could 
stop the interview at any time.  Excerpts of the protocol are available upon request from 
AHRQ.  To date, there have been no tests of reliability and validity with the HIVRN 
adult patient interview questions.    
 
Figure 4 provides a flow chart for the sampling frame for the current study.  As noted 
below, patients with three or more case managers were excluded.  Also, due to low 
frequency, patients who self-reported their race as American Indian/Alaska Native (n=6); 
other single race (n=20); or Asian/Pacific Islander (n=1) were excluded.   Patients who 
had 0-1 outpatient visits were also excluded because of low frequency (n=67).  More 





















6 AI/AN; 20 other single race; 1 
API; 9 missing race/ethnicity; 
44 patients with 3 or more case 
anagers; 67 0/1 outpt. vism its 
 
 
391 patients with  
1 case manager 
83 patients with 2 
case managers 
323 patients with no 
case manager 
Figure 4. HIVRN Adult Patient Interview Sampling Frame, Current Study. 
 
HIVRN Data Use Permission 
The student researcher met in person with clinical managers Drs. Richard Moore and 
Kelly Gebo of the HIVRN Coordinating Center at JHU, Baltimore, Maryland, on  
June 16, 2004.  Dr. Richard Conviser, a member of the student researcher’s dissertation 
committee and then HRSA project officer for the HIVRN study, was also present.  The 
purpose of the meeting was to obtain permission to use the HIVRN adult patient 
interview data for dissertation purposes only.  Following this meeting, the student 
researcher signed a confidentiality statement with JHU.  A signed confidentiality 
statement between the student investigator and JHU dated August 2, 2004 is included in 




A hard copy of the full set of the patient interview questions was shared with the student 
researcher as well as a diskette with the requested data in the Statistical Package for the 
Social Sciences software (SPSS) format.  A copy of the HIVRN adult patient interview is 
included in Appendix B.  All patient identifiers, including site ID and names of health 
care clinics or hospitals, were removed from the dataset provided to the student 
investigator.  Based on the full HIVRN adult patient interview, a codebook with specific 
information on variables used in the present study was developed; the codebook is 
included in Appendix C.  An IRB package was submitted to the University of Maryland, 
College Park Human Subject Review Committee in September 2004.  A copy of the 
approved application, dated October 22, 2004, is included in Appendix D.  A copy of the 
approved JHU IRB documents and patient informed consent forms are included in 
Appendix E.  
 
Variable Construction and Measurement 
A. Dependent Variable 
HIV/AIDS-related Outpatient Care Visits 
The dependent variable in this study was the level of HIV/AIDS outpatient care visits in 
the last six months.  Virtually all HIVRN patients self-report they have a regular source 
of care, but the number of outpatient care visits may differ.  McNeil, Sheffield, and 
Bartlett (2004) note that seeing patients every three months allows for routine medical 
evaluation and monitoring of physical health; however, some patients may require more 
visits if they experience complications with medications, co-occurring health issues, and 
unpredicted health changes.  Provider characteristics may also influence the number of 
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outpatient visits; this information is not available for this study.  To assess this dependent 
variable, the number of outpatient visits reported over the last six months was categorized 
as follows:  2-5 visits (average use); and 6+ visits (high use).  Overall, the number of 
visits in the sample ranged from 0 through 86, with a mean of 13.24 visits; a median of 5 
visits, and a multimodal distribution at both 2 and 6 visits.  Outliers were assessed by 
checking standardized residuals >1.96 at the .05 level.  If outliers comprised less than 
five percent of the data, they were deleted in multivariate analyses so that they did not 
bias results. 
 
B. Primary Covariate 
Patient Sex 
Patient sex continues to play an important role in access to appropriate HIV/AIDS-related 
care.  In the original data collection, interviewers recorded patient sex; this was not a self-
reported item.  The response options for this item were “male” and “female.”   For the 
purposes of this study, the respondent’s sex was coded as “1” for female and “2” for 
male.   
 
C.  Primary Independent Variable: Formal Social Support  
Scope 
A variety of different measures have been used in research to date to define case 
managers (i.e., providers of formal social support).  HCSUS researchers have defined a 
case manager as “a social worker, nurse, AIDS service organization staff member, staff in 
other service organizations, or anyone else who is assigned to help you get and 
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coordinate care.” (Katz  et al., 2001).  Chernesky and Grube (1999), two leaders in the 
field of HIV/AIDS case management, define case managers as individuals who help 
HIV-positive persons with the supportive services required to maintain a reasonable 
quality of life.  As operationalized in this study, the definition for a case manager or case 
worker provided to HIVRN adult patients from the interview instrument is as follows: 
“…a professional in a medical or social service agency who helps you to arrange for 
services or programs you need.” (p. 56)  The similarity of these case manager definitions 
suggests a reasonable argument for face validity.  To the best of the student researcher’s 
knowledge, other types of validity for case management have not been addressed. 
 
HIVRN adult patients were asked if they have a case manager and how many case 
managers they have had in the last six months.  Patients who have one or two case 
managers were coded “1”; patients who do not have a case manager were coded “0.”  
Patients who have three or more case managers were not asked further questions about 
number of visits and types of referrals/services provided, and they were excluded from 
the study.   
 
Intensity  
The literature suggests that a connection with a case manager has some benefit on in 
reducing unmet need (Katz et al., 2001).  HCSUS patients who had at least one contact 
in-person or by telephone with their case manager in the previous six months had less 
unmet need for several supportive services; however, similar associations were not found 
for patients who had case manager contact(s) in their use of outpatient care, inpatient 
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hospitalization, or ER usage during the last six months (Katz et al., 2001).  Of note, 
HCSUS data were collected during the period that HAART was becoming the standard of 
care in 1996.  The HIVRN adult patient interview data, which were collected in 2003, 
may offer new information on this issue.  To assess intensity of formal social support for 
the present study, the number of in-person contacts, a continuous variable, was used.  The 
variable measuring in-person contacts for this study was the sum of the number of visits 
for patients with one case manager plus the number of visits for those patients with a 
second case manager.  
 
Type 
Formal social support provided by a case manager may be of several types.  For the 
purposes of this study, the two types of social support considered include informational 
and instrumental.  Informational support was operationalized in terms of the number of 
positive responses to the following two items: personal advice provided by a case 
manager, yes =1, no=0, and advice about HIV-related medications, yes=1, no =0.  
Instrumental support was operationalized on the basis of the following three items, 
summed to form a score:  referral to medical services, yes=1, no=0; referral to social 
services, yes=1, no=0; and/or help with filling out forms to obtain benefits, yes=1, no=0 
(overall summative instrumental support score range 0-3).  Because this study was 
interested in addressing the individual type of formal social support provided across up to 
two case managers, rather than being assigned an overall formal social support score, 
each patient had a summative score by type of support (0-4 for informational support, and 
0-6 for instrumental support).   
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D. Other Covariates 
D.1 Other Predisposing Covariates 
Race/Ethnicity 
Respondents’ race and ethnicity is important to consider in any health study because of 
well-documented disparities on the basis of this socially constructed demographic.  
HIVRN adult patient interview respondents self-report their race/ethnicity in eight 
different categories.  For descriptive purposes only, initial recoded categories 
corresponded to CDC’s race/ethnicity reporting system for adults living with HIV/AIDS.  
These include White, not Hispanic; Black, not Hispanic; Hispanic; Asian/Pacific Islander 
(AAPI); and American Indian/Alaska Native (AIAN).  Because of small frequencies in 
the latter two categories, these groups were excluded from further bivariate and 
multivariate analyses.  Using White as the reference category, two dummy variables were 
created.  Coding was as follows:  Black =1, other=0; Hispanic=1, other=0.  This strategy 
allowed for comparisons among three racial/ethnic groups.  
 
Age 
Individuals of all ages are vulnerable to HIV infection; however, the majority of cases in 
the U.S. are among those aged 25-44 (CDC, 2005b).  Respondents’ ages were calculated 
based on the year of the interview minus reported date of birth year.  Age was 
categorized according to HCSUS groups to support comparisons of results.  These groups 
were as follows:  20-34 years, 35-49 years; and 50+.  All patients in the HIVRN adult 
patient interview were at least age 20; the oldest age reported was 85 years.  The mean 
age was 45.34 years, the median was 45 years, and the mode was 44 years.  Using the 
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group 35-49 years old as the reference category, two dummy variables were created.  
Coding was as follows:  age 20-34 years =1, other=0; age 50+=1, other=0.  This strategy 
allowed for comparisons among three age groups. 
 
D. 2  Other Enabling Resources 
Access to Health Resources - Insurance 
Health insurance plays a critical role in patient access to and receipt of timely care.  Lack 
of insurance has been shown to influence health-seeking behaviors among chronically ill 
patients and to have a negative impact upon early diagnosis and treatment.  HIVRN 
patients are asked to self-report on the type(s), if any, of health insurance they had in the 
past six months.  Patients were asked several series of questions to ascertain if they had 
any insurance coverage whatsoever during that time.  Insurance categories include 
Medicaid, Medicare, private insurance, other types of public insurance (i.e. WIC, Ryan 
White, Veterans, Champus/Tricare, other county-level programs), and no health 
insurance at all.  Patients were read a definition for Medicaid and Medicare from the 
HIVRN patient interview as follows:  “Medicaid is a state program for low income 
persons or for persons on public assistance.” (p. 30) “Medicare is a health insurance 
program for people 65 years old or over and for people who are disabled.” (p. 30) 
 
Recoding considered several issues.  First, because Medicare is reserved for the very old 
and the very sick, i.e., patients who have progressed to AIDS or those who are HIV-
positive and who also have severe physical or mental disabilities, it was important to 
consider these patients separately from those receiving other forms of public insurance.  
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A preliminary review of the HIVRN adult patient interview data indicated that nearly 
46% of HIVRN adult patients report Medicaid/Other Public Insurance coverage.   There 
were four proposed insurance categories, as follows:  
1. Medicaid/Other Public Insurance (i.e., WIC, Veterans benefits) – this is a 
combined category of Medicaid plus other forms of public assistance. 
2. Medicare 
3. Private Insurance 
4. No insurance at all 
Three dummy variables were created with “Medicaid/Other Public Insurance” as the 
reference category.  This strategy allowed for comparisons by insurance status.  These 
categories included: Medicare=1, other =0; private insurance=1, other =0; and No 
insurance at all=1, other =0. 
 
Education 
Level of education is generally acknowledged as having a relationship with 
socioeconomic status and access to health care in the United States.  Lower levels of 
education have also been shown to contribute to risky health behaviors that play a role in 
HIV transmission.  Patients who are better educated may also be in a position to better 
navigate the health care system.  To assess education, respondents were asked “What is 
the highest degree/diploma you have earned?”  The full range of responses included “less 
than high school,” “high school/GED,” “junior college,” “four year college,” and 
“graduate school.”  For analysis purposes, recoding into three categories included 
“none/less than high school,” “high school/GED,” and “college.”  Using “high 
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school/GED” as the reference category, two dummy variables were created to compare 
results by educational status: None/less than high school=1, other=0; and college 
(including junior college, four year college and graduate school) =1, other =0. 
 
Employment 
Employed persons may be likely to have health insurance, given their working status; 
however, this is not true across the board.  Health insurance benefits are becoming 
increasingly limited in many industries and thus, it cannot be assumed that all working 
individuals have benefits.  Persons who are physically able to continue working part-or 
full-time may also be in better health than their counterparts who are disabled.  For 
analysis purposes, employment was recoded into two categories: working full-time/part-
time =1; and not working =0.    
 
Living Arrangement  
HIV-positive patients who live in households with other persons may have greater access 
to informal support through family members, co-habiting partners, and friends.  
Additional support can help patients with a variety of their day-to-day needs.  
Respondents were asked if they live alone, if there were others in the household, or if 
they were homeless.  Recoded categories included the following: “living alone,” “others 
in house,” and “homeless.”   Using “living with others in the house” as the reference 
category, two dummy variables were created: living alone=1, other =0; and homeless=1, 




D.3. Other Need for Services Covariates 
Stage of Illness - CD4 nadir 
CD4 nadir is an indicator of the greatest extent to which HIV has ravaged the immune 
system.  In addition, specific levels of CD4 counts are used as guidelines by clinicians for 
prescribing HAART.  CD4 counts are indicative of a need for HAART (generally when 
CD4 <350 cells/mm3), the transition to AIDS (fewer than 200 cells/mm3), and a clinical 
need for other types of services (for advanced illness, generally when CD4 <50 
cells/mm3).  Higher CD4 counts (above 500 cells/mm3) generally reflect fewer symptoms 
and a lower need for crisis-oriented services.  Patients whose CD4 counts are below 200 
cells/mm3 have more advanced disease and are considered to have transitioned from HIV 
infection to AIDS (HHS Treatment Guidelines, 2003).  There are substantive differences 
in severity of illness and the incidence of opportunistic infections, as reflected by CD4  
count levels.  In general, patients whose CD4 counts are above 500 cells/mm3 are 
healthier than those whose CD4 counts are below 500 cells/mm3.  For the purposes of this 
study, CD4 count was recoded into four categories:  less than 50 cells/mm3, 50-200 
cells/mm3, 201-500 cells/mm3, and over 500 cells/mm3, respectively.  Patients whose 
CD4 count was between 201 and 500 cells/mm3 comprised the reference category.  Three 
dummy variables were created:  less than 50 cells/mm3=1; other =0; 50-200 cells/mm3 
=1; other =0; and over 500 cells/mm3 =1; other =0.   A follow-up yes/no HIVRN 






Change in Health Status 
A change in HAART regimen is a proxy for a change in health status, specifically (in the 
short run) a change to poorer health status.  HIVRN patients were asked to self-report on 
the set of individual antiretroviral drugs they were taking at the time of the interview as 
well as over the previous six months.  Subsequently, JHU used this information to create 
a dichotomous HAART variable, indicating whether the combination of drugs that 
patients were taking was recommended by medical experts.  For the purposes of this 
study, stable HIV condition was operationalized as no change in health status regimen, 
i.e., the patient was on HAART six months ago and is still on the same HAART drugs 
currently; or was not on HAART either six months ago or at the time of the interview.  
Unstable HIV condition was operationalized as a change in health status; for example, 
not being on HAART six months ago and being on HAART currently, or having different 
combinations of HAART drugs at the two times, which is indicative of a failure of the 
first regimen.  Decisions on patient need for HAART and/or a change in regimen were 
made by HIVRN clinicians who are experienced with HIV/AIDS-related clinical care, 
not by the student researcher.   For analyses, HAART use from the past six months was 
compared with current HAART use.  Patients who have changed regimens were coded 
“1”; patients who had not changed HAART regimens or have not been prescribed 
HAART during the interview recall period were coded “0.” 
 
Perceived Health Status 
Perceived health status provides a measure of self-reported patient health that may affect 
use of HIV-related health care services.  Self-reported health status has been shown to be 
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a strong predictor of health care utilization, with an inverse relationship between ‘good’ 
or ‘excellent’ health and health services use (e.g., Bierman et al., 1999).  For the purposes 
of this study, perceived health status was assessed on the basis of the HIVRN patient 
interview item, “Overall, how would you rate your current health?”  This item was 
answered using an 11 point ordinal scale, with “0” assigned to the worst possible health, 
“5” assigned to half-way between worst and best, and “10” assigned to the “best possible 
health.”  Intermediate numbers, such as “2” and “6,” were subjectively defined by the 
patient and were not assigned a text value.  Perceived health was kept as a continuous 
variable for analyses, as assigning cut-off levels would be arbitrary. 
 
Illicit Drug Use 
HIV-positive patients who have a history of illicit drug use, particularly injection drug 
behavior, are at higher risk for some co-morbidities, particularly hepatitis C.  To assess 
illicit drug use, patients were asked if they have ever used eight specific drugs, and 
whether they have used any of these substances by injection.  The eight drugs were as 
follows: sedatives, amphetamines, analgesics, marijuana, cocaine, inhalants, LSD, and 
heroin.  For analysis purposes, three drug use categories were created: no drug use 
history, drug use history but no injection use, and drug history with injection use.  Drug 
use history but no injection use was the reference category.  The recodes for the other 
categories was as follows: no drug use history =1, other =0; drug use history with 





E. Data Analysis 
The Statistical Package for the Social Sciences (SPSS version 12.0 for Microsoft 
Windows, 2003) was used to analyze the data for the present study.  A description of the 
sample, including numbers and percentages, is provided for all variables in the analytic 
framework. 
 
Bivariate analyses were conducted to assess the association between the two levels of 
outpatient visits and each of the independent variables in the analytic framework for each 
race/ethnic group by sex.  Variables besides patient sex that were significantly associated 
with the outcome variable were retained for inclusion and controlled for in multivariate 
modeling.  If race/ethnicity had been significantly associated with the dependent variable, 
separate analyses were planned for each racial/ethnic group (White, Black, Hispanic).  
 
In addition, bivariate analyses were conducted to assess associations among formal social 
support variables, patient sex, and other patient characteristics.  Any covariates that 
appeared to have significant associations with the major independent variable (social 
support), dependent variable (level of HIV/AIDS-related outpatient visits) and primary 
covariate (patient sex) were retained in multivariate models and examined for their 
confounding effects.  Multicollinearity was also assessed.  High multicollinearity results 
in a higher probability of non-significant findings, whereas low levels of collinearity 
usually do not pose a major problem.  To identify multicollinearity, various diagnostic 
tests can be reviewed in SPSS, including the variance inflation factor (VIF) and the 
tolerance statistic.  Experts suggest that a VIF of 10 or higher suggests multicollinearity; 
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a tolerance figure below 0.1 also indicates reason for concern.  Predictors that might have 
shown high multicollinearity were reviewed for possible deletion from the models.   For 
multivariate analyses, significance level was set at p < .05.    
 
The focus of this research was whether formal social support predicts levels of 
HIV/AIDS-related outpatient care visits.  This entailed using a binary logistic regression 
model that is characterized by a group of predictors and an outcome with two categories.  
The limitation of this model is that it groups outpatient visits into only two categories and 
considers them identical; i.e., a group of 2 through 5 visits considers patients with 2 visits 
the same as patients with 5 visits.  This dichotomous outcome may oversimplify and 
arbitrarily categorize HIV/AIDS health services utilization.  Because there were 
insufficient numbers of patients with 0-1 visits, it was not possible to use a multinomial 
regression model with more than two outcome categories.  Another strategy would have 
been to keep the dependent variable continuous in multivariate analyses.  This strategy 
was not used because the dependent variable was not normally distributed in this dataset, 
and it was not clear that an increase in the number of outpatient visits could be interpreted 
in a meaningful way to represent improvement in care.    
 
Univariate Statistics 
To determine the normality of the distribution of the primary independent variable and 
the covariates, measures of central tendency were assessed.  These included frequency 
distributions that provided information about means, medians, modes, skew and kurtosis, 
as appropriate for the type of data.  Nominal data, such as sex, had a mode; while ordinal 
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data, such as patient perception of current health, had both a median and a mode.  The 
number of case managers before any recoding was an example of a ratio level variable 
that had a mean, median, and a mode.  The shape of the frequency distributions for the 
key variables patient sex, formal social support, and levels of outpatient visits were also 
examined for outliers.  Numbers and percentages of missing data for each variable were 
checked as well as whether missing data was random across the sample.  Missing data 
was given a consistent numerical code in SPSS before analyses were run (i.e., a value of 
9).  Approximately five percent of missing data was accepted before deletion from the 
analyses (Tabachnick & Fidell, 2001).   
 
Bivariate Statistics 
Bivariate statistics are those tests that illustrate a variety of relational associations 
between two variables and are important to show linear and nonlinear relationships.   
Bivariate tests were conducted to assess the association between levels of HIV/AIDS-
related outpatient visits and each of the independent variables for each racial /ethnic 
group by patient sex (see Table 2).  In addition, bivariate tests for this study helped to 
identify which covariates were associated with the outcome variable.  Significant 
covariates were included in the multivariate models.  Table 2 shows each of the 
independent variables, the type of variable (after recoding takes place), and the bivariate 






Table 2   
Level of HIV/AIDS-related Outpatient Visits by Formal Social Support, 
Patient Sex, Race/Ethnic Group and Other Covariates 
 




     Scope  
     Intensity (in person) 
     Type (instrumental) 












Sex Nominal Chi-square 
Race/Ethnicity Nominal Chi-square 
Age Ordinal Chi-square 
Change in Health Status  Nominal Chi-square 
CD4 Nadir  Ordinal Chi-square 
Illicit Drug Use Nominal Chi-square 
Perceived Health Ordinal Spearman Rho 
Health Insurance Nominal Chi-square 
Education Ordinal Chi-square 
Employment Nominal Chi-square 
Living Arrangement Nominal Chi-square 
 
Bivariate relationships between social support and the covariates were examined to 
determine whether significant interactions with formal social support should be tested in 
the multivariate analyses to clarify the relationship between social support and the 
dependent variable.  As noted above, multicollinearity was also examined to determine 
whether any covariates should be dropped from the analysis because of redundancy.  
In Table 3 below, each of the independent variables, the type of variable (after recoding 










Table 3  
Formal Social Support-Scope (1 or 2 Case Managers vs. No Case Manager) by  
Select HIVRN Patient Covariates 
 
Independent Variable Type of Variable after 
Recode 
Bivariate Test 
Sex Nominal Chi-square 
Race/Ethnicity Nominal Chi-square 
Age Ordinal Chi-square 
Change in Health Status  Nominal Chi-square 
CD4 Nadir Ordinal Chi-square 
Illicit Drug Use Nominal Chi-square 
Perceived Health Ordinal Spearman Rho 
Health Insurance Nominal Chi-square 
Education Ordinal Chi-square 
Employment Nominal Chi-square 
Living Arrangement Nominal Chi-square 
 
In Table 4 below, each of the independent variables, the type of variable (after recoding 
takes place), and the bivariate test with patient sex is shown. 
 
Table 4 
Patient Sex by Other Select HIVRN Patient Covariates 
 
Independent Variable Type of Variable after 
Recode 
Bivariate Test 
Race/Ethnicity Nominal Chi-square 
Age Ordinal Chi-square 
Change in Health Status  Nominal Chi-square 
CD4 Nadir Ordinal Chi-square 
Illicit Drug Use Nominal Chi-square 
Perceived Health Ordinal Spearman Rho 
Health Insurance Nominal Chi-square 
Education Ordinal Chi-square 
Employment Nominal Chi-square 
Living Arrangement Nominal Chi-square 
 
F. Data Analysis Approach 
In general, logistic regression models are used to predict a binary dependent variable and 
to determine the percentage of variance – or R2 in this variable explained by a group of 
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independent variables.  Additionally, the logistic regression family of models can be 
useful in looking at interaction effects, and to learn about the influence of covariates 
serving as controls (Garson, 2006).     
 
The main statistical analysis for this study was binary logistic regression, which is called 
for when the dependent variable is a dichotomy.  This type of regression uses the 
principles of maximum likelihood estimation, also referred to as the natural log of the 
odds of the dependent variable occurring or not.  Logistic regression estimates the 
probability of an event taking place (Garson, 2006). 
 
Assumptions for binary logistic regression include no outliers, low error in explanatory 
variables, low multicollinearity, and a large enough sample to reduce the possibility of 
high standard errors.  A normal distribution is not required for this type of regression 
model; thus, skewed distributions can be used without transformation.  In SPSS, binary 
logistic regression is found under the Analyze-Regression-Binary Logistic drop down 
option.  If the chi-square test of goodness of fit is not significant, the model has adequate 
fit.  In SPSS output, this information is shown in the “Goodness of Fit” table.  The log-
likelihood ratio and overall classification percentages were used to interpret significance 
and classification for all predictors in the model.  Exponential beta coefficients were used 






G. Research Questions 
Primary Research Question - Does the scope  of formal social support predict the levels 
of HIV/AIDS-related outpatient care visits?  Does this association vary by patient sex? 
 
Data Analysis Approach 
 
To answer this question, a binary logistic regression was conducted with patient sex, 
Predisposing covariates, Enabling Resources covariates and Need for Services covariates 
entered in Block 1 of the model, and Formal Social Support-Scope (one or two case 
managers) entered in Block 2.  This sequence addressed the specific classification of 
Formal Social Support-Scope after controlling for the variables in Block 1.  The 
categorical outcome variable was the levels of HIV/AIDS-related outpatient care visits, 
as previously described.  If patient sex was shown to be a significant covariate in the 
testing of this model, the cross-product of the variables “patient sex” and “Social 
Support-Scope” would be created and added to the multivariate model to determine if 
there was an interaction when predicting levels of HIV-related outpatient visits. 
 
Secondary Research Question - Does the intensity of formal social support received 
predict the levels of HIV/AIDS-related outpatient care visits?  Does this association vary 
by patient sex? 
 
Data Analysis Approach  
 
To answer this question, a binary logistic regression was conducted, respectively, with 
patient sex, Predisposing covariates, Enabling Resources covariates and Need for 
Services covariates entered in Block 1 of the model, and Formal Social Support-Intensity 
entered in Block 2.  This sequence addressed the specific classification of Formal Social 
Support-Intensity after controlling for the variables in Block 1.  The regression analysis 
included the in-person contact summative score for the first case manager plus the 
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continuous score for those patients with a second case manager.  The categorical outcome 
variable was the levels of HIV/AIDS-related outpatient care visits, as previously 
described.  If patient sex was shown to be a significant covariate in the testing of this 
model, the cross-product of the variables “patient sex” and “Social Support-Intensity” 
would be created and added to the multivariate model to determine if there was an 
interaction when predicting levels of HIV-related outpatient visits. 
 
Secondary Research Question – Does the type of formal social support received predict 
the levels of HIV/AIDS-related outpatient care visits?  Does this association vary by 
patient sex? 
 
Data Analysis Approach  
 
To answer this question, a binary logistic regression was conducted, respectively, with 
patient sex, Predisposing covariates, Enabling Resources covariates, and Need for 
Services covariates entered in Block 1 of the model, and Formal Social Support-Type 
entered in Block 2.  This sequence addressed the specific classification of Formal Social 
Support-Type after controlling for the variables in Block 1.  As previously described, this 
latter covariate is of two types: instrumental or informational support, with several items 
comprising each of the types.  Because this study was interested in addressing the 
individual type of formal social support by up to two case managers, rather than an 
overall formal social support score, each patient had a summative score by type of 
support (0-4 for informational support and 0-6 for instrumental support).  Each of these 
scores was entered in Block 2, respectively.  The categorical outcome variable was levels 
of HIV/AIDS-related outpatient care visits, as previously described.  If patient sex was 
shown to be a significant covariate in the testing of these models, the cross-product of the 
variables “patient sex” and “Social Support-Type” would be created and added to the 
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multivariate models to determine if there was an interaction when predicting levels of 
HIV-related outpatient visits. 
 
One additional sub-analysis was undertaken in this study to further explore possible 
relationships.  This sub-analysis addressed whether any significant relationships found in 
the entire study sample remained when HIV-positive patients with two case managers 
were excluded.  The number of patients who self-reported having two case managers was 
83.  The analyses under the secondary research questions were repeated, selecting out 
those patients with two case managers.  Given the lack of a strong connection in the 
literature between having more than one case manager and outpatient care visits, no 
differences were expected between HIV-positive patients with one case manager and 
those with two case managers.  
 
Quality of HIVRN Data 
The HIVRN adult patient interview includes self-reported data from 951 HIV-positive 
patients who receive primary care at 17 U.S. clinical care sites serving more than 15,000 
people living with HIV/AIDS.  Quality control and coordination of data collection is 
carried out by Johns Hopkins University Medical Center, under contract with the Federal 
Department of Health and Human Services.  Survey questions on sensitive topics, such as 
drug use, and the potential for recall bias, can affect the number of missing data as well 
as over- and under-reporting.  To limit these occurrences, an approved protocol was 
followed for data collection, using one-on-one patient interviews.  Patients could refuse 
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to answer any question or could stop the interview at any time.  To date, there have been 
no other tests of reliability and validity with the HIVRN patient interview questions.   
 
These analyses may give further support to the view that acute care-based systems need 
to be changed to alternative systems that focus on chronic illness models (as the IOM’s 
2003 report proposes).  Alternatively, the findings may suggest that an even deeper 
transformation of healthcare delivery may be required.  
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Chapter 4: Results 
The 2003 HIVRN Adult Patient Interview sampling frame included 951 participants from 
14 HIVRN sites across the country.  The sample was stratified by provider site, ethnicity, 
and patient sex, with intentional oversampling of Hispanics and women.  Of the total, 648 
(68%) of participants were male and 303 (32%) were female.  For purposes of the current 
study, the sampling frame consisted of 797 adult respondents.  Of this total, 543 
participants were male and 254 were female.  Respondents who self-reported three or 
more case managers (n=44); were American Indian/Alaska Native (n=6); or single race 
other than White, Black or Hispanic (n=21) were excluded due to low frequencies.  Nine 
participants (<1%) of the overall HIVRN adult patient interview sample recorded their 
race/ethnicity as “don’t know,” “refused,” or left the race/ethnicity question blank.  These 
respondents were also excluded from analyses. 
 
Univariate Statistics 
The mean age for the study sample (N=797) was 45.51 (SD=8.31); the median was 45; 
and the mode was 44.  A majority of the study sample was African American (53%), 
followed by White (33%), and Hispanic (14%).  A total of 41% (n=324) of the 
respondents had ever been given an AIDS diagnosis by a doctor.  Also, a majority of the 
participants in the study sample reported having one or two case managers (59%) as 
compared to no case manager (41%); and more than three-quarters of patients (77%) 
were not working.  About 5% of participants in the larger HIVRN adult patient interview 
sample (N=951) self-reported having three or more case managers over the past six 





 Demographic and Background Characteristics of the Study Sample 
_____________________________________________________________________ 






Respondents 797(100) 543 (68) 254 (32) 
Age 
 20-34 years 
 35-49 years 
 50+ years 






































 <50 cells/mm3 
 50-200 cells/mm3 
 201-500 cells/mm3 
 >500 cells/mm3 
 Don’t Know 


























Illicit Drug Use History 
 No Drug Use 
 Drug Use/No Injection 






















 Medicaid/Other Publica 
 Medicare 
 Privateb 


















 None/Less than High School 
 High School/GED 
 College 

















 Full/part time 
















Table 5 (continued) 
 Demographic and Background Characteristics of the Study Sample 
___________________________________________________________________________ 







 Living Alone 
 Others in house 


















Change in Health Status 
 Change in HAART Regimen 














Perceived Health Status (11 point scale, 0= worse,  
10= best) 
 Mean  





















a includes WIC, VA, Ryan White, Champus/Tricare, other county-level programs. 
b includes current private insurance and private insurance six months ago. 
 
 
Table 6 illustrates respondents’ responses to questions about ever using illicit drugs 
broken down by eight individual drugs.  Marijuana was the drug most frequently used by 
the study sample (n=444, 56%), while inhalants were the drug least frequently self-
reported (n=113, 14%).  A total of 22% of patients in the study sample reported ever 












Frequencies and Percents for Ever Used Select Illicit Drugs 
 






Sedatives 151 (19) 643 (81) 3 (<1) 
Amphetamines 149 (19) 646 (81) 2 (<1) 
Marijuana 444 (56) 350 (44) 3 (<1) 
Analgesics 135 (17) 660 (83) 2 (<1) 
Cocaine 339 (43) 450 (57) 8 (1) 
Inhalants 113 (14) 682 (87) 2 (<1) 
LSD 141 (18) 653 (82) 3 (<1) 
Heroin 163 (21) 632 (79) 2 (<1) 
Note. N=797. 
 
Table 7 illustrates univariate level statistics for the primary independent variable – formal 
social support.  As previously noted, for the purposes of this study, formal social support 
was defined as having one or two case managers.  A majority of patients reported having 
one or two case managers in the last six months.  Of those patients who reported having 
one or two case managers (n=474), 82% had 1 case manager.   
 
Table 7 
Formal Social Support – Scope (Number of Case Managers  
in the Last 6 months) 
 
Scope (# of Case Managers) n(%) 
0 Case Managers 323 (41) 
1 Case Manager 391 (49) 
2 Case Managers 83 (10) 
1 or 2 Case Managers 474 (59) 




For patients with one case manager, the number of in-person visits ranged from 0 to 180, 
with a mean of 5.89, a median of 2, and a mode of 1.  For patients with a second case 
manager, the number of visits for the second case manager ranged from 0 to 32, with a 
mean of 3.25, a median of 2, and a mode of 2.  The number of in-person contacts was 
kept as a continuous variable in this study.  A summative score of the continuous score 
for patients with one case manager plus the continuous score for patients with a second 
case manager was created.  
 
Tables 8 and 9 show information about the type of formal social support provided.  Two 
types of social support – informational and instrumental –made up of a total of five 
individual survey items were used as proxies for these support types.  The three items that 
comprised instrumental support included referral to medical services, referral to social 
services, and help with filling out forms to obtain benefits.  The two items that comprised 
informational support included personal advice provided by a case manager and advice 
about HIV-related medications.  Patients reported what types of services they received 
across up to two case managers.   For the first case manager, the most frequent response 
across both types of formal social support – informational and instrumental - was 
personal advice (n=177; 45%).  For the second case manager, the most frequent response 
across both types of formal social support –information and instrumental - was help with 









Frequencies and Percents for Items Comprising Type of Formal Social Support 
(Instrumental and Informational) in the last 6 months, First Case Manager 
 




Instrumental   
   Medical Services 167 (43) 221 (57) 
   Social Services 164 (42) 223 (57) 
   Benefit Forms 146 (37) 241 (62) 
Informational   
   Advice about HIV meds  138 (35) 250 (64) 





Frequencies and Percents for Items Comprising Type of Formal Social Support 
(Instrumental and Informational) in the last 6 months, Second Case Manager 
 




Instrumental   
   Medical Services 30 (36) 52 (63) 
   Social Services 36 (43) 46 (55) 
   Benefit Forms 27 (33) 54 (65) 
Informational   
   Advice about HIV meds  24 (29) 58 (70) 





Each patient in the study sample who reported having one or two case managers was 
given an informational support score and an instrumental support score, respectively.  
Among the patients with one case manager, for instrumental support, 85 patients (n=388; 
22%) self-reported receiving help with all three types of support - help with medical 
services, help with social services, and help with filling out forms for benefits; for 
informational support, 116 patients (n=388, 30%) self-reported receiving both personal 
advice and HIV-related medication advice.  Among patients with a second case manager, 
for instrumental support, 17 patients (n=81, 21%) self-reported receiving all three 
services; for informational support, 19 patients (n=81, 23%) received both services.   See 
Tables 10 through 13 for more information about the type of formal social support 
provided to patients in the study sample.  For each patient, a summative score by type of 
support (0-4 for informational support and 0-6 for instrumental support) was created and 
was used in the bivariate analyses, described below.   
 
Table 10 
Instrumental Support Score, First Case Manager 
 
Number of Servicesa n (%) 
None 152 (39) 
1 Service                                                           76 (19) 
2 Services   73 (19) 
3 Services 85 (22) 
Note. n=386.  
a Maximum of 3 services: help with medical services, help with social services, help with forms 







Instrumental Support Score, Second Case Manager 
 
Number of Servicesa n (%) 
None 34 (42) 
1 Service  18 (22) 
2 Services  12 (15) 
3 Services  17 (21) 
Note. n=81.  
a Maximum of 3 services: help with medical services, help with social services, help with forms 
for benefits.  
 
 Table 12 
Informational Support Score, First Case Manager 
 
Number of Servicesa n (%) 
None 189 (48) 
1 Service  83 (21) 
2 Services  116 (30) 
Note. n=388.  




Informational Support Score, Second Case Manager 
 
Number of Servicesa n (%) 
None 42 (51) 
1 Service  20 (24) 
2 Services 19 (23) 
Note. n=81.  








Before bivariate tests were carried out, recoding of variables was completed, as described 
in Chapter 3.  As depicted in Table 14, the main outcome variable – level of outpatient 
visits – was recoded into two levels:  average (2-5 visits) and high (6+ visits).   Of note, a 
small minority of patients (n=67) had 0-1 visits in the larger study sample.  This 
comprised less than 10% of the study sample.   
 
Table 14 
Frequencies and Percents for Level of HIV-related Outpatient Visits,  
Last Six Months 
 
Level of Outpatient Visits Study Sample 
n(%) 
Average (2-5 visits) 397 (50) 
High (6+ visits) 400 (50) 
Note. N=797. 
 
Of the group of 67 patients with 0-1 visits, 18 were female and 49 were male.  Twenty-
one of these patients were White; 41 were Black; and five were Hispanic.  Given the 
statistical limitations of using these numbers in bivariate and multivariate analyses, this 
group of patients was not included in further analyses.  Notwithstanding, this group is an 
important cohort to explore in future research to better understand their particular needs 
that lead to inconsistent contact with their outpatient clinical care site.  For continuity of 





Bivariate tests - primarily Pearson chi-squares - were carried out to illustrate a variety of 
relational associations between the variables in the analytic framework.  The first series 
of these tests was conducted to determine if there were any significant associations 
between the two levels of outpatient visits – average (2-5 visits) or high (6+ visits)  and 
each of the independent variables in the analytic framework by patient sex (see Figure 2, 
Chapter 3).  Variables besides patient sex that may be significantly associated with the 
dependent variable were retained and controlled for in multivariate modeling.  This group 
of tests also was informative to see how all study variables related to each other, and 
which confounding variable relationships needed to be addressed in the final multivariate 
models.   
 
Given the importance of determining if a significant association existed between 
race/ethnicity and the dependent variable, given the possibility of a three-way interaction 
with patient sex, this bivariate test was run first.  There was no significant association 
found between race/ethnicity and level of outpatient visits for this study- χ2 (2, N=797) = 
4.49, p=.106 (not shown).  This bivariate test was repeated with patient sex – the primary 
covariate – as a stratifying variable.  As seen in Tables 15 and 16, no significant 
associations were found - p=.348; Males -χ2 (2, N=543) = 2.11; p=.256; Females- χ2 (2, 
N=254) = 2.50. 
 
Subsequently, a series of chi-square tests with the dependent variable was carried out, 
with patient sex as a stratifying variable (see Tables 15 and 16).   Results showed that 
having one or two case managers, perceived health status, and employment were all 
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significantly associated with level of outpatient visits for both males and females.  Age 




 Bivariate Test, Level of HIV/AIDS-related Outpatient Visits by  
Study Covariates, Male Patients 
 















Race/ethnicity 2.11 2 .348 
Age  .042 2 .979 
Change in Health Status 3.53 1 .060 
CD4 Nadir 4.38 3 .224 
Illicit Drug Use 3.77 2 .152 
Health Insurance 6.79 3 .079 
Education .505 2 .777 
Employment 15.60 1 .000* 
Living Arrangement 1.55 2 .461 
  Spearman Rho Significance 
Case Manager Intensity 





Instrumental Support  .024 .679 
Informational Support  -.003 .959 






















Bivariate Test, Level of HIV/AIDS-related Outpatient Visits by 
 Study Covariates, Female Patients 
 










Race/ethnicity 2.50 2 .286 
Age    .04 2 .045* 
Change in Health Status .600 1 .439 
CD4 Nadir 1.59 3 .662 
Illicit Drug Use .954 2 .621 
Health Insurance 6.03 3 .110a 
Education .589 2 .745 
Employment 9.33 1 .002* 
Living Arrangement 3.66 2 .160 
  Spearman Rho Significance 






Instrumental Support  -.017 .826 
Informational Support  -.001 .992 
Perceived Health Status  -.151 .016* 
Note. n=254. 
a2 cells had an expected count less than 5.  
*p<.05. 
 
There was no significant relationship between level of outpatient visits and informational 
support scores for male and female patients in the study sample.  Likewise, there was no 
significant relationship between level of outpatient visits and instrumental support scores 
for male and female patients (see Tables 15 and 16).  A point biserial Spearman 
correlation was conducted to examine if a relationship existed between perceived health 
status (an ordinal variable) and level of outpatient visits.  Results showed that a 
significant negative relationship existed for both males and females and level of 
outpatient visits, suggesting that as perceived health status increases, outpatient visits 
decrease.  Of note, for patients with 0, one or two case managers, patient sex was not 
significantly associated with level of outpatient visits - χ2 (1, N=797) = 1.30, p=.253.  
108  
 
Because patient sex was the primary covariate of interest, it was retained in the 
multivariate analyses.    
 
As discussed in Chapter 3, bivariate tests were carried out with formal social support (one 
or two case managers vs. no case manager) by select HIVRN patient covariates under the 
Predisposing, Enabling Resources, and Need for Services headings from the study’s 
analytic model.  Table 17 shows the results from these analyses.  Significant associations 
were found between formal social support (one or two case managers vs. no case 
manager) and patient sex- χ2 (1, N=797) =9.53, p=.002; health insurance- χ2 (3, N=797) 
=56.22, p=.000; education - χ2 (1, N=797) =29.82, p=.000; and employment –  
χ2 (1, N=797) =29.83, p=.000.  There were no significant associations found between 
formal social support (one or two case managers vs. no case manager) and race/ethnicity, 
age, perceived health, CD4 nadir, illicit drug use, change in health status, or living 













Formal Social Support – Scope (1 or 2 Case Managers vs. no 
Case Manager) by Select HIVRN Patient Covariates 
 
Variable Chi-Square df P-value 
Patient Sex 9.53 1 .002* 
Race/ethnicity 4.05 2 .132 
Age  3.78 2 .151 
Change in Health 
Status 
.006 1 .940 
CD4 Nadir .224 3 .974 
Illicit Drug Use 1.28 2 .527 
Health Insurance 56.22 3 .000* 
Education 18.87 2 .000* 
Employment 29.83 1 .000* 
Living Arrangement 3.91 2 .141 
  Spearman Rho Significance 
Perceived Health 
Status 




Additionally, bivariate tests were carried out with patient sex (male/female) by select 
HIVRN patient covariates under the Predisposing, Enabling Resources, and Need for 
Services headings from the study’s analytic model.  Table 18 shows the results from 
these analyses.  Significant associations were found between patient sex (male/female) 
and race/ethnicity, age, CD4 nadir, illicit drug use, health insurance, education, and living 
arrangement.  Female patients in the study sample were more likely to be Black, between 
the ages of 20-49; have less than a high school education; have higher CD4 counts; be 
unemployed; and have Medicaid as their form of insurance than male patients in the 
study sample.  Variables that were not significant were change in health status, 






 Patient Sex by Select HIVRN Patient Covariates 
 
Variable Chi-Square df P-value 
Race/ethnicity 40.08 2 .000* 
Age  7.39 2 .025* 
Change in Health 
Status 
.968 1 .325 
CD4 Nadir 8.34 3 .040* 
Illicit Drug Use 6.54 2 .038* 
Health Insurance 15.17 3 .002*a 
Education 40.99 2 .000* 
Employment 6.54 1 .062 
Living Arrangement 21.18 2 .000* 
  Spearman Rho Significance 
Perceived Health 
Status 
 -.022 .526 
Note. N=797. 
a1 cell had an expected count less than 5.  
*p<.05. 
 
In determining which variables to retain for multivariate analyses, and to limit 
confounding, multicollinearity was assessed using the variance inflation factor option in 
SPSS.  High multicollinearity can result in a higher probability of non-significant 
findings.  As discussed below, none of the covariates entered into the logistic regression 
models had high multicollinearity.  
 
In the following section on multivariate analyses, the goal was to identify significant 
associations between formal social support and level of HIV/AIDS outpatient visits.  
Significant covariates from the first series of bivariates were included to control for their 
effect in the analysis.  These included formal social support-scope (one or two case 
managers vs. no case manager), employment status, age, and perceived health status. 
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Because patient sex was the primary covariate of interest, it was retained in the 
multivariate analyses.    
 
Multivariate Analyses  
The frequency distributions for formal social support-scope (one or two case managers 
vs. no case manager), and level of outpatient visits – 2-5 visits (average) and 6+ visits 
(high)- were examined for outliers before recoding took place.  Because the current study 
sample excluded individuals who had more than three case managers, outliers were not a 
concern for this variable.  The number of outpatient visits in the full HIVRN adult patient 
sample (N=951) ranged from 0 through 86, with a mean of 13.24; a median of 5, and a 
multimodal distribution at 2 and 6 visits.  The number of outpatient visits in the study 
sample (N=797) ranged from 2 through 81 with a mean of 7.17; a median of 6, and a 
mode of 6.  The frequency distribution for this outcome variable was extremely right- 
skewed (skewness =4.395); however, the multivariate test for this study – a logistic 
regression - allows for a non-normal distribution.  Because the dependent variable did not 
remain as a continuous variable for bivariate and multivariate analyses, there was no 
outlier issue.  
 
Hypothesis Testing 
The following section of Chapter 4 addresses the three research questions and hypotheses 
that were introduced in Chapter 1.  Results are presented for each question, followed by 
the results for the sub-analysis.  The sub-analysis addresses the secondary research 
questions, excluding patients with two case managers.  
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Primary Research Question - Does the scope of formal social support predict levels of 
HIV/AIDS-related outpatient care visits?  Does this association vary by patient sex? 
 
It was hypothesized that patients with formal social support (one or two case managers) 
would be more likely to have HIV/AIDS-related outpatient care visits as compared to 
patients without formal social support (without a case manager).  This hypothesis was 
supported for both males and females.   
 
To answer this question, a binomial logistic regression was conducted with perceived 
health, employment, and age entered in Block 1 of the model, and formal social support –
scope (one or two case managers vs. no case manager) entered in Block 2.  The 
dichotomous outcome variable was level of HIV/AIDS-related outpatient care visits (2-5 
visits vs. 6+ visits).  Mulicollinearity diagnostics were conducted to determine if two or 
more variables were sharing too much of the same variance. Variance inflation factors 
were under 2.0 for all variables in the model, suggesting the absence of multicollinearity.   
 
Results from the first block of the equation (not shown) were significant, χ2 (5) =50.14, 
p<.000.  The predictors in the equation – perceived health status, employment, age, and 
patient sex – correctly classified 53.4% of patients who had 2-5 outpatient visits, and 
65.7% of the patients who had 6+ visits.  The overall correct classification occurred 
59.6% of the time.  In Block 2 of the model, formal social support - scope was entered.  
The model remained significant, χ2 (6) =79.94, p<.000.  With all five predictors in the 
model, 60.8% of the patients who had 2-5 outpatient visits were correctly classified as 
were 66.5% of patients with 6+ visits.  The overall correct classification rose to 63.6%. 
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Beta coefficients are presented in Table 19.  For patients who were employed, the odds of 
having 6+ outpatient visits decreased by 1.81 times (1.0 ÷ value of Exp(B).  For every 
unit increase in perceived health status, the odds of having 6+ outpatient visits decreased 
by 1.21 times.  In comparison, for patients who have one or two case managers, the odds 
of having 6+ outpatient visits increased by 2.33 times.   Patient sex and age were not 
significant predictors of outpatient utilization.  
Table 19 
Logistic Regression on Employment, Perceived Health Status, and Formal Social 
Support-Scope Predicting Levels of HIV/AIDS-related Outpatient Care Visits 
  
 
B S.E. Wald Sig. Exp(B)
95.0% C.I. 
for Exp(B) 
            Lower Upper 
Block 1        
 Patient sex -.147 .158 .859 .354 .863 .633 1.18 
 Age 20-34 .379 .279 1.85 .174 1.46 .845 2.53 
 Age 50+ .078 .165 .223 .637 1.08 .782 1.49 
 Employment -.751 .180 17.47 .000 .472 .332 .671 
  Perceived Health 
Status 
-.192 .041 21.53 .000 .825 .761 .895 
Block 2        
 Patient sex -.060 .162 .136 .712 .942 .685 1.29 
 Age 20-34 .501 .283 3.135 .077 1.65 .948 2.87 
 Age 50+ .128 .169 .577 .448 1.137 .817 1.58 
 Employment -.594 .185 10.324 .001* .552 .384 .793 
  Perceived Health 
Status  
-.193 .042 21.163 .000* .825 .759 .895 
  FSS-Scopea .844 .156 29.196 .000* 2.33 1.71 3.16 
Note. N=797.  Age 35-49 was the reference category. 







Secondary Research Question - Does the intensity of formal social support predict 
levels of HIV/AIDS-related outpatient care visits?  Does this association vary by patient 
sex? 
 
It was hypothesized that level of HIV/AIDS-related outpatient care visits would not be 
associated with levels of intensity of formal social support.  As previously noted, 
intensity refers to in-person contact with one or two case managers.  This hypothesis was 
supported; there was no difference for patients in their levels of outpatient visits on the 
basis of the number of in-person contacts with one or two case managers.  Only 
employment and perceived health status remained significant predictors in the final 
multivariate model. 
 
To answer this research question, a binomial logistic regression was conducted with 
patient sex, age, perceived health, and work status (not employed vs. employed full- or 
part-time) entered in Block 1 of the model, and formal social support – intensity (number 
of in-person case manager visits across up to two case managers) entered in Block 2.  The 
dichotomous outcome variable was level of HIV/AIDS-related outpatient care visits (2-5 
“average” vs. 6+ “high” visits).  Mulicollinearity diagnostics were conducted. Variance 
inflation factors were under 2.0 for all variables in the model, suggesting the absence of 
multicollinearity.   
 
 
Results from the first block of the equation (not shown) were significant, χ2 (5) =18.36, 
p<.003.  The predictors in the equation – perceived health and work status – correctly 
classified 23.0% of patients who had 2-5 outpatient visits, and 90.6% of the patients who 
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had 6+ visits.  The overall correct classification was 63.1%.  In Block 2 of the model, 
formal social support - intensity was entered.  The model remained significant,  
χ2 (6) =18.62, p<.005.  With all five predictors in the model, 23.0% of the patients who 
had 2-5 outpatient visits were correctly classified, as were 90.6% of patients with 6+ 
visits.  The overall correct classification did not change. 
 
Beta coefficients are presented in Table 20.   For patients who were employed, the odds 
of having 6+ outpatient visits decreased by 2.12 times.  For every unit increase in 
perceived health status, the odds of having 6+ outpatient visits decreased by 1.15 times.  
Formal social support - intensity (number of in-person case manager visits across up to 
two case managers), patient sex, and age were not significant in further classifying the 















 Logistic Regression on Employment, Perceived Health Status, and Formal Social 




B S.E. Wald Sig. Exp(B)
95.0% C.I. 
for Exp(B) 
           Lower Upper 
Block 1        
 Patient sex -.054 .532 8.38 .791 .947 .634 1.42 
 Age 20-34 .347 .409 .720 .396 1.42 .635 3.15 
 Age 50+ .103 .224 .212 .645 1.11 .715 1.72 
 Employment -.762 .264 8.36 .004 ,467 .279 .782 
  Perceived Health Status -.139 .055 6.42 .011 .871 .782 .969 
Block 2        
 Patient sex -.059 .205 .082 .775 .943 .631 1.41 
 Age 20-34 .348 .408 .726 .394 1.42 .636 3.15 
 Age 50+ .106 .224 .225 .635 1.11 .717 1.73 
 Employment -.751 .264 8.07 .004* .472 .281 .792 
  Perceived Health Status -.140 .055 6.51 .011* .870 .781 .968 
  FSS-Intensitya .003 .007 .249 .618 1.00 .990 1.02 
Note. n=452. Age 35-49 was the reference category.  
aFSS - Intensity: number of in-person case management visits over the past six months.   
*p <.05. 
 
Secondary Research Question – Does the type of formal social support predict levels of 
HIV/AIDS-related outpatient care visits?  Does this association vary by patient sex? 
 
It was hypothesized that increased instrumental formal social support would be 
associated with increased levels of HIV/AIDS-related outpatient care visits.  It was also 
hypothesized that increased informational formal social support would not be associated 
with increased levels of HIV/AIDS-related outpatient care visits. 
 
The first part of this hypothesis was not supported.  Patients who received instrumental 
support from case managers were not significantly more likely to have HIV/AIDS-related 
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outpatient care visits than patients without this type of support.  The second part of the 
hypothesis was supported: there was no significant difference for patients receiving 
informational support from case managers in their levels of HIV/AIDS-related outpatient 
visits.   
 
To answer this research question, a binomial logistic regression was conducted with 
patient sex, age, perceived health and work status (not employed vs. employed full-or 
part-time) entered in Block 1 of the model, and formal social support – (summed 
instrumental and informational scores, respectively, for up to two case managers) entered 
in Block 2.  The dichotomous outcome variable was level of HIV/AIDS-related 
outpatient care visits (2-5 “average” vs. 6+ visits “high” visits).  Mulicollinearity 
diagnostics were conducted.  Variance inflation factors were under 2.0 for all variables in 
the model.  These results suggest the absence of multicollinearity.   
 
Results from the first block of the equation (not shown) were significant, χ2 (5) =22.56 
p<.000.  The predictors in the equation – patient sex, age, perceived health, and 
employment status – correctly classified 26.3% of patients who had 2-5 outpatient visits, 
and 87.3% of the patients who had 6+ visits.  The overall correct classification was 
62.4%.   In Block 2 of the model, both instrumental and informational type summary 
scores were entered.  The model remained significant, χ2 (7) =24.42, p<.001.  With all six 
predictors in the model, 27.4% of the patients who had 2-5 outpatient visits were 
correctly classified, as were 87.0% of patients with 6+ visits.  The overall correct 




Beta coefficients are presented in Table 21.   For patients who were employed, the odds 
of having 6+ outpatient visits decreased by 2.30 times.  For every unit increase in 
perceived health status, the odds of having 6+ outpatient visits decreased by 1.18 times.  
Patient sex and age were not significant predictors.  Neither instrumental nor 
informational type of formal social support was significant in further predicting the level 
of HIV/AIDS-related outpatient visits.  
Table 21 
  Logistic Regression on Employment, Perceived Health Status, and Formal  
Social Support-Type (Instrumental and Informational) Predicting Levels  




B S.E. Wald Sig. Exp(B) 
95.0% C.I. 
for Exp(B) 
            Lower Upper 
Block 1        
 Patient sex -.045 .203 .048 .826 .956 .642 1.42 
 Age 20-34 .210 .391 .288 .591 1.23 .573 2.66 
 Age 50+ .179 .222 .648 .421 1.19 .77 1.85 
 Employment -.796 .261 9.32 .002 .451 .271 .752 
  Perceived Health -.161 .054 8.77 .003 .851 .765 .947 
Block 2        
 Patient sex -.043 .204 .044 .833 .958 .642 1.43 
 Age 20-34 .202 .392 .265 .607 1.22 .567 2.64 
 Age 50+ .175 .222 .621 .431 1.19 .771 1.84 
 Employment -.832 .264 9.93 .002* .435 .259 .730 
  Perceived Health Status -.168 .055 9.35 .002* .846 .760 .942 
 FSSa-Instrumental -.106 .078 1.83 .177 .900 .772 1.05 
  FSSa-Informational .064 .110 .336 .562 1.06 .859 1.32 
Note. n = 466.  Age 35-49 was the reference category. 







Sub-Analysis- Formal Social Support Intensity and Type 
 
A sub-analysis was conducted to address whether any significant relationship found in 
the study sample remained when patients with two case managers (n=83) were excluded.  
The main analyses under the secondary research questions were repeated, selecting out 
those patients with two case managers.  No significant differences were expected when 
patients with two case managers were selected out.  As hypothesized, and explained 




Patient sex, age, perceived health, and work status (not employed vs. employed full-or 
part-time) were entered in Block 1 of the model, and formal social support - intensity 
(number of in-person case manager visits) was entered in Block 2.  The dichotomous 
outcome variable was the level of HIV/AIDS-related outpatient care visits (2-5 “average” 
vs. 6+ “high” visits).  Mulicollinearity diagnostics were conducted. Variance inflation 
factors were under 2.0 for all variables in the model, suggesting the absence of 
multicollinearity.   Results of the first block of the equation were significant, χ2 (5) = 
20.54, p < .001.  Patient sex, age, perceived health and work status correctly classified 
27.0% of patients with 2-5 outpatient visits and 86.9% of patients with 6+ outpatient 
visits with an overall correct classification of 63.5%.  Formal social support - intensity 
was entered into the second block of the equation, χ2 (6) = 20.94, p < .002.  The correct 




Beta coefficients are presented in Table 22.   For patients who were employed, the odds 
of having 6+ outpatient visits decreased by 2.18 times.  For every unit increase in 
perceived health, the odds of having 6+ outpatient visits decreased by 1.19 times.  Formal 
social support - intensity did not individually predict the level of outpatient visits for 
participants with only one case manager. 
 
Table 22 
Logistic Regression on Employment, Perceived Health Status, and Formal Social 




B S.E. Wald Sig. Exp(B)
95.0% C.I. 
for Exp(B) 
            Lower Upper 
Block 1        
 Patient sex -.221 .224 .968 .324 .802 .516 1.24 
 Age 20-34 .419 .448 .874 .350 1.52 .632 3.65 
 Age 50+ .116 .242 .231 .631 1.12 .699 1.81 
 Employment -.776 .285 7.40 .007 .460 .263 .805 
  Perceived Health Status -.173 .060 8.35 .004 .842 .749 .946 
Block 2        
 Patient sex -.216 .225 .920 .338 .806 .519 1.25 
 Age 20-34 .432 .449 .025 .336 1.54 .369 3.72 
 Age 50+ .117 .242 .235 .628 1.12 .700 1.81 
 Employment -.780 .285 7.46 .006* .459 .262 .802 
  Perceived Health Status -.174 .060 8.43 .004* .841 .748 .945 
  FSSa-Intensity .000 .000 .041 .525 1.00 .999 1.00 
Note. n=389. Participants with 2 case managers were excluded from the analysis.  Age 35-49 was 
the reference category. 
aFSS- Formal Social Support - Intensity: the number of in-person case management visits over 








To answer this sub-question, a binomial logistic regression was conducted that excluded 
participants with two case managers.  Patient sex, age, perceived health and work status 
(not employed vs. employed full- or part-time) were entered in Block 1 of the model, and 
formal social support - type (instrumental and informational scores) was entered in  
Block 2.  The dichotomous outcome variable was the levels of HIV/AIDS-related 
outpatient care visits (2-5 “average” vs. 6+ “high” visits).  Mulicollinearity diagnostics 
were conducted.  Variance inflation factors were under 2.0 for all variables in the model, 
suggesting the absence of multicollinearity.     
 
Results of the first block of the equation were significant, χ2 (5) = 22.31, p < .000.  
Patient sex, age, perceived health and work status correctly classified 27.3% of patients 
with 2-5 outpatient visits and 87.2% of patients with 6+ visits, with an overall correct 
classification of 63.8%.  Formal social support - type (instrumental and informational) 
were entered into the second block of the equation, χ2 (7) = 22.33, p < .002.  The overall 
correct classification rose slightly to 64.1%.    
  
Beta coefficients are presented in Table 23.  For patients who were employed, the odds of 
having 6+ outpatient visits decreased by 2.28 times.  For every unit increase in perceived 
health, the odds of having 6+ outpatient visits decreased by 1.20 times.  Patient sex, age, 







  Logistic Regression on Employment, Perceived Health Status, and Formal Social 
Support-Type (Instrumental and Informational) Predicting Levels  




B S.E. Wald Sig. Exp(B) 
95.0% C.I. 
for Exp(B) 
            Lower Upper 
Block 1        
 Patient sex -.231 .228 1.02 .312 .794 .508 1.24 
 Age 20-34 .437 .450 .945 .331 1.55 .641 3.74 
 Age 50+ .154 .244 .396 .529 1.17 .723 1.88 
 Employment -.817 .288 8.02 .005 .442 .251 .778 
  Perceived Health Status -.182 .061 8.97 .003 .834 .740 .939 
Block 2        
 Patient sex -.234 .230 1.04 .308 .791 .504 1.24 
 Age 20-34 .433 .451 .923 .337 1.54 .637 3.73 
 Age 50+ .152 .245 .384 .536 1.16 .720 1.88 
 Employment -.823 .294 7.82 .005* .439 .247 .782 
  Perceived Health Status -.182 .061 8.95 .003* .834 .740 .939 
 FSSa- Instrumental -.003 .103 .000 .976 .997 .814 1.22 
  FSSa- Informational -.013 .142 .009 .925 .987 .747 1.30 
Note. n=384.  Patients with 2 case managers were excluded.  Age 35-49 was the reference 
category.  





Chapter 5: Discussion, Recommendations, and Conclusions 
 
There are few other studies that address the impact of case management on the level of 
HIV/AIDS outpatient visits in the post-HAART era from a sex/gender perspective.  The 
evolution of HIV/AIDS from an acute condition into a chronic illness, and the increasing 
incidence of cases among women both call for greater attention to targeted supportive 
interventions.  This chapter highlights and discusses significant results, provides 
recommendations for future study within a changing health and socio-political context, 
and draws out implications for public health research and policy. 
 
Summary of Results 
 
The study sample was derived from the 2003 HIVRN adult patient interview, which 
included 951 participants from 14 HIVRN sites across the country.  Of this total, 648 
(68%) of participants were male and 303 (32%) were female.  For the purposes of the 
current study, the sampling frame consisted of 797 adult respondents (543 males and 254 
females) who self-reported their race/ethnicity as Black, White or Hispanic; had 0, one or 
two case managers; and had at least two outpatient visits during the six month study 
period.  The outcome variable for the current study was operationalized as an “average” 
(2-5) or a “high” (6+) number of outpatient visits based on input from three HIV/AIDS 
experts.  Patients with two outpatient care visits meet the minimum recommended 
number of visits per six month period put forth by the International AIDS Society.  
Patients with fewer than two outpatient visits per six month period were not included in 
the study sample because of their low frequency in the dataset.  Given provider expertise 
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and other structural supports at HIVRN sites, these patients may be more likely to 
maintain continuity of care than those at other clinical sites.  
 
Formal social support was operationalized as having one or two case managers.  In 
bivariate analyses, age was a significant predictor of the level of outpatient visits for 
female patients but not for males.  Significant results in multivariate analyses were as 
follows: both male and female patients who were employed either part- or full-time, or 
had higher self-reported perceptions of their health were significantly less likely to have 
6+ outpatient visits, while patients with one or two case managers were significantly 
more likely to have 6+ outpatient visits.  No significant associations were found among 
the study participants between the number of in-person case management visits and the 
level of outpatient visits, nor was there a significant difference in the level of outpatient 
visits corresponding to the type of support – instrumental or informational - provided by 
one or two case managers.  Patient sex was not a significant predictor of the level of 
outpatient visits in the multivariate analyses.  In sub-analyses that separated out patients 
with one case manager from those with two case managers, no new predictors emerged.   
 
Discussion- Primary Research Question  
The primary research question for this study focused on whether formal social support 
was associated with the level of HIV/AIDS-related outpatient care visits.  For both adult 
males and females in the study sample, having one or two case managers versus not 
having a case manager more than doubled the odds of having a high level of outpatient 
visits (6+ visits).  There are at least two possible explanations for this finding.  The first 
explanation is that both case management and outpatient visits are patient-driven, and 
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formal social support is not associated with level of outpatient visits.   Patients with one 
or two case managers versus those with no case manager may be particularly well-
invested in slowing disease progression, managing symptoms, and maintaining and 
improving their quality of life in the community setting.   This group of patients may also 
have a history of active healthcare seeking behavior before their HIV/AIDS diagnosis 
from other chronic illness experiences.  Therefore, engaging with their health care 
providers more frequently is part of their commitment to chronic illness self-management 
and their sense of personal self-efficacy.  This explanation supports a view of case 
management as a patient-driven service as opposed to an integrated system component.  
Patient satisfaction with characteristics of their health care setting, such as limited 
waiting time, clear information, and provider availability during an urgent crisis may also 
contribute to this perspective.  
 
The second explanation views the process as case-manager driven, suggesting that formal 
social support is indeed associated with the level of outpatient visits.   Case managers 
may be playing a supportive role in helping patients make and keep their outpatient 
appointments.  Also, the integration of primary care and ancillary services may reduce 
fragmentation of services (Conviser & Pounds, 2002).  In the current study, information 
on where patients went for case management visits and whether these locations were part 
of HIVRN clinical sites was not available, but this is an area for future exploration. 
 
Current study findings also support work published in the 2002 AIDS Care journal 
supplement that focused on the role of case managers to facilitate entry into and retention 
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in primary care; that is, patients with case managers were more likely to have continuity 
of care than patients without them.  Having a case manager provides HIV-positive 
individuals with a person who can listen to their health status concerns as well as help 
plan and arrange services tailored to patient needs in cost-effective ways.  These 
conversations between patients and their case managers may lead to the identification of 
a clinical need for outpatient care and coverage for other needed services.    
 
Using the HCSUS sample, Katz and colleagues (2001) did not find a significant 
association between case management and receipt of appropriate levels of outpatient care 
(the latter being defined as one visit per three month period between January 1996 and 
April 1997).  Nonetheless, in that study, persons who were more likely to have case 
managers were women, non-Whites, injection drug users, persons with other risk factors 
(defined as heterosexual transmission, persons who had received infected blood, and 
persons with other known or unknown exposures), and those with lower education levels, 
lower incomes, public or no insurance, or lower CD4 counts.  Katz and colleagues (2001) 
found that HCSUS patients who needed income assistance and were categorized as 
unemployed were more likely to have contact with case managers; however, this contact 
was not associated with any difference in the level of outpatient care.  In the current 
study, those more likely to have one or two case managers were women, Hispanics, those 
with less than a high school education, those on Medicaid or Medicare, and those who 
were not employed – all consistent with the HCSUS findings.  Thus, both studies suggest 
that socially disadvantaged groups of patients may need the assistance of case managers 
to navigate the health care system.   
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Two groups of patients who may have challenging health care issues are patients with 
lower CD4 counts and those with a history of illicit drug use.  Interestingly, there was no 
significant association in the current study between CD4 count and the likelihood of 
having one or two case managers.  Furthermore, there was no significant association 
between CD4 count with the level of outpatient visits, although a majority of the study 
sample at the time of the interview (n=486, 61%) would be classified as having had AIDS 
based on a self-reported CD4 count of less than 200 cells/mm3 .   Fewer patients (n=324, 
41%) recalled that they had ever been told by a doctor that they had AIDS.  This 
discrepancy suggests that providers may not be communicating clearly with their patients 
about their compromised immune systems, or that patients may not understand the 
connection between a low CD4 count and an AIDS diagnosis.  Patients may also have 
forgotten they had been told by a doctor some time ago that they had AIDS.  For those 
patients who are aware of their AIDS diagnosis, inpatient care may be needed.  Inpatient 
and ER care use has been looked at elsewhere in both HCSUS and non-HCSUS studies in 
relation to ancillary service use (Betz et al., 2005; Katz et al., 2001, Markson et al., 
1998).   
 
In relation to illicit drug users, previous research has suggested that HIV-positive patients 
who are also substance users have more difficulty than non-drug users with keeping in 
contact with outpatient care providers (Bing et al., 2001; Masson, Sorenson, Phibbs, & 
Okin, 2004; Sorenson et al., 2003).  In the current study, there were no significant 
differences between patients with and without histories of illicit drug use in having one or 
two case managers; neither did having one or two case managers versus not having a case 
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manager predict the level of outpatient visits.  HIVRN adult patients with a history of 
substance use may have received or may currently be receiving substance abuse treatment 
through other connections at HIVRN sites, which could be confounding any case 
manager impact on the level of outpatient service use.  
Other Significant Findings 
Other significant covariates in the final multivariate models besides having one or two 
case managers were part- or full-time employment and self-perception of health status.  
In the analytic model for the current study (see Chapter 2), employment was considered 
an Enabling Resource, while self-perception of health was regarded as a Need for 
Service.  Patients in the study sample who were employed part- or full-time (n=183, 
23%) were significantly less likely to have 6+ outpatient visits.  Practically speaking, 
those who are able to work part- or full-time are likely to be in better health; they may 
also be less likely to take the time to visit a health care provider, or alternatively, to be 
able to take time off during the work day to take advantage of clinic hours of operation.  
Working patients were also less likely than those who were unemployed to have one or 
two case managers.  These patients may have social support systems in the workplace 
instead.  Working patients may also be going for fewer outpatient visits to preserve 
limited health insurance benefits, or to avoid drawing attention to their health because of 
absences during the work day.  Workplace policies that allow HIV-positive workers to 
take time off for health care appointments during the day may help them follow through 




Interestingly, although more than 75% of patients in the study sample were not working, 
their self-perception of health was relatively high, as discussed below.  They may be 
engaged in activities other than a paid job that provide a sense of well-being, such as 
volunteering or mentoring others in the community.  Feeling well may also be a result of 
participation in mental health or faith-based services.  Patients who feel well could be 
expected to postpone or delay outpatient care.  These ideas speak to the larger subject of 
quality of life for patients living with a chronic illness and how addressing this complex 
issue can help to understand other facets of their health service utilization.  
 
For both males and females, the mean self-reported health status score on the scale used 
in the study was 7.19, with a score of 10 representing “best health.”  Interestingly, female 
patients’ mean score was slightly higher – 7.25 – than male patients’ mean score at 7.16; 
this was not a statistically significant difference (the study measure of perceived health 
status was based on a 0-11 point ordinal scale, with “0” assigned worst possible health 
and “10” assigned “best possible health”).  There was a negative correlation between self-
reported health scores and level of outpatient visits: patients with higher self-reported 
health status scores were significantly less likely to have 6+ outpatient visits (r= -.183, 
p=<.01).   
 
As theorized by Andersen’s (1968) conceptual model of health services utilization 
described in Chapter 1, patient perception of health status is an important consideration 
that drives need.  From a policy standpoint, Meyerson and colleagues (2007) noted that a 
standard number of HIV primary care visits may not align with patients’ perception of 
130  
 
their own well-being and other day-to-day priorities, and that being “in care” or “out of 
care” is more complex when viewed through the patient lens.  Further research is needed 
to examine the relationship between self-reported health status and the level of outpatient 
visits for patients living with HIV/AIDS.  
 
Discussion- Secondary Research Questions 
Two secondary research questions in the present study addressed whether the intensity 
and types of formal social support were associated with levels of HIV-related outpatient 
care visits.  Intensity of formal social support was defined as the number of in-person 
visits with a case manager.  A summative score was created, consisting of the number of 
visits for patients with one case manager plus the number of visits for patients with a 
second case manager.  The total number of in-person visits with these case managers did 
not predict the level of HIV-related outpatient visits.  However, the quantity of case 
management visits may not be as important as the quality of visits, or the tailoring of the 
frequency of visits to patient social service needs.  If this is true, patients with fewer visits 
may benefit as much as those with more visits.  Patients’ perceived health status may also 
have a stronger influence on outpatient health care utilization than case management 
contact, as discussed above. 
 
HCSUS patients who saw or spoke to their case manager at least once in the six months 
before the baseline data collection period (January 1996 and April 1997) and still had a 
case manager at follow-up (data collection between December 1996 and July 1997) did 
not differ in their utilization of primary care from patients without a case manager at 
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baseline or at follow-up.  In contrast, Magnus and colleagues (2001) found that more than 
one contact per month with a case manager among a cohort of 198 HIV-positive women 
was associated with improved retention in primary care.  Although the research literature 
affirms the role of case managers in helping HIV-positive patients manage their illness 
(Chernsesky & Grube, 1999; Katz et al. 2000; Kucera, 1998; Piette, Fleishman, & Mor, 
1992), it is likely that each patient has different needs and challenges in connecting to a 
case manager, who may serve as a link to outpatient clinical care.  A pre-determined 
number of case management contacts for all HIV-positive patients may help contain costs 
but may not be in the best interest of patients across all situations.   
 
Besides the impact of intensity of case management contact on levels of HIV-related 
outpatient visits, this study also addressed the type of formal social support in an effort to 
further understand the impact of case management for HIV-positive patients.  Although a 
few published studies have categorized case management services, the present study is 
believed to be one of the first to investigate whether certain types of formal social support 
are sex/gender-specific and the extent of the role they play in connecting HIV-positive 
men and women to outpatient care.  Two types of formal social support – informational 
and instrumental – made up of two and three individual HIVRN interview items, 
respectively, were used as proxies for these support types.  Patients reported what types 
of services they received across up to two case managers.  In multivariate analyses, 
neither type of formal social support was significant in predicting levels of HIV-related 
outpatient visits.  It is possible that the instrumental and informational support items, 
which were taken from the larger HIVRN adult patient interview, did not reflect these 
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particular constructs.  Other possible individual services provided by case managers, 
including linkages to transportation, housing, legal help, childcare, complementary and 
alternative therapies, and final will preparation, were not included in the development of 
the study proxies; it is possible some of these services may have been sex/gender-
specific, e.g., childcare.  Formal reliability and validity tests on the informational and 
instrumental support constructs were outside the scope of this dissertation; however, 
these constructs were perceived to have acceptable face validity.   
 
In the early 1990s, Fleishman, Mor, and Piette (1991) noted that patients with a greater 
need for social services had more frequent contact with case managers, suggesting that a 
positive relationship exists between need and contact.  The HIVRN items used in the 
current analyses dealt with patient self-reported receipt of a particular service, which is 
different from patient self-reported need; an item example of the former was “did you 
receive help with medical services?”  There exists a set of HIVRN items that ask patients 
about whether they needed a particular service.  An item example was “did you need 
home care or personal assistance in the last six months?”  These items should be used in a 
future study to examine the potential relationship between patient identified need, receipt 
of a service to meet that need from a case manager, and other clinical care services.   
Other Findings 
Among patients who had one case manager, the most frequent response across both types 
of formal social support – informational and instrumental - was personal advice (n=177; 
45%).  Among patients with two case managers, the most frequent response across both 
types of formal social support – informational and instrumental - was help with social 
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services (n=36; 43%).  Another interesting observation in the study sample was that 
although a majority of patients reported having one or two case managers, this did not 
necessarily mean they saw the case manager during the study period and received study-
defined services.  For example, among patients who self-reported having one case 
manager (n=391, 49%), 152 (39%) said they did not receive one of three possible 
services falling under instrumental support, including help with medical services, help 
with social services, or help with filling out forms for benefits.  Similarly, among patients 
who self-reported having two case managers, (n=83, 10%), 34 (42%) said they did not 
receive any of these services.  One hundred eighty nine (48%) patients with one case 
manager did not receive one of two possible services under the informational support 
type, including help with HIV-related medications and personal advice.  On the other 
hand, a small minority of patients with one or two case managers did receive all three 
services under instrumental support as well as both services under informational support.  
These results suggest that there are multiple factors that influence patient receipt of 
formal social support provided by case managers.  Patient self-perceived and actual need, 
enabling resources, case manager access and availability, and other features and 
dimensional qualities of the patient-provider relationship, not all of which were addressed 
in the current study, may all contribute to receipt of services and subsequent connections 
to outpatient care.  
 
Limitations 
Several limitations of the present study must be noted.  Although the HIVRN patient 
interview questions evolved from the HCSUS research, and preliminary results using the 
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HIVRN clinical dataset show a resemblance to HCSUS findings, the HIVRN is not a 
nationally representative sample of patients living with HIV/AIDS or of institutions 
providing their care.  The HIVRN patient interview data provides a cross-sectional view 
of health services use in 2003 and thus, cannot be used to examine trends over time in 
health services.  The Data Coordinating Center at Johns Hopkins University Medical 
Center has combined data across sites to achieve a uniformly constructed multi-site 
database.  To protect patient confidentiality, no researcher outside of JHU has been given 
access to site-specific information.    
 
A potential bias may exist as a result of patient interview data coming from intact clinical 
sites where clients are well-situated in regular care, and are virtually all covered by some 
form of public/private health insurance.  This bias may lead to an overestimate of the 
number of outpatient and case manager visits among HIVRN adult patients relative to a 
cross-section of people in care for HIV/AIDS.  If this were so, patients may have more 
outpatient visits because they have more complex needs, because HIVRN providers have 
greater than average expertise, because more enabling services are available to them, or 
for a variety of other possible reasons.  It is reasonable to believe that formal social 
support can facilitate entry into and retention in HIV care and enhance other outpatient 
care services.  Overcoming barriers to meeting social and personal needs may allow 





Patients with 6+ outpatient visits may have had all their visits in one month, or these 
visits may have been spread out over the study period.  Each of these scenarios presents a 
different picture of patient health: clustered visits may be more likely to occur during 
health crises, while evenly distributed visits might represent adherence to a standard of 
outpatient care.  It is possible that several follow-up visits were linked to a single visit or 
that some outpatient visits were follow-up visits related to medication side effects, lab 
results, or other co-morbid conditions; it is also possible that case managers and 
outpatient clinic care providers were located near one another or even in the same 
building, allowing easier and more frequent access to care.  Dates for outpatient visits, 
available in the HIVRN clinical dataset, may be useful to better understand these possible 
situations. 
 
For the purposes of the current study, the number of outpatient visits was operationalized 
as “average” (2-5 visits) and “high” (6+ visits), based on input from three HIV/AIDS 
experts.  Other HIV/AIDS-related studies have used an even more basic framework than 
the current study for recording medical services use; in a recent article by Knowlton and 
colleagues (2005), the operationalization of outpatient medical service use was recorded 
as “none” versus “any” during the previous six months.  The categories for outpatient 
visits used in this study assume that patients with dissimilar numbers of visits, e.g., two 
and five visits, are similar.  Developing strategies to model the number of outpatient 
visits as a continuous variable is a goal for further research.  A broader range of 
outpatient visit categories may provide a closer approximation to the continuum of care 
provided to HIV-positive patients.   
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Diversity of patient racial/ethnic backgrounds was limited, as patients who participated in 
the HIVRN adult patient interview were predominantly White (31%) and Black (51%).  
Furthermore, patients were asked to self-identify with only one racial/ethnic group.  This 
limits understanding regarding multi-racial patients.  Also, patients who were 
transgendered were not identified.  Data on patient household income, as well as self-
reported HIV risk factors such as transmission route, were not available in the HIVRN 
adult patient interview database.  Viral load, an additional important indicator of illness 
progression and treatment response, was not collected during the HIVRN adult patient 
interview but was captured in the HIVRN clinical dataset.  Cross-referencing the HIVRN 
clinical and patient interview datasets is an ongoing effort by the JHU Data Coordinating 
Center. 
 
It is possible that patients with mental health and substance abuse problems were 
underrepresented in the HIVRN sample since such patients may be less likely than others 
to have sought clinical care in the settings in which the interviews were conducted or to 
have made themselves available for interviews.  All of the HIVRN items related to 
mental health employed the same six-month reference period (or a shorter period, i.e., 
four weeks) as the clinical service use outcomes.  Thus, it was not possible to establish a 
history or lifetime experience of mental health issues that may have been associated with 
level of HIV-related outpatient visits in this study sample.  In contrast, interview items 
about patients’ ever having used illicit drugs allowed for consideration of this variable as 
a covariate.  Illicit drug use was not found to be a significant predictor of the level of 
HIV-related outpatient visits in this study.  This may speak to the level of experience or 
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skill of providers in the HIVRN in dealing with patients with histories of substance 
abuse.  
 
For the purposes of this study, case managers were conceptualized as one kind of formal 
social support system to help connect patients to outpatient care.  Still, the natural 
progression of HIV/AIDS may include some inpatient hospitalizations, despite providers’ 
best attempts to maintain connections to community-based resources, including 
outpatient care (Katz et al., 2001).  Patient follow-through with referrals for services by 
case managers was not verified in the HIVRN adult patient interview.  Also, only those 
patients who self-reported having a case manager were asked follow-up questions about 
supportive/referral services.  It is possible that some patients were referred to social 
services by individuals, such as friends and colleagues, who fill informal social support 
roles and are part of a larger social support network.  Also, patients who live with others 
may have access to informal social support in their living environments as compared to 
those who live alone or are homeless; however, patients’ other family members may also 
include elderly parents or dependent children whose needs may take precedence over 
their own.  Information about the positive or negative aspects of informal social support 
was not available from the HIVRN adult interview dataset.  In the present study, a 
significant association was found between patient sex and living arrangement (defined as 
living alone, living with others, or homeless).   HIV-positive men were more likely to be 
living alone than HIV-positive women in the current study.  There was no difference 
between male and female study patients in the proportions who were homeless.  There 
was no significant association between having a case manager or not having a case 
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manager and living arrangement, nor did living arrangement significantly predict the 
level of outpatient visits.  Given that more than 50% of the total study sample lived with 
others, more research is needed to understand how shared living space influences patient 
participation in outpatient disease management.    
 
Because information about the HIVRN case management support service/referral items 
was limited, the validity and reliability of these patient interview sections must be 
interpreted with caution.  Informational and instrumental support, as well as other types 
of support such as financial and emotional, are multi-dimensional constructs with 
transactional qualities between helpers, clients, and networks that are not fully captured 
in the HIVRN adult patient interview.  Other research has shows that ongoing emotional 
support is particularly important to patients living with HIV/AIDS (Heath & Rodway, 
1999; Zich & Temoshok, 1987).  Emotional support may also play a role in helping some 
patients access outpatient services (Knowlton, Hua & Latkin, 2005).   
 
As previously noted, the interview sections have not undergone reliability and validity 
tests.  Lack of reliability testing raises the question whether different items within the 
same construct will yield similar results under similar conditions; lack of validity testing 
for types of formal social support raises the question whether what was measured in the 
present study may actually be instrumental or informational support.  Notwithstanding, 
the literature on case managers as one form of social support for HIV-positive patients 
suggests there is a reasonable degree of face validity.  Other HIVRN researchers may 
shed additional light on these issues.  The findings from the present exploratory study can 
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be used as a starting point for further examining and evaluating the relationship between 
types of formal social support and levels of outpatient care in samples of HIV-positive 
men and women, thus contributing to the understanding of HIV/AIDS comprehensive 
care.   
 
As previously noted, the student researcher was not able to assess findings by HIVRN 
site.  The data comes from 14 different sites; although a standard protocol was used for 
the interviews, it is possible that some variation in the interview process took place by 
site.  Along these lines, given the sensitive nature of HIV-related care, fear of stigma and 
discrimination, and other challenges associated with living with HIV/AIDS, it is possible 
that patients’ self-reported answers may reflect some measure of social desirability bias.  
The overall number of items to respond to during the interview may have been physically 
tiring for some patients, thus affecting the accuracy of their responses.  Finally, not all 
variables in the HIVRN adult patient interview were analyzed for this study; it is possible 
that additional variables may contribute to a better understanding of HIV/AIDS-related 
health services utilization.   
Conclusions and Recommendations for Future Study 
In this study, HIV-positive men and women who had one or two case managers were 
significantly more likely to have a high level of outpatient visits (6+) than their 
counterparts who did not have a case manager.  While these results could suggest the 
importance of case managers for helping patients living with HIV/AIDS connect to 
outpatient care, this study did not find that informational or informational support 
provided by case managers led to this outcome.  An alternative patient-driven explanation 
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for the relationship between case management and more outpatient visits is that some 
patients who seek case managers also seek more outpatient care.  The number of in-
person case management contacts over the six month study period and the type of support 
– informational or instrumental - provided by the case manager(s) were not significant 
predictors of the level of outpatient care.  There is an ongoing need to understand the 
transactional nature of case manager-provided support and those tangible services that 
may help connect patients to outpatient care.  Patients who were employed part- or full-
time and had higher self-perceptions of their health were also significantly less likely to 
have high levels of outpatient visits.  No sex/gender-specific differences were found in 
the current study.  Recommendations for future areas of research are outlined below. 
 
Recommendations for HIV/AIDS Case Management Research 
This study was unique in its focus on the impact of case management from a sex/gender 
perspective on levels of HIV/AIDS outpatient visits in the post-HAART era, and in its 
question concerning whether a “one size fits all” approach to case management is the best 
strategy.  Research to date has shown that having HIV/AIDS is not a “one size fits all” 
experience; that men and women affected by HIV/AIDS have different physical, social, 
cultural, and mental health issues (Heath & Rodway, 1999; Lichenstein, Laska, & Clair, 
2002; Thorne, McCormick, & Carty, 1997; Rao Gupta, 2000; Zierler & Krieger, 1997) as 
well as different priorities in managing their own health and caring for those around 
them.  Thus, it remains possible, although it was not observed in this study, that certain 
HIV/AIDS case management services may be more helpful for women than for men, just 
as some services may be more helpful for men than for women.  Focus groups and other 
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qualitative research strategies could be useful to gather more information about these 
similarities and differences.  Addressing case management from a sex/gender perspective 
supports other similar HHS research and policy efforts that are addressing the importance 
of effective models and systems of care from this angle (HHS, 2007).    
 
Other studies may also address the creation of different formal social support service 
scales organized by type as well as a composite scale of services that could be adapted 
and tested for use among different groups of HIV-positive persons.  When developing 
descriptions of case management services and frequency of use, researchers should pay 
attention to making response options as measurable as possible.  Studies that address 
networks of formal social support provided by case managers, in addition to informal 
social support provided by family members, friends, and colleagues, may be helpful in 
further understanding the personal and functional aspects of social support in HIV/AIDS 
patients’ lives.   Because the course of HIV illness changes over time, it is also essential 
to learn more about which case management services may be best introduced into patient 
care at different times in the illness trajectory; for example, at the time of initial diagnosis 
or when a patient has developed full-blown AIDS.    
 
Recommendations for Patient-Level Research 
As previously noted, patients in the study sample who had one or two case managers 
were significantly more likely to have 6+ outpatient visits than those without a case 
manager.  There were no sex/gender-specific differences in the association of the level of 
outpatient visits.  As to other sex/gender-specific differences, female patients in the study 
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sample were more likely to be Black, between the ages of 20-49; have less than a high 
school education; have higher CD4 counts; be unemployed; and have Medicaid as their 
form of insurance.    
 
There was a small group of patients in the study sample (n=43, 5%) who had three or 
more case managers.  This group of patients was not asked follow-up questions about the 
types of services they received from case managers and thus, they were not included in 
the bivariate or multivariate analyses.  It is possible that patients were assigned different 
case managers at different sites where they obtained care.  More information is needed 
about the characteristics of this cohort in larger samples and whether having multiple 
case managers improves health outcomes.  HIV-positive patients with three or more case 
managers may be at a disadvantage if their care coordination is not well-managed and 
communicated with all members of their medical and social service team.   
 
There were 323 patients (41%) in the study sample who reported they did not have a case 
manager during the study period.  It is possible a case manager was not available to these 
patients or that they did not want a case manager at the time.  These patients may also 
have had other persons helping them coordinate their care, obviating the need for a case 
manager.  Previous HIV/AIDS case management research has suggested that persons 
with greater needs were more likely to have a case manager (Emlet & Gusz, 1998; 
Fleishman, Mor, & Piette, 1991), while more recent literature has suggested that case 
managers can intercede early and help patients meet their social service needs while 
maintaining a high quality of life (Chernesky & Grube, 2000; Mitchell & Linsk, 2001).  
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How case managers fit into the existing social support structure of HIV-positive patients’ 
lives, as well as over time, is an important area for further research. 
 
Additional patient-level research is needed to learn more about how perceptions of health 
and need play into receipt of outpatient care.  As noted earlier, Meyerson and colleagues 
(2007) posited that HIV-positive patients’ relationship with the outpatient care system is 
complicated by their own sense of well-being or illness and does not always follow 
policymakers’ recommendations.   Other researchers have also noted that self-perceptions 
play a large role in patient receptivity to social support (Burgoyne & Saunders, 2000; 
Gant & Ostrow, 1995; Hudson, Lee, Miramontes, & Portillo, 2001; Serovich, Brucker, & 
Kimberly, 2000).  At the same time, if CD4 count alone were used as a measure of health, 
a significant number of male and female patients in this study could be expected to self-
report a low perception of health status, given that their self-reported counts were at or 
below 200 cells/mm3 (the cut-off point for AIDS); however, this was not found to be the 
case.  Patients who have low CD4 counts and have high perceptions of their health status 
may have found worthwhile connections to support systems that were not addressed in 
the current study, such as mental health, faith-based, and workplace support groups, all of 
which can help with feeling well.  Further research is needed to determine whether these 
types of supportive activities are sex/gender-specific and whether or how they influence 
levels of HIV/AIDS-related outpatient care.  Quality of life studies are particularly 





Recommendations for Health Care Policy  
As researchers continue to develop new HIV treatments that can help patients live with 
and manage their illness for years to come, the U.S. health care system will face critical 
challenges. As health insurance plans increasingly impose restrictions and limitations on 
paying for care, long-term HIV/AIDS treatment costs continue to grow.  According to 
Schackman and colleagues (2006), the estimated undiscounted lifetime cost of medical 
care for HIV-positive adults could be as high as $618,900.  This figure does not include 
costs for mental health and substance abuse treatment or for case management services.  
Payers of last resort continue to be stretched to meet more patient needs. 
 
Federal funding for HIV/AIDS has undergone major changes in the past few years.  The 
Ryan White CARE Act, which was reauthorized for three years in December 2006 and is 
now referred to as Title XXVI of the PHS Act as amended by the Ryan White HIV/AIDS 
Treatment Modernization Act of 2006, has redefined criteria and formulas for funding 
eligibility to states, territories, public and private providers, and organizations to cover 
costs for more than half a million people a year (Kaiser Family Foundation, 2007).  For 
the first time in the history of CARE Act legislation, at least 75% of funds must be spent 
on a group of “core medical services” for Parts A-C (formerly known as Titles I-III).  
These core medical services include, among other services, outpatient care, mental health 
and substance abuse services, and medical case management.  Although there has been 
some concerted effort to shift funding toward evidence-based HIV prevention, public 
funding through Medicaid, Medicare, and Ryan White programs is focused largely on 
treatment (Kaiser Family Foundation, 2007).  Analyzing the impact of the reauthorized 
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Ryan White Program over the next three years will be critical to future health policy and 
research decisions.  Health care policymakers should also address the gender-based 
inequities in HIV risk within the larger context of diverse social, economic, and political 
systems.  
 
In the current study, nearly all patients had some form of health insurance, which may 
explain why the levels of outpatient visits were so positively skewed, and why health 
insurance was not found to be a significant predictor of outpatient service utilization.  Of 
the 797 patients in the study sample, 71% had Medicaid or a combination of Medicaid 
with WIC, Veterans, Ryan White CARE Act, Champus/Tricare, or other county level 
program benefits, while 12% of the sample was covered under Medicare and 16% had 
private insurance.  Among HCSUS patients in the mid-1990s, researchers estimated that 
nearly 20% of individuals living with HIV/AIDS were uninsured, one-third had private 
insurance, and the remainder were covered by Medicaid and Medicare (Kaiser Family 
Foundation, 2004).  Currently in various parts of the U.S., the number of HIV-positive 
patients with health insurance coverage is highly variable, as are the experience levels of 
HIV/AIDS clinicians.  Patients who are not well-connected to providers, who do not have 
the means to pay for their care, and whose other social service needs are not met are 
likely to be in and out of the health care system.  In contrast, HIV-positive and other 
chronic care patients who have support to navigate the health care system and maintain 
continuity of care may be able to extend the length and quality of their lives.   
146  
 
Appendix A – Confidentiality Statement 
147  
 
Appendix A – Confidentiality Statement  
148  
 
Appendix A – Confidentiality Statement  
149  
 
Appendix B – HIVRN Adult Patient Interview  
 
HIV Research Network -- Patient Interview DRAFT 7 
 
1.8 INTERVIEWER:  CODE ONE 
 
  PERSONAL INTERVIEW   ...................................   1 
 




1.9 INTERVIEWER:  CODE ONE 
 
  INTERVIEW WITH RESPONDENT  ...................   1 
 




1.10 INTERVIEWER:  CODE ONE 
 
  ENGLISH INTERVIEW   .......................................   1 
 









     Unless otherwise indicated, every item has these "hidden" values   refused = -1 
                                                                                                              don't know = -2 
 
This interview is about your health care and related issues.  It will take about 2 hours.  
We can take a break any time you feel you need one; just let me know.  You will be paid 
$30  in cash for completing the interview. 
 
 
1. Before we begin, I need to give you an informed consent document to read and 
sign, along with a brochure that explains more about the study. 
 (Circle One) 
FULL INFORMED CONSENT ALREADY SIGNED   ........................   1 SKIP TO 
NEXT SECTION 
FULL INFORMED CONSENT NOT SIGNED   ...................................   2 
 
HAVE RESPONDENT READ AND SIGN INFORMED CONSENT FORM. 
RETAIN TOP COPY OF INFORMED CONSENT FORM. 
LEAVE BOTTOM COPY AND BROCHURE WITH RESPONDENT. 
 
POINT OUT 1-800 NUMBER IN BROCHURE IN CASE 
RESPONDENT 
HAS ANY QUESTIONS OR PROBLEMS (1-800-700-2464). 
 
 
2. HAS R SIGNED INFORMED CONSENT? 
 (Circle One) 
YES   ....................................  1 
 
NO   ......................................  2 DO NOT PROCEED 




Section A:  Usual Source of Medical Care 
 
RECORD TIME THIS SECTION BEGINS:________________ 
 
A0.  CODE RESPONDENT’S GENDER. 
 (Circle One) 
    MALE   ............................................................  1 
 FEMALE  ........................................................  2 
 
I’d like to start by asking where you get medical care for HIV. 
 
A1.  Is there one place in particular, like a doctor's office or clinic, where you usually 
go for most of your HIV treatment, like examinations, CD4 tests or prescriptions 
for HIV-related medicines? 
 (Circle One) 
 YES   ................................................................  1 
NO   ..................................................................  2 SKIP TO A7 
DON'T KNOW   ............................................... -2 SKIP TO A7 
 
A2. What is the name of this place? 
 
 _______________________________________________________________________  
PROVIDER NAME 
 
A3. Let's call this your usual source of care.  How long have you had this usual source 
of care for treatment of HIV? 
ENTER HOW LONG:    CIRCLE UNIT: DAYS   ..............  1 
(VARIABLE COMBINES 2 RESPONSES — UNITS-DAYS) WEEKS   ............  2 
MONTHS   ........  3 
YEARS   ............  4 
 
A4. In the past 12 months, have you had an urgent problem due to your HIV 
infection? This would be a problem that you thought needed care right away from 
a doctor, nurse or other health care provider. 
 (Circle One) 
 YES   ................................................................  1 
NO   ..................................................................  2 SKIP TO A5 




A4a When you had an urgent problem due to HIV, how would you rate the length of 
time you had to wait before you could see your usual source of HIV care (when you did 
not already have an appointment scheduled)? 
 
 (Circle One Number) 
 | | | | | | | | | | | 
 0 1 2 3 4 5 6 7 8 9 10 
Worst possible  Half-way Best possible 
    
               DID NOT SEE -- JUST SPOKE OVER THE PHONE  …………………-3 
 
A4b. When you had an urgent problem due to HIV, how would you rate the length of 
time it took for you to get advice over the telephone from your usual source of 
HIV care? 
 (Circle One Number) 
 | | | | | | | | | | | 
 0 1 2 3 4 5 6 7 8 9 10 
Worst possible half-way best possible 
      
             DID NOT SPEAK ON PHONE -- SAW PROVIDER ………………….-3 
 
 
A5. About how much time does it usually take you to get to your usual source of HIV 
care from where you live? 
 
 a.  ENTER HOW LONG:  b.  CIRCLE UNIT: MINUTES   ......  1 
HOURS   .........  2 
 
 
A6. When you go to your usual source of HIV care for a scheduled appointment, about 
how long do you usually have to wait from the time you arrive to the time you 
actually see a doctor, nurse, or other care provider? 
 
 a.  ENTER HOW LONG:  b.  CIRCLE UNIT: MINUTES  ..............  1 





Now I have some questions about the medical people who treat your HIV infection.  
These are doctors, nurses, or physician's assistants who you see for HIV treatment.  I'll 
call them "HIV care providers."   
 
 
A7. In the last 12 months, how often did your HIV care providers listen carefully to 
you? 
 
 (Circle One) 
    Never ......................................................   1  
Sometimes  ……………………..…….2 




A8. In the last 12 months, how often did your HIV care providers explain things in a 
way you could understand? 
 
 (Circle One) 
    Never ......................................................   1  






A9. In the last 12 months, how often did your HIV care providers show respect for 
what you had to say? 
 
 (Circle One) 

















A10. In the last 12 months, how often did your HIV care providers spend enough time 
with you? 
 
 (Circle One) 







A10a. In the last 12 months, how often did your HIV care providers talk to you about 
possible problems you had with taking your HIV medicines? 
 
 (Circle One) 




NOT TAKING MEDS………………… -3 
DON'T KNOW………………………….-2 
 
A10b.  How would you rate how well your HIV care providers informed you about the 
possible side effects of your medications? 
 
 (Circle One Number) 
 | | | | | | | | | | | 
 0 1 2 3 4 5 6 7 8 9 10 
Worst possible half-way best possible 
 
   NEVER DISCUSSED SIDE EFFECTS  -5 
 
 
A11.  We want to know your rating of your HIV-related health care in the last 12 months.  
Use any number from 0 to 10, where 0 is the worst health care possible and 10 is the best 
health care possible.  How would you rate your health care? 
 (Circle One Number) 
 | | | | | | | | | | | 
 0 1 2 3 4 5 6 7 8 9 10 
Worst possible health Half-way  Best possible care 





                                  B. Symptoms  
 
B1.  I am now going to ask you several questions about your health during the past three months. 
























2= Yes   
-2= DK 


























-2 = DK 
 










treatment  with 
another  




   dose of med 
4=other 
-2 = DK 
 
  GO TO NEXT 
SYMPTOM 
 
1  Problems with sleep 
     
 
2  Changes in mood 
     
3 Dizziness or 
problems with balance 
     
4  Frequent or severe 
headaches 
     
5  Fatigue or loss of 
energy  
     
6 Aches, weakness, or 
inflammation in  
muscles or joints  
     
7  Nausea or  stomach 
difficulties (swelling, 
pain, bloating) 
     
8 Bowel problems 
(diarrhea, loose stool)  
     
9  Problems with 
sexual function 
     
10  Skin rash, itching,  
sores or discoloration 
     
11.  Problems with 
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12.  Changes in your 
body shape due to fat 
deposits 
     
13.  Loss of appetite or 
change in the taste of 
food 
     
14.  Vivid dreams      
15.  Trouble with your 
eyes, such as seeing 
spots or blind areas in 
your vision 
     
16.  Fevers, sweats, or 
chills 
     
17.  Pain, numbness, 
or tingling in your 
hands or feet 
     
18. Persistent 
coughing, difficulty 
breathing, or difficulty 
catching your breath 
that lasted for more 
than 1 week 
     
 
B2.  Of all the CD4 tests you have ever had, what was your lowest count? 
 
 ENTER COUNT 1 COUNT:  
      NEVER HAD A CD4 TEST ...................... -5 
   DON'T KNOW…………………………..-2 
 
 IF B2 = DK, REF GO TO B3, ELSE GO TO B6 
 
B3.  Was your lowest CD4 count less than 500? 
 
 YES ....................................................................1  
 NO ......................................................................2 
  
 IF B3 = 2, REF, GO TO B6 
 
B4.  Was it less than 200? 
 
 YES ....................................................................1  
 NO ......................................................................2 
  





B5. Was it less than 50? 
  
 YES ....................................................................1  
 NO ......................................................................2 
  
B6.  Has a doctor ever told you that you had AIDS? 
 
 YES ....................................................................1   
 NO ......................................................................2 
  
 
C.  UTILIZATION OF CARE 
 
Section CA.  Nursing Home / Residential Care Stays 
 
 
CA1. During the last 6 months, were you a patient in a residential care facility, a 
nursing home or hospice overnight or longer? 
 (Circle One) 
YES ..........................  1 
NO ............................  2   SKIP TO CB1 
 
 
CA2.  How many different times were you admitted to such a facility during the last 6 
months? 
 TIMES:   IF ‘0’, SKIP TO NEXT SECTION 
 
 
CA3. In total, how many nights did you spend in residential facilities in the last 6 
months? 
 
 NIGHTS:   
 
 




Section CB.  Inpatient Hospital Stays 
 
 
CB1. During the last 6 months, were you a patient in a hospital overnight or longer?  
CODE YES IF CURRENTLY INPATIENT. 
 (Circle One) 
YES………… 1 
NO……………2 SKIP TO CB34     
 
CB2. How many times were you admitted to the hospital overnight or longer during the 
last 6 months? 
 
 
 TIMES:   IF ‘0’, SKIP TO NEXT SECTION 
 
 
CB3. Let’s start with the most recent stay.  What is the name of the hospital?  
 ________________________________________________________________________  
HOSPITAL NAME 
 
CB4. How many nights were you in the hospital for this stay? 
 
 NIGHTS:   
 
 
CB4a. Were you in an intensive care unit during this hospital stay? 
 (Circle One) 
YES  .........................................  1 
NO  ...........................................  2 SKIP TO CB5 
REFUSED  ................................ -1 
DON'T KNOW  ........................ -2 
 
CB4b. How many nights (were you in intensive care)? 
 





CB5. While you were in the hospital for this stay, did you have any kind of surgery or 
procedure performed in the operating room? 
 (Circle One) 
YES  .........................................  1 
NO  ...........................................  2 
REFUSED  ..............................  -1 
DON'T KNOW  ......................  -2 
 
CB6. INTERVIEWER:  CHECK QUESTION CB2 
CB2 = 1 TIME  ......................... 1SKIP TO CB32 
CB2 = 2 OR MORE TIMES  .... 2 
 
HOSPITAL STAY 2 
 
CB7. Did you have any other hospital stays during the last 6 months? 
 
 (Circle One) 
YES  .........................................  1 
NO  ...........................................  2 SKIP TO CB32 
REFUSED  ................................ -1 SKIP TO CB32 
DON'T KNOW  ........................ -2 SKIP TO CB32 
 
CB8. Now let's talk about the stay before your most recent stay.  What is the name of 
the hospital?   
 (Circle One) 
SAME HOSPITAL AS FIRST STAY  ..  2  
 
 ________________________________________________________________________  
HOSPITAL NAME 
 
CB9. How many nights were you in the hospital for this stay? 
 







CB10. Were you in an intensive care unit during this hospital stay? 
 (Circle One) 
YES  .........................................  1 
NO  ...........................................  2 SKIP TO CB11 
REFUSED  ................................ -1 
DON'T KNOW  ........................ -2 
 
CB10a. How many nights (were you in intensive care)? 
 
 NIGHTS:   
 
CB11. While you were in the hospital for this stay, did you have any kind of 
surgery 
or procedure performed in the operating room? 
 (Circle One) 
YES  .........................................  1 
NO  ...........................................  2 
REFUSED  ..............................  -1 
DON'T KNOW  ......................  -2 
 
CB12. INTERVIEWER:  CHECK QUESTION CB2 
CB2 = 2 TIMES  ....................... 1SKIP TO CB32 
B2 = 3 OR MORE TIMES  ....... 2 
 
HOSPITAL STAY 3 
 
CB13. Did you have any other hospital stays during the last 6 months? 
 (Circle One) 
YES  .........................................  1 
NO  ...........................................  2 SKIP TO CB32 
REFUSED  ................................ -1 SKIP TO CB32 










CB14. Now for the stay before the one you just told me about.  What is the name of the 
hospital?   
 (Circle One) 
SAME HOSPITAL AS STAY #1 ..........  1  
SAME HOSPITAL AS STAY #2 ..........  2  
 __________________________________________________________________  
HOSPITAL NAME 
 
CB14a. How many nights were you in the hospital for this stay? 
 
 NIGHTS:   
 
 
CB15. Were you in an intensive care unit during this hospital stay? 
 (Circle One) 
YES  .........................................  1 
NO  ...........................................  2 SKIP TO CB16 
REFUSED  ................................ -1 
DON'T KNOW  ........................ -2 
 
 
CB15a. How many nights (were you in intensive care)? 
 
 NIGHTS:   
 
 
CB16. While you were in the hospital for this stay, did you have any kind of 
surgery or procedure performed in the operating room? 
 (Circle One) 
YES  .........................................  1 
NO  ...........................................  2 
 
CB20. INTERVIEWER:  CHECK QUESTION CB2 
CB2 = 3 TIMES  ....................... 1SKIP TO CB32 






HOSPITAL STAY 4 
 
CB21. Did you have any other hospital stays during the last 6 months? 
 (Circle One) 
YES  .........................................  1 
NO  ...........................................  2 SKIP TO CB32 
REFUSED  ................................ -1 SKIP TO CB32 
DON'T KNOW  ........................ -2 SKIP TO CB32 
 
CB22. Now for the stay before the one you just told me about.  What is the name of the 
hospital?  
 (Circle One) 
SAME HOSPITAL AS STAY #1 ..........  1  
SAME HOSPITAL AS STAY #2 ..........  2  
SAME HOSPITAL AS STAY #3 ..........  3  
 
 ________________________________________________________________________  
HOSPITAL NAME 
 
CB23. How many nights were you in the hospital for this stay? 
 
 NIGHTS:   
 
 
CB24. Were you in an intensive care unit during this hospital stay? 
 (Circle One) 
YES  .........................................  1 
NO  ...........................................  2 SKIP TO CB25 
REFUSED  ................................ -1 
DON'T KNOW  ........................ -2 
 
CB24a. How many nights (were you in intensive care)? 
 






CB25. While you were in the hospital for this stay, did you have any kind of 
surgery or procedure performed in the operating room? 
 (Circle One) 
YES  .........................................  1 
NO  ...........................................  2 
 
 
CB26. INTERVIEWER:  CHECK QUESTION CB2 
CB2 = 4 TIMES  ....................... 1SKIP TO CB32 
CB2 = 5 OR MORE TIMES  .... 2 
 
HOSPITAL STAY 5 
 
CB27. Did you have any other hospital stays during the last 6 months? 
 (Circle One) 
YES  .........................................  1 
NO  ...........................................  2 SKIP TO CB32 
REFUSED  ................................ -1 SKIP TO CB32 
DON'T KNOW  ........................ -2 SKIP TO CB32 
 
CB28. Now for the stay before the one you just told me about.  What is the name of the 
hospital?  
 (Circle One) 
SAME HOSPITAL AS STAY #1 ..........  1  
SAME HOSPITAL AS STAY #2 ..........  2  
SAME HOSPITAL AS STAY #3 ..........  3  
SAME HOSPITAL AS STAY #4 ..........  4  
 
 
 _______________________________________________________________________  
HOSPITAL NAME 
 
CB29. How many nights were you in the hospital for this stay? 
 






CB30. Were you in an intensive care unit during this hospital stay? 
 (Circle One) 
YES  .........................................  1 
NO  ...........................................  2 SKIP TO CB31 
REFUSED  ................................ -1 
DON'T KNOW  ........................ -2 
 
 
CB30a. How many nights (were you in intensive care)? 
 
 NIGHTS:   
 
CB31. While you were in the hospital for this stay, did you have any kind of 
surgery 
or procedure performed in the operating room? 
 (Circle One) 
YES  .........................................  1 
NO  ...........................................  2 
 
 CB32.     Were any hospitalizations in the past six months due to side effects of 
HIV medications you were taking? 
 (Circle One) 
YES  .........................................  1 
NO  ...........................................  2  
 REFUSED……………………  -1 
DON'T KNOW……………….  -2 
 
 
 CB33.     Were any hospitalizations in the past six months due to complications of 
AIDS, like PCP, MAC, "toxo," "crypto", or some other opportunistic infection? 
 (Circle One) 
YES  .........................................  1 
NO  .............................................   2 (go to CB34)  
 REFUSED………………….  -1 (go to CB34) 







CB33a.  How many different times were you admitted to the 
hospital to treat an opportunistic infection in the last six 
months? 
 
  ____________ times 
  DON'T KNOW  -2 
 
CB34.  We've been talking about inpatient hospitalizations in the past six months.  Now 
think about the six months before that.  In this earlier six-month period, were you 
a patient in a hospital overnight or longer?   
 (Circle One) 
YES………… 1 
NO .   2 SKIP TO NEXT SECTION 
 
CB35. How many times were you admitted to the hospital overnight or longer during the 




 DON'T KNOW   -2 
  
 
Section CC.  Visits to Emergency Rooms and Urgent Care Centers 
 
CC1. During the last 6 months, did you ever go to an emergency room, or urgent care 
center for medical care? 
 (Circle One) 
YES ..........................  1 
NO ............................  2  SKIP TO D1
 
 




 ER's:   IF ‘0’, SKIP TO NEXT SECTION 
 
 CC3.    What was the name of the emergency room that you went to (IF > 1 ADD: most 
often)? 





CC4. Thinking about all the visits you made to the (NUMBER IN CC2) different 
emergency rooms, how many total visits did you make in the past 6 months? 
 
PROBE IF ZERO:  You told me earlier that you went to an emergency room in 
the 
last 6 months.  Please include that visit in your answer 
 
 VISITS:   
 
CC5. How many of the (NUMBER IN CC4) visits led directly to a hospital stay? 
 VISITS:   
 
CC6.   Think about the last time you went to an emergency room.  What did you go there 
for? 
 (Circle One) 
1. An illness that you thought was related to HIV infection……………..1 
2. An accident or an injury……………………………………………….2 
3. Pregnancy-related care……………………………………………..….3 
4. Alcohol or drug-related condition……………………………………..4 
5. An illness that wasn't related to HIV infection ………………………. 5 
6. Another person was sick or injured……………………………………6 
7. Don't remember………………………………………………………..7 
 
CC7.  When you went to the emergency room last time, did you decide to go on your 
own, or did a health care provider tell you to go there? 
 
   ON MY OWN………………………..1 
    
   TOLD TO GO THERE………………2 
 
CC8.     Were any emergency room visits in the past six months due to side effects of 
HIV medications you were taking? 
 (Circle One) 
YES  .........................................  1 
NO  ...........................................  2  





Section CD.  Medical Visits 
 
People with HIV infection often make visits for medical care.  Many also get treated for 
mental or emotional problems, and some get treated for problems with drugs or alcohol.  
I'd like to ask you about all these services.  Let's start with medical care, for HIV and for 
other medical problems that you may have had.  For these questions, please don't include 
visits that were only to treat mental or emotional problems, or for drug or alcohol 
problems. 
 
CD1.   In the past 6 months, how many times did you go to a clinic, private doctor's 
office, or HMO for medical care?  Don't count visits to an emergency room. 
Visits______________________ 
 
 PROBE IF NONE:  Please think about visits to your usual sources of medical care 
and any other kinds of doctors or clinics you might have gone to in the last 6 months. 
 
 
CD2. Think about the care center you visited the greatest number of times.  What was 




CD3 Did you go to any other office or clinic for medical care in the past 6 months? 
 
 (Circle One) 
YES  .........................................  1 
NO  ...........................................  2 SKIP TO CD4 
REFUSED      - 1  SKIP TO CD4 
DON'T KNOW    -2  SKIP TO CD4 
 
CD3a. Besides (NAME from CD2), how many different places did you go for medical 
care in the past 6 months? 
 












CD4. Think about (NAME from CD2).  What kind of care center is this? 
 (Circle One) 
 A private doctor's office  ...................................................................  1 
An STD or public health clinic  ........................................................  2 
A hospital clinic or outpatient department  .......................................  3 
Another kind of medical clinic or health center ……………..……..4 
REFUSED    ........................................................................ …….-1 
DON'T KNOW  ............................................................................  -2 
 
 
CD5. How many visits did you make to (NAME from CD2) in the last 6 months? 
 
VISITS:    
 
REFUSED   -1 
DON'T KNOW   -2 
 
CHECK CD3a.  IF NUMBER OF PROVIDERS > 1, CONTINUE WITH CD6.  IF 
ONLY ONE PROVIDER, GO TO CD10. 
 
CD6. Think about the clinic, doctor's office, or HMO that you visited the second most 
number of times.  What kind of care center was this? 
 (Circle One) 
 A private doctor's office      1 
An STD or public health clinic    2 
A hospital clinic or outpatient department   3 
Another kind of medical clinic or health center  4 
 
 
CD7. How many visits did you make to this care center in the last 6 months? 
 
 VISITS:   
 
REFUSED   -1 
DON'T KNOW -2 
 
CHECK CD3a.  IF NUMBER OF PROVIDERS > 2, CONTINUE WITH CD8.  IF 








CD8. Think about the clinic, doctor's office, or HMO that you visited the third most 
number of times.  What kind of care center was this? 
((Circle One) 
 A private doctor's office      1 
An STD or public health clinic    2 
A hospital clinic or outpatient department   3 
Another kind of medical clinic or health center  4 
 
 
CD9. How many visits did you make to this care center in the last 6 months? 
 
VISITS:   
REFUSED   -1 
DON'T KNOW  -2 
 
 
CD10.  Have you had a doctor visit in the last six months mainly because you had a 
medication side effect? 
(Circle One) 
YES  .........................................................................................  1 







Section CE.  Mental Health Providers 
 
CE1. Now let's talk about treatment for mental or emotional problems, or for problems 
with stress or nerves.  Did you visit a mental health provider on an individual or 
family basis for emotional or personal problems during the last 6 months?  
Include any visits to a psychiatrist, psychologist, psychiatric social worker, 
psychiatric nurse, or marriage or family counselor.  Don't include any visits that 
were only for drug or alcohol problems. 
 (Circle One) 
YES  .................................................  1 
NO  ...................................................  2  SKIP TO CE3 
REFUSED  ........................................ -1 SKIP TO CE3 
DON'T KNOW  ................................. -2 SKIP TO CE3 
 
CE2. In total, how many visits to mental health providers did you make during the last 
6 months? 
 VISITS:   
 
CE3. Did you attend support or psychotherapy groups in the last 6 months? (Do not 
include 12-step groups or groups primarily for substance abuse.) 
 (Circle One) 
YES  .................................................  1 
NO  ...................................................  2  SKIP TO CE5 
REFUSED  ........................................ -1 SKIP TO CE5 
DON'T KNOW  ................................. -2 SKIP TO CE5 
 
CE4. In total, how many visits to support or psychotherapy groups did you make during 
the last 6 months? 
 VISITS:   
 
CE5. Did you ever visit with any other provider, such as a minister, priest, or rabbi 
about emotional or personal problems in the last 6 months? 
 (Circle One) 
YES  .................................................  1 






Section CF:  Substance Abuse Treatment Services 
 
CF1.   During the last 6 months, did you receive any treatment or counseling for drug or 
alcohol use? This would include going to any groups such as NA or AA.   
 
 (Circle One) 
YES  1 
NO  2   
SKIP TO CG1 
 
 
CF1a.   In the last 6 months, did you attend any NA or CA meetings?  
 
 (Circle One) 
YES  1 
NO  2  
 
 
CF1b. In the last 6 months, did you attend any meetings of Alcoholics Anonymous? 
 
 (Circle One) 
YES  1 
NO  2 
 
 
CF1c. In the last 6 months, how many times did you attend a 12-step or self-help group 
(such as AA, NA, or CA) or support group primarily for drug or alcohol related 
problems? 
 





CF2. Let's talk about outpatient visits for drug or alcohol problems, other than the ones 
we just mentioned.  How many different outpatient treatment programs or 
providers did you use in the past six months? 
 
     _______________ (NUMBER) 
 





CF2a. Think about the outpatient drug or alcohol treatment program or provider you 
went to most often.  How many days did you receive treatment in this outpatient 
program, or visit this professional in an outpatient setting for drug or alcohol 
related problems?  Don't include any medical visits you've already told me about. 
 
    DAYS: ___  
 
CHECK CF2.  IF NUMBER OF PROVIDERS > 1, CONTINUE WITH CF2b.  IF 
ONLY ONE PROVIDER, GO TO CF3. 
 
CF2b. Think about the drug or alcohol treatment provider you went to the next most 
number of times.  How many days did you receive treatment from this provider?  
    DAYS: ___  
 
 
CHECK CF2.  IF NUMBER OF PROVIDERS > 2, CONTINUE WITH CF2c.  IF ONLY 
ONE OR TWO PROVIDERS, GO TO CF3. 
 
CF2c. Think about the drug or alcohol treatment provider you went to the next most 
number of times.  How many days did you receive treatment from this provider?  
    DAYS: ___  
 
 
CF2d. Of all the visits you just told me about, how many were for detox only? 
 
    DAYS: ___  
 
CF3. In the last six months, were you enrolled in a residential treatment program, a 
halfway house, or a therapeutic community for drug or alcohol problems? 
 (Circle One) 
YES  .................................................  1 
NO  ...................................................  2   SKIP TO CF4 
REFUSED               -1  SKIP TO CF4 
DON'T KNOW             -2  SKIP TO CF4 
 
 CF3a.  How long were you enrolled in this program? 
 
   ______________DAYS 
   ______________WEEKS 







CF3b.  Were any of these times for detox only? 
 
 (Circle One) 
YES  .................................................  1 
NO  ...................................................  2   SKIP TO CF4 
REFUSED               -1  SKIP TO CF4 
DON'T KNOW             -2  SKIP TO CF4 
 
 
 CF3c.  How long were you in inpatient or residential detox? 
 
   ______________DAYS 
   ______________WEEKS 
   ______________ MONTHS 
 
 
CF4. In the last six months, were you enrolled in a methadone maintenance program? 
 (Circle One) 
YES  .................................................  1 
NO  ...................................................  2   SKIP TO CF5 
REFUSED               -1  SKIP TO CF5 
DON'T KNOW             -2  SKIP TO CF5 
 
 CF4a.  How long were you enrolled in this program? 
 
   ______________DAYS 
   ______________WEEKS 







Section CG.  Home Health Services 
 
CG1. During the last 6 months, did you receive help at home with medical problems, 
personal care, housekeeping, or other services? 
 (Circle One) 
YES   1 
NO   2  SKIP TO CH1 
 
 
CG2.  (HAND R CARD #31) Please look at this card and tell me which specific types 
of help you received at home during the last 6 months.  PROBE:  Any other type 
of help?  CODE EACH TYPE OF HELP RECEIVED BELOW.  INCLUDE 
PAID AS WELL AS UNPAID HELP. 
(Circle All That 
Apply) 
 a. TPN OR PARENTERAL NUTRITION (FEEDING BY VEIN)  .  1 
 b. INFUSION THERAPY  .................................................................  2 
 c. INJECTIONS OR SHOTS  ............................................................  3 
 d. OTHER MEDICAL TREATMENT OR EXAMINATION (SUCH AS 
  ADMINISTERING MEDICATION BY MOUTH OR INHALATION 
  OR CHANGING BANDAGES)  ...................................................  4 
 e. PHYSICAL, OCCUPATIONAL OR SPEECH THERAPY  ........  5 
 f. PERSONAL CARE SUCH AS ASSISTANCE GETTING DRESSED 
AND UNDRESSED, BATHING, OR GETTING INTO OR OUT OF 
BED…………………………………………………………………….6 
 g. HOUSEKEEPING OR FOOD PREPARATION  .........................  7 
 h. MEAL DELIVERY  ......................................................................  8 














CG3. (HAND R CARD 32)  Who helped you during the last 6 months? 
PROBE:  Anyone else? 
(Circle All That 
Apply) 
 PAID HELPER  ...........................................................................................1 
UNPAID VOLUNTEER  ............................................................................2 
FRIEND OR RELATIVE WHO LIVES WITH YOU  ...............................3 
FRIEND OR RELATIVE WHO DOES NOT LIVE WITH YOU  .............4 
OTHER HELPER  .......................................................................................5 
 
CG4. INTERVIEWER CHECK CG3. 
 (Circle One) 
 CODE 1  IS CIRCLED ................................1 
 CODE 1  IS NOT CIRCLED .......................2   SKIP TO CG6 
 
CG5. On average, how many hours per week of paid home help did you have in the last 
6 months?  Please include all types of paid home help in your answer—not just 
help related to health care. 
 
 HOURS:  _____________ 
 
 
 CG5a. How many weeks did you have paid home help in the last 6 months? 
 
 WEEKS:  ____________  
 
 
CG6. INTERVIEWER CHECK CG3. 
 (Circle One) 
CODE 2 OR 3 OR 4 OR 5 IS CIRCLED  ...  1 














CG7. Think about the unpaid helper who helped you most often during the last 6 
months. 
Is that person: 
 (Circle One) 
A volunteer, .....................................  1 SKIP TO CG9 
A friend,...........................................  2 
Your partner or spouse, ...................  3 SKIP TO CG9 
Another family member, .................  4 
Some other helper ............................  5 
 
 
CG8. Does he or she live with you? 
 (Circle One) 
 YES  ................................................  1 
 NO  ..................................................  2 
 
 
CG9. On average, how many hours per week of help did you get from all unpaid helpers 
in the last 6 months? 
 HOURS:  ____________  
 
 CG9a. How many weeks did you have unpaid helpers in the last 6 months? 
 




Section CH.  Dental Services 
 
CH1. During the last 6 months, did you see a dentist, oral surgeon, or other professional 
dental care provider? 
 (Circle One) 
YES ..........................  1 
NO .............................  2 
 
 
CH2. During the last 6 months, how many times did you see the dentist, dental surgeon, 
oral surgeon, orthodontist, periodontist, endodontist, dental hygienist, dental 
technician, denturist, or any other person for dental care for a dental check-up? 
 
 VISITS:   
 
Section CI.  Other Services 
 
CI1. Did you receive care from any medical practitioners such as optometrists, foot 
doctors, nutritionists or chiropractors in the past six months? 
 (Circle One) 
YES ..........................  1 
NO ............................  2 
 
 
CI2. Did you receive treatment from any alternative therapist, for example, a massage 
therapist, acupuncturist, herbalist, or any other alternative practitioner? 
 (Circle One) 
YES ..........................  1 
NO ............................  2 
 
 
CI3. During the last 6 months, did you buy or replace any special medical equipment 
like eyeglasses, a cane, a hospital bed, a wheelchair, or a nebulizer? 
 (Circle One) 
YES ..........................  1 






D.  INSURANCE COVERAGE 
 
 
RECORD TIME THIS SECTION BEGINS:________________ 
 
 
Now I’d like to talk with you about health insurance. 
 
D1. Have you been covered by Medicaid or (STATE NAME FOR MEDICAID) in the 
last 6 months?  (Medicaid is a state program for low income persons or for 
persons on public assistance.) 
 (Circle One) 
YES  .................................................................  1 
NO  ...................................................................  2  SKIP TO D5 
REFUSED  ........................................................ -1 SKIP TO D5 
DON'T KNOW  ................................................ -2    SKIP TO D5 
 
D2. Are you presently covered by Medicaid? 
 (Circle One) 
YES  .................................................................  1 
NO  ...................................................................  2  
REFUSED  ........................................................ -1 
DON'T KNOW  ................................................ -2  
 
D3. In what month and year were you first covered by (Medicaid/STATE PROGRAM 
NAME)? 
 





D4. During the last 6 months, for approximately how many months were you covered 
by (Medicaid/STATE PROGRAM NAME)? 







D5. Are you presently covered by Medicare?  (Medicare is a health insurance program 
for people 65 years old or over and for people who are disabled.) 
 (Circle One) 
YES  .................................................................  1 
NO  ...................................................................  2  SKIP TO D6a 
REFUSED  ........................................................ -1 SKIP TO D6a 
DON'T KNOW  ................................................ -2 SKIP TO D6a 
 
D6. In what month and year were you first covered by Medicare? 
 MONTH:   YEAR:  _______ 
 
 
D6a.      Do you get help paying for drugs through the ADAP program, also known as the 
AIDS Drug Assistance program?  
 
 (Circle One) 
YES   ..........................................  1 
NO   ............................................  2 
 
 
D7. Have you received coverage from any other public insurance program during the 
last 6 months?  This includes any public programs such as VA benefits, 
TRICARE, or a county program. 
 (Circle One) 
YES  ...........................................................  1 
NO  .............................................................  2  SKIP TO D10 
REFUSED  .................................................. -1 SKIP TO D10 
DON'T KNOW  .......................................... -2 SKIP TO D10 
 
 
D8. (HAND R CARD #25)  What are the names of these programs? 
 (Circle All That Apply) 
 a. WIC (WOMEN, INFANTS AND CHILDREN)   1 
 c. VETERANS ADMINISTRATION (VA)  .......  2 
 d. CHAMPUS/TRICARE  ...................................  3 
 e. COUNTY PROGRAM  ...................................  4 




D9. Are you presently covered by any of these programs? 
 (Circle One) 
YES   ..........................................................  1 
NO   ............................................................  2 
 
D10. Are you now covered by any private health insurance that pays any part of 
hospital or doctor bills? 
 (Circle One) 
YES  .................................................................  1 
NO  ...................................................................  2  SKIP TO D12 
REFUSED  ........................................................ -1 SKIP TO D12 
DON'T KNOW  ................................................ -2 SKIP TO D12 
 
 
D10a. Are you covered by more than one private insurance plan that pays for any 
part  of your hospital or doctor bills? 
 (Circle One) 
YES  .................................................................  1 
NO  ...................................................................  2  SKIP TO D11 
REFUSED  ........................................................ -1 SKIP TO D11 
DON'T KNOW  ................................................ -2 SKIP TO D11 
 
 
 D10b. How many private insurance plans do you have (that cover any part of 
your hospital or doctor bills)? 
 #:  ___________ 
 
 
D11. (READ IF D10a CODED 1 [YES]:  I want to ask you about your primary 
private insurance plan, that is, the plan that pays most of the cost of your hospital 











It is important that we have the complete and accurate name of your (primary) 
private insurance plan.  Do you have something like an ID card or bill with the 
name of your (primary) private insurance plan on it? 
 (Circle One) 
YES   ..........................................................  1 
NO   ............................................................  2 
 
 
D11a. RECORD NAME FROM CARD OR ASK: 
What is the complete name of this plan? 
 
  _______________________________________________  
 
D11b. Is this plan a health maintenance organization or HMO? 
 (Circle One) 
YES   ...............................................   1 
NO   .................................................   2 
REFUSED  ......................................  -1 
DON'T KNOW  ...............................  -2 
 
D11c. Does (this plan/PLAN NAME FROM D11a) allow you to go to any doctor you 
want or does it require you to choose from a group or list of doctors? 
 (Circle One) 
ANY DOCTOR  ..............................   1 
SELECT FROM GROUP/LIST  .....   2 
REFUSED  ......................................  -1 
DON'T KNOW  ...............................  -2 
 
D11d. Does your insurance require you to obtain approval from them before seeing a 
specialist 
for medical care? 
 (Circle One) 
YES   ...............................................   1 








D11e.  In what month and year were you first covered by this plan? 
 
 MONTH:   YEAR:   
 
D11f.  Does your private insurance pay for treatment of mental or emotional problems? 
 (Circle One) 
YES   ...........................................   1 
NO   .............................................   2 
DON'T KNOW ………………….-2 
 
D11g. Does your private insurance pay for treatment of drug or alcohol abuse problems? 
 (Circle One) 
YES   ...........................................   1 
NO   .............................................   2 
DON'T KNOW…………………..-2 
 
D11h. Do you have insurance that covers dental services? 
 (Circle One) 
YES   ...........................................   1 
NO   .............................................   2 
REFUSED  .................................. -1  
DON'T KNOW  .......................... -2  
 
D11i. Do you have private insurance that covers prescription medication? 
 (Circle One) 
YES   ...........................................   1 
NO   .............................................   2 
REFUSED  .................................. -1  
DON'T KNOW  .......................... -2  
 
 CHECK D10. 
 (Circle One) 
D10 IS CODED 1  .......................   1  SKIP TO D13 






D12.     Did you ever have private health insurance? 
 
 (Circle One) 
YES         1 




D12a. When was the last time you had private insurance coverage? 
 
 /   
                     MO/YR 
 
D13. INTERVIEWER:  CHECK D1, D5, D9, D10.  IS ANY OF THESE CODED 1? 
 (Circle One) 
YES   .............................................   1  SKIP TO D15 
NO   ...............................................   2  
 
D14. I have recorded that you have not been covered by any private or public health 
insurance in the last 6 months.  Is that correct? 
 (Circle One) 
YES  ..............................................   1  SKIP TO D17 
NO  ................................................   2 
REFUSED  .....................................  -1  SKIP TO D17  
DON'T KNOW  ..............................  -2  SKIP TO D17 
 
D14a. Were you covered by private or public insurance in the last 6 months? 
 (Circle One) 
 PRIVATE ………………………..  1 RETURN TO D10 
PUBLIC  ........................................   2  RETURN TO D1 









D15. Have you been without public or private insurance at any time during the last 6 
months? 
 (Circle One) 
 YES  ..............................................   1 
 NO  ................................................   2  SKIP TO D18 
REFUSED  .....................................  -1 
DON'T KNOW  ..............................  -2 
 
D16. During the last 6 months, for how many months were you without insurance — 
either public or private? 
 # MONTHS:  ________  
OR 
REFUSED ......................................  -1 
DON’T KNOW ..............................  -2 
 
CHECK D10.  IF D10 CODED 2 (NO), ASK D17.  ALL OTHERS SKIP TO D18. 
 
D17. (HAND R CARD #27)  Why don’t you have private health insurance? 
 (Circle All That Apply) 
 a. TOO EXPENSIVE  ..................................................  1 
b. LOST JOB WITH INSURANCE COVERAGE  .....  2 
c. DENIED COVERAGE BECAUSE OF HIV  
STATUS ....……………………………………………..3 
d. DENIED COVERAGE FOR OTHER MEDICAL 
   CONDITION  .........................................................  4 
e. FEAR OF JEOPARDIZING PRIVACY ..................  5 
f. OTHER .....................................................................  6 
 
 
D18. At the time you first tested positive for HIV, did you have any public or private 
health insurance? 
 (Circle One) 
YES  ...........................................  1 
NO  .............................................  2 SKIP TO D19 
REFUSED  .................................. -1 SKIP TO D19 





D18a. What kind of health insurance did you have at that time? 
 (Circle All That Apply) 
 Private insurance, .....................................................  1 
Medicaid, ..................................................................  2 
Medicare, or .............................................................  3 
Other public insurance? ............................................  4 
 
D19. Are you currently participating in any clinical trials or clinical research studies? 
 (Circle One) 
YES  ..............................................   1 
NO  ................................................   2  SKIP TO D21 
REFUSED  .....................................  -1  SKIP TO D21 
DON'T KNOW  ..............................  -2  SKIP TO D21 
 
D20. (HAND R CARD #28)  What services are being provided in the trial(s)? 
 (Circle One) 
CHECK-UPS ONLY  ...........................................   1 
MEDICATIONS ONLY  ......................................   2 
MEDICAL CARE (NO MEDICATIONS) ONLY  3 
MEDICATIONS AND MEDICAL CARE  ..........   4 
NO MEDICAL CARE OR MEDICATION  ........   5 
 




D22. During the last 6 months, did you ever make a decision not to use private 
insurance to pay for medical care or prescription medications related to HIV 
infection? 
 (Circle One) 
YES  ..............................................   1 








D23. During the last 6 months, did you ever make a decision not to use private 
insurance to pay for treatment for drug or alcohol problems? 
 (Circle One) 
 
YES …………………………...1 
NO …………………………… 2 
 
E.  HEALTH-RELATED QUALITY OF LIFE 
 
 
RECORD TIME THIS SECTION BEGINS:________________ 
 
 
These next questions are about your overall health and quality of life. 
 
 
E1. (HAND R CARD 33).  Overall, how would you rate your current health ? Use 
any number from 0 to 10 
 (Circle One Number) 
 | | | | | | | | | | | 
 0 1 2 3 4 5 6 7 8 9 10 
Worst possible health Half-way Best possible 
(as bad as or  between worst health 
worse than and best 
being dead) 
 
E2. I’m going to read you a list of activities.  Please tell me if your health limited you 
a lot, a little or not at all in doing each of these activities in the past four weeks.  
IF R SAYS HE/SHE DOES NOT DO ACTIVITY FOR REASON OTHER 
THAN HEALTH, CODE 3 - NOT LIMITED AT ALL. 











a. Vigorous activities, such 
as running, lifting heavy 
objects, participating in 
strenuous sports? 1 2 3
b. Climbing one flight of 
stairs? 1 2 3
c. Walking more than a 
mile? 1 2 3
187  
 
d. Walking one block? 1 2 3
e. Bathing or dressing 
yourself? 1 2 3
f. Preparing meals or doing 
laundry? 1 2 3
g. Shopping? 1 2 3
h. Getting around inside 
your home? 1 2 3
i. Feeding yourself?  1 2 3
j. The kinds or amounts of 
moderate activities you can 
do, like moving a table, 
carrying groceries, or 
bowling? 1 2 3
  
 
E3. During the past four weeks, has your health prevented you from (READ 
ACTIVITY) all of the time, some of the time, or none of the time? 














a. Working at a job, doing 
work around the house, or 
going to school? 1 2 3
b. Doing certain kinds or 
amounts of work, 
housework, or schoolwork? 1 2 3
c. Taking care of paperwork 
for health insurance or 
medical bills?  1 2 3
  
 
E4. During the past four weeks, how many days did your health cause you to stay in 
bed for 1/2 a day or more? 
 








NOTE:  RESPONSE CAN’T BE >28. 
 
 
E5. During the past four weeks, how much did pain interfere with your normal work 
(including work outside the house and housework)?  Would you say: 
 
 (Circle One) 
Not at all, ...................................................   1 
A little bit, .................................................   2 
Moderately, ...............................................   3 
Quite a bit, or .............................................   4 
Extremely? ................................................   5 
 
 
E6. During the past four weeks, to what extent has your physical health or emotional 
problems interfered with your normal social activities with family, friends, 
neighbors, or groups?  Would you say: 
 
 (Circle One) 
Not at all, ...................................................   1 
A little bit, .................................................   2 
Moderately, ...............................................   3 
Quite a bit, or .............................................   4 
Extremely? ................................................   5 
 
E7. In general, would you say your health in the past four weeks was: 
 
 (Circle One) 
Excellent, ...................................................   1 
Very Good, ................................................   2 
Good, .........................................................   3 
Fair, or .......................................................   4 








E8. (HAND R CARD #35)  Please indicate the extent to which the following 
statements are true or false for you during the past four weeks: 
 












a. I seem to get sick a little easier 
than other people 1 2 3 4 5
b. I have been feeling bad lately 1 2 3 4 5
c. I am somewhat ill 1 2 3 4 5
 
  
E9. (HAND CARD #36)  How much of the time during the past four weeks (READ 
ITEM).  Would you say all of the time, most of the time, a good bit of the time, 
some of the time, a little of the time, or none of the time? 






















a. Have you felt calm and 
peaceful? 1 2 3 4 5 6
b. Have you felt downhearted 
and depressed? 1 2 3 4 5 6
c. Did you feel tired? 1 2 3 4 5 6
d. Have you been a happy 
person? 1 2 3 4 5 6
e. Have you been a very 
nervous person? 1 2 3 4 5 6
f. Did you have enough energy 
to do the things you wanted to 
do? 1 2 3 4 5 6
g. Have you felt so down in the 
dumps that nothing could cheer 
you up? 1 2 3 4 5 6
h. Have you been anxious or 
worried? 1 2 3 4 5 6
i. Have you felt depressed? 1 2 3 4 5 6
j. Did you have a lot of energy? 1 2 3 4 5 6




E10. During the past four weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting with 
friends, relatives, etc.)?  These answer choices are a little different.  Would you 
say: 
 
 (Circle One) 
 All of the time, ..........................................   1  
Most of the time, .......................................   2 
Some of the time, ......................................   3 
A little of the time, or ................................   4 
None of the time? ......................................   5 
 
E11.How much bodily pain have you had during the past 
four weeks?  Would you say: 
 
 (Circle One) 
 None, .........................................................   1 
Very mild, ..................................................   2 
Mild, ..........................................................   3 
Moderate, ...................................................   4 
Severe, or  ..................................................   5 




Section F:   Medications and Adherence 
 
RECORD TIME THIS SECTION BEGINS:________________ 
 
F1. Drugs for HIV infection are sometimes called antiretroviral drugs.  I'm going to 
show you a list of antiretroviral drugs.  Over the last 6 months, which of the 
following drugs have you taken? 
CODE ALL THAT APPLY 
Antiretroviral drugs  
AZT (Retrovir, Zidovudine, ZDV)     Y  N 
ddI (Videx, Didanosine)      Y  N 
ddC (Hivid, Zalcitabine)      Y  N 
D4T (Zerit, Stavudine)      Y  N 
3TC (Lamivudine, Epivir)      Y  N 
Ritonavir (Norvir)       Y  N 
Indinavir (Crixivan)       Y  N 
Saquinavir (Invirase, Fortovase)     Y  N 
Nevirapine (Viramune)      Y  N 
Delavirdine (Rescriptor)      Y  N 
Nelfinavir (Viracept)       Y  N 
Abacavir (Ziagen)       Y  N 
Efavirenz  (Sustiva)       Y  N 
Amprenavir (Agenerase)      Y  N 
Trizivir        Y  N 
Lopinavir (Kaletra)       Y  N 
Combivir        Y  N 
Tenofovir        Y  N 
DID NOT TAKE ANY IN LAST 6 MONTHS   ....................   1   SKIP TO F17 
 DON'T KNOW………………………………-2   SKIP TO F17 
 
IF MORE THAN ONE DRUG CIRCLED, ASK F2, OTHERWISE SKIP TO F5 
 
F2.  Over the last 6 months, on about how many days did your doctor tell you to take 
more than one anti-HIV drug? 
 
PROMPT:  6 MONTHS = 180 DAYS 
 
ENTER NUMBER OF DAYS:   ____________________ 
 
 
F3.        F3 DROPPED 
F4.   F4 DROPPED 
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F5. Which of the following drugs are you supposed to be taking today?  (DO NOT 
ASK ABOUT DRUGS THAT THE PERSON HAS NOT TAKEN IN THE PAST 
6 MONTHS.) 
CODE ALL THAT APPLY 
Antiretroviral drugs  
AZT (Retrovir, Zidovudine, ZDV)     Y  N 
ddI (Videx, Didanosine)      Y  N 
ddC (Hivid, Zalcitabine)      Y  N 
D4T (Zerit, Stavudine)      Y  N 
3TC (Lamivudine, Epivir)      Y  N 
Ritonavir (Norvir)       Y  N 
Indinavir (Crixivan)       Y  N 
Saquinavir (Invirase, Fortovase)     Y  N 
Nevirapine (Viramune)      Y  N 
Delavirdine (Rescriptor)      Y  N 
Nelfinavir (Viracept)       Y  N 
Abacavir (Ziagen)       Y  N 
Efavirenz  (Sustiva)       Y  N 
Amprenavir (Agenerase)      Y  N 
Trizivir        Y  N 
Lopinavir (Kaletra)       Y  N 
Combivir        Y  N 
Tenofovir        Y  N 
NOT TAKING ANY  .............................................................   1   SKIP TO F17 
DON'T KNOW……………………………………………...   -2   SKIP TO F17 
 
 
F6.  Most people with HIV have many pills to take at different times during the day.  
Many people find it hard to always remember their pills.  We need to understand 
how people with HIV are really doing with their pills.  We want to ask you about 
does you may have missed.  Don’t worry about telling me that you don't take all 
your pills.  We want to know what is really happening.  (ASK THE FOLLOWING 
FOR EACH PILL PERSON IS CURRENTLY TAKING.) 
 
 F6a1.  Let's start with _____ (FIRST DRUG).  How many doses did you miss 
taking yesterday? 
       ______________doses 
 
  F6a2. How many doses did you miss taking the day before yesterday (that is, 
two days ago)? 
       ______________doses 
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F6a3. How many doses did you miss three days ago? 
       ______________doses 
 
  F6a4.   How many doses did you miss altogether in the past two weeks? 
       ______________doses 
 
 (ASK IF PERSON TAKING 2 OR MORE DRUGS) F6b1.  Now let's talk 
about_____ (SECOND DRUG).  How many doses did you miss taking yesterday? 
       ______________doses 
 
  F6b2. How many doses did you miss taking the day before yesterday (that is, 
two days ago)? 
       ______________doses 
 
  F6b3. How many doses did you miss three days ago? 
       ______________doses 
 
  F6b4.   How many doses did you miss altogether in the past two weeks? 
       ______________doses 
 
 
 (ASK IF PERSON TAKING 3 OR MORE DRUGS) F6c1.  Now let's talk 
about_____ (THIRD DRUG).  How many doses did you miss taking yesterday? 
       ______________doses 
 
  F6c2. How many doses did you miss taking the day before yesterday (that is, 
two days ago)? 
       ______________doses 
 
  F6c3. How many doses did you miss three days ago? 
       ______________doses 
 
  F6c4.   How many doses did you miss altogether in the past two weeks? 
       ______________doses 
 
 (ASK IF PERSON TAKING 4 OR MORE DRUGS) F6d1.  Now let's talk 
about_____ (FOURTH DRUG).  How many doses did you miss taking yesterday? 
       ______________doses 
 
  F6d2. How many doses did you miss taking the day before yesterday (that is, 
two days ago)? 
       ______________doses 
 
  F6d3. How many doses did you miss three days ago? 




  F6d4.   How many doses did you miss altogether in the past two weeks? 
       ______________doses 
 
F7.   During the past three days, on how many days have you missed taking all your 
pills? 
 
       None   1 
       One day  2 
       Two days  3 
       Three days  4 
       DON'T KNOW -2 
     
F8.  Most anti-HIV medications need to be taken on a schedule, such as "two times a 
day" or "three times a day" or "every eight hours."  How closely did you follow 
your specific schedule over the last three days? 
 
       Never   1 
       Some of the time 2 
       About half the time 3 
       Most of the time 4 
       All of the time  5 
 
[Next 2 questions are part of Chesney scale but not part of Chris Mathews' shortened 
instrument.] 
 
F9.  Do any of your HIV medications have special instructions, such as "take with food," 
or "on an empty stomach," or "with plenty of fluids"? 
 
      YES………………….. 1 
      NO…………………… 2  SKIP TO F10 
      DON'T KNOW     -2  SKIP TO F10 
 
 F9A.  How often did you follow those special instructions over the last three days? 
 
 
       Never   1 
       Some of the time 2 
       About half the time 3 
       Most of the time 4 








F10.  Some people find that they forget to take their pills on the weekend days.  Did you 
miss any of your anti-HIV medications last weekend -- last Saturday or Sunday? 
       YES………………….. 1 
       NO…………………… 2   
       DON'T KNOW     -2  
 
F11.   When was the last time you missed any of your medications? 
       Within past week  1 
       1-2 weeks ago   2 
       2-4 weeks ago   3 
       1-3 months ago  4 
       More then 3 months ago 5 
       Never skip medications 6 
       DON'T KNOW  -2 
 
F12. How well does taking HIV medications fit into your daily routine? 
       Not at all well   1 
       A little bit   2 
       Somewhat   3 
       Very well   4 
       Extremely well  5 
       DON'T KNOW  -2 
 
F13. In the past six months, have you had any symptoms that made you stop taking any 
of your HIV medications? 
       No    1 
       Yes    2 
       Never stopped a med  3 
       DON'T KNOW  -2 
 
F14       DROPPED 
 
F15. How much difficulty do you have taking your HIV medications because of side 
effects? 
       No difficulty   1 
       Some difficulty  2 
       A lot of difficulty  3 










F16. How would you rate your HIV doctor in terms of his or her concerns for your 
safety from bad side effects of HIV medications? 
       Excellent   1 
       Very good   2 
       Good    3 
       Fair    4 
       Poor    5 
       DON'T KNOW  -2 
 
F17.    Please tell me if your doctor, nurse or another health care provider did any 
of the following  things the last time he or she gave you your antiretroviral 
medication. 
 
Your doctor, nurse, or other health care provider explained why it was important 
that you take every dose of your antiretroviral medication. 
 
 YES ....................................................................1   
 NO ......................................................................2 
   
F17A.  (Your doctor, nurse or other health care provider) Gave you special ways to 
remember to take your antiretroviral medication.  
 
 YES ....................................................................1   
 NO ......................................................................2 
 
 
F17B.  (Your doctor, nurse or other health care provider) Clearly explained how 
and when to take your antiretroviral medication.  
 
 YES ....................................................................1   
 NO ......................................................................2 
 
 
 F18.  In the past 6 months, have you taken any drugs to prevent an episode of PCP 
(Pneumocystis or AIDS pneumonia) ?  
 
 READ LIST IF NEEDED: 
 
 Septra or Bactrim (TMP/SMX, Trimethoprim/Sulfamethoxazole) by mouth 
 
 Inhaled or aerosolized Pentamidine (AeroPent, NebuPent, PneumoPent) 
 






 YES ....................................................................1  
 NO ......................................................................2 
 DON'T KNOW………………………………………….-2 
 
 
F19.  In the past six months, have you taken any drugs to prevent an episode of MAC 
(Mycobacterium avium complex) infection?  
 
 
 READ IF NECESSARY: 
 
Clarithromycin (Biaxin, Klacid) 
Azithromycin (Zithromax)            




 YES ....................................................................1  
 NO ......................................................................2 
       DON'T KNOW……………………………… -2   
 
F20.  In the past six months, have you taken any drugs to prevent other opportunistic 
infections besides PCP and MAC?  
 
 YES ....................................................................1  
             NO 2  (go to next question) 
DON'T KNOW……………………………………-2  (go to next question)  
 
F20a.  What are the names of the medicines that you took to prevent opportunistic 





F21.  In the past six months, have you taken any drugs to treat hepatitis or other problems 
with your liver?  
 
 YES ....................................................................1  
                  NO 2  (go to next question) 
       DON'T KNOW……………………………………-2    (go to next question)  
 
F21a.  What are the names of the medicines that you took to treat hepatitis or liver 







F22.  In the past six months, have you taken any drugs to treat high blood pressure or 
hypertension?  
 
 YES ....................................................................1  
                  NO 2  (go to next question) 
       DON'T KNOW………………………………-2   (go to next question)  
 
F22a.  What are the names of the medicines that you took to treat high blood 





F23.  In the past six months, have you taken any drugs to treat diabetes or problems with 
high blood sugar?  
 
 YES ....................................................................1  
                   NO 2  (go to next question) 
        DON'T KNOW……………………………….-2   (go to next question)  
 
F23a.  What are the names of the medicines that you took to treat diabetes or high 





F24.  In the past six months, have you taken any drugs to treat high cholesterol?  
 
 YES ....................................................................1  
                   NO 2  (go to next question) 
        DON'T KNOW………………………………-2   (go to next question)  
 
F24a.  What are the names of the medicines that you took to treat high cholesterol 





F25.  In the past six months, have you taken any drugs to treat arthritis?  
 
 YES ....................................................................1  
                  NO 2  (go to next question) 




F25a.  What are the names of the medicines that you took to treat arthritis in the 





F26.  In the past six months, have you taken any drugs to treat chronic pain?  
 
 YES ....................................................................1  
                  NO 2  (go to next question) 
      DON'T KNOW……………………………….-2   (go to next question)  
 
F26a.  What are the names of the medicines that you took to treat chronic pain in 





F27.  In the past six months, have you taken any drugs to treat asthma?  
 
 YES ....................................................................1  
                   NO 2  (go to next question) 
        DON'T KNOW……………………………….-2  (go to next question)  
 
 
F27a.  What are the names of the medicines that you took to treat asthma in the 





F28.  In the past six months, have you taken any drugs to treat stomach ulcers or reflux 
(gastroesophageal reflux)?  
 
 YES ....................................................................1  
                  NO 2  (go to next question) 
       DON'T KNOW………………………………  -2  (go to next question)  
 
F28a.  What are the names of the medicines that you took to treat reflux or ulcers 









F29.  In the past six months, have you taken any drugs to treat cancer?  
 
 YES ....................................................................1  
                   NO 2  (go to next question) 
        DON'T KNOW………………………………-2    (go to next question)  
 
F29a.  What are the names of the medicines that you took to treat cancer in the 






F30.  In the past six months, have you taken any drugs to treat skin problems?  
 
 YES ....................................................................1  
                   NO 2  (go to next question) 
        DON'T KNOW……………………………….-2   (go to next question)  
 
F30a.  What are the names of the medicines that you took to treat skin problems 







F31. Over the last 6 months, have you regularly taken any drugs for depression, anxiety, 
or emotional problems?   
 (Circle One) 
 YES   .........................................   1 




F32. Is it one of the drugs on this card?  (SHOW CARD #24) 
 
















 (Circle One) 
  YES     1 
NO     2 SKIP TO NEXT SECTION 
 
F32a. Over the last 6 months, on about how many days did you take any of these 
drugs? 
  
 PROMPT:  6 MONTHS = 180 DAYS 
 
ENTER NUMBER OF DAYS:   ...................  
 
    F33.  Other than the medicines that you've already mentioned, what other drugs have 






G:   Drug Use- Dependence 
 
 
RECORD TIME THIS SECTION BEGINS:________________ 
 
G1. The next questions are about your use of drugs on your own.  By “on your own” we mean 
either without a doctor’s prescription, in larger amounts than prescribed, or for a longer 
period than prescribed.  (HAND R CARD #40)  With this definition in mind, did you 
ever use any of the following drugs on your own? 
 
 (INTERVIEWER:  If necessary, clarify:  “By ‘on your own’ we mean either without 

















G1a. ...sedatives, sleeping pills, or tranquilizers on your 
own? (e.g. Librium, Valium, Ativan, Meprobamate, 







use in       
the past 6  
months? 





G1b. ...amphetamines (am-FET-ah-means) or other 
stimulants on your own?  (e.g. Methamphetamine, 
Crystal Methamphetamine, Preludin, Dexedrine, 







use in the 
past 6 
months? 





G1c. ...analgesics (an-uhl-JEEZ-icks) or other prescription 
painkillers on your own?  (NOTE: this does not 
include normal use of aspirin, Tylenol without 
Codeine, etc., but does include use of Tylenol with 
Codeine and other Rx painkillers like Demerol, 
Darvon, Darvocet, Percodan, Percoset, Codeine, 







use in the 
past 6 
months? 













use in the 
past 6 
months? 














use in the 
past 6 
months? 
         
  
  













G1f. ...inhalants (other than cocaine) that you sniff or 
breathe to get high or to feel good?  (e.g. Amyl 
 nitrate [Poppers, Ammo], Freon, Nitrous Oxide 







use in the 
past 6 
months? 





G1g. ...LSD or other hallucinogens (ha-LOOSE-en-oh-








use in the 
past 6 
months? 












use in the 
past 12 
months? 
         
  
 













2. ZERO “YES” RESPONSES IN G1a - G1h  GO 
TO NEXT SECTION 
 
 








G3. In your lifetime, did you ever find that you had to use much larger amounts of 
(NAME OF DRUG/any of these substances) than usual to get the same effect or that 










5.  NO 
 
 
GO TO G4 
 













G4. In your lifetime, did you ever have any emotional or psychological problems from 
using -- such as feeling uninterested in things, feeling depressed, suspicious of 
people, paranoid, 

















 G4a. Have you had any emotional or psychological problems from using drugs 



















G5.  Have you ever used any of these substances by injection? 
 (Circle One) 
YES ..........................  1 
NO .............................  2  SKIP TO G6
 
 G5a.  In the past 6 months, have you injected any of these substances? 
 (Circle One) 
YES ..........................  1 
NO .............................  2 
 
G6    In the past six months, did you talk about your drug use with the doctor who's 
treating your HIV infection? 
 (Circle One) 
YES ..........................  1 
NO .............................  2 
 
H.   Alcohol Use 
 
RECORD TIME THIS SECTION BEGINS:________________ 
 
These next questions ask about the past 4 weeks, rather than the past 6months.  
 
 
H1. During the past 4 weeks, on how many days did you have a drink containing 
alcohol? 
IF NONE, ENTER 0 AND GO TO NEXT SECTION. 
 
# DAYS:  _______________  
 
 
H2. During the past 4 weeks, how many drinks did you have on a typical day when 
you were drinking?  By a drink we mean a can of beer, a glass of wine, or a shot 
of hard liquor. 
 
# DRINKS:  _____________  
 
 
H3. On how many days in the past 4 weeks did you have 5 or more drinks?  By a 
drink we mean a can of beer, a glass of wine, or a shot of hard liquor. 
 




H4.    In the past six months, did you talk about your alcohol use with the doctor who's 
treating your HIV infection? 
 (Circle One) 
YES ..........................  1 
NO .............................  2 
 
 
I. Social Services 
 
 
RECORD TIME THIS SECTION BEGINS:________________ 
 
 
I1.   Do you now have a case manager or case worker?  This is a professional in a 
medical or social service agency who helps you to arrange for services or 
programs you need. 
 (Circle One) 
YES    1   
 NO    2  (SKIP TO  I9) 
 






I3.  (IF MORE THAN 1 IN I2: Think of the case manager that you have the most 
contact with.)  Over the last six months, how many times did you see this case 
manager in person? 
 
 NUMBER ______________ 
 
I4. How many times did you talk to this case manager on the phone in the last six 
months? 
  MORE THAN ONCE A WEEK…………………… 1 
  ABOUT ONCE A WEEK    2 
  EVERY OTHER WEEK    3 
  ABOUT ONCE A MONTH               4 
  LESS THAN ONCE A MONTH   5 






I5. How did this case manager help you in the past six months?  (Code all that 
apply) 
 
  a.  Helped you get or referred you to 
  medical services    Y N 
 
b. Helped you get or referred you to 
social services     Y N 
 
c. Helped you fill out forms for benefits 
or entitlements (like SSI)   Y N 
 
d. Gave you advice about taking your 
HIV medications    Y N 
 
e.  Gave you advice about your personal 
life or your problems    Y N 
 
CHECK:  IF NUMBER OF CASE MANAGERS EQUALS ONE IN I2, SKIP TO  I9. 
 
I6.  Think of the case manager that you have the next most contact with.  Over the last 
six months, how many times did you see this case manager in person? 
 
 NUMBER ______________ 
 
I7. How many times did you talk to this case manager on the phone in the last six 
months? 
  MORE THAN ONCE A WEEK…………………… 1 
  ABOUT ONCE A WEEK    2 
  EVERY OTHER WEEK    3 
  ABOUT ONCE A MONTH               4 
  LESS THAN ONCE A MONTH   5 
  NO PHONE CONTACT AT ALL   6   
 
I8. How did this case manager help you in the past six months?  (Code all that 
apply) 
 
  a.  Helped you get or referred you to 
  medical services    Y N 
 
b. Helped you get or referred you to 
social services     Y N 
 
c. Helped you fill out forms for benefits 




d. Gave you advice about taking your 
HIV medications    Y N 
 
e.  Gave you advice about your personal 
life or your problems    Y N 
 
I9. I'm going to read a list of problems that people with HIV often have.  For each 




A. Did you receive any housing assistance in the last six months? (Circle One) 
YES  .................................................  1  
NO  ...................................................  2  
REFUSED               -1  
DON'T KNOW             -2  
 
1.   Did you have a problem with housing or need help in finding a place 
to live in this time period?   
(Circle One) 
YES  .................................................  1 
NO  ...................................................  2   SKIP TO I9B 
REFUSED               -1  SKIP TO I9B 
DON'T KNOW             -2  SKIP TO I9B 
 
2.    Did any professional (like a case manager, nurse, doctor) try to help 
you deal with your housing problem? 
(Circle One) 
YES  .................................................  1 
NO  ...................................................  2   
REFUSED               -1  
DON'T KNOW             -2  
 
 
B. Did you receive any financial assistance (like SSI) in the last six months?
 (Circle One) 
YES  .................................................  1  
NO  ...................................................  2  
REFUSED               -1  




1 Did you have a problem with your finances or need help in getting 
income assistance in this time period?   
(Circle One) 
YES  .................................................  1 
NO  ...................................................  2   SKIP TO I9C 
REFUSED               -1  SKIP TO I9C 
DON'T KNOW             -2  SKIP TO I9C 
 
2.    Did any professional try to help you deal with your financial problem? 
(Circle One) 
YES  .................................................  1 
NO  ...................................................  2   
REFUSED               -1  
DON'T KNOW             -2  
 
 
C. Did you receive any transportation assistance in the last six months?  
(Circle One) 
YES  .................................................  1  
NO  ...................................................  2  
REFUSED               -1  
DON'T KNOW             -2  
 
1. Did you have a problem with or need help with transportation in this 
time period?   
(Circle One) 
YES  .................................................  1 
NO  ...................................................  2   SKIP TO I9D 
REFUSED               -1  SKIP TO I9D 
DON'T KNOW             -2  SKIP TO I9D 
 
2.    Did any professional try to help you deal with your transportation 
problem? 
(Circle One) 
YES  .................................................  1 
NO  ...................................................  2   
REFUSED               -1  






D. Did you receive any assistance in trying to get a job in the last six months?
 (Circle One) 
YES  .................................................  1  
NO  ...................................................  2  
REFUSED               -1  
DON'T KNOW             -2  
 
1. Did you have a problem with employment or need to find a job in this 
time period?   
(Circle One) 
YES  .................................................  1 
NO  ...................................................  2   SKIP TO I9E 
REFUSED               -1  SKIP TO I9E 
DON'T KNOW             -2  SKIP TO I9E 
 
2.    Did any professional try to help you deal with your employment 
problem? 
(Circle One) 
YES  .................................................  1 
NO  ...................................................  2   
REFUSED               -1  
DON'T KNOW             -2  
 
 
E. Did you receive any legal assistance in the last six months?  
(Circle One) 
YES  .................................................  1  
NO  ...................................................  2  
REFUSED               -1  
DON'T KNOW             -2  
 
1.   Did you have a legal problem or need help getting legal advice in this 
time period?   
(Circle One) 
YES  .................................................  1 
NO  ...................................................  2   SKIP TO I9F 
REFUSED               -1  SKIP TO I9F 








2.    Did any professional try to help you find someone to help you  with 
your legal problem? 
(Circle One) 
YES  .................................................  1 
NO  ...................................................  2   
REFUSED               -1  
DON'T KNOW             -2  
F. Did you need treatment for drug or alcohol problems in the last six months? 
(Circle One) 
YES  .................................................  1 
NO  ...................................................  2   SKIP TO I9G 
REFUSED               -1  SKIP TO I9G 
DON'T KNOW             -2  SKIP TO I9G 
 
1. Did any professional try to help you get treatment for drug or 
alcohol problems? 
(Circle One) 
YES  .................................................  1 
NO  ...................................................  2   
REFUSED               -1  
DON'T KNOW             -2  
 




YES  .................................................  1 
NO  ...................................................  2   SKIP TO I9H 
REFUSED               -1  SKIP TO I9H 
DON'T KNOW             -2  SKIP TO I9H 
 
2. Did any professional try to help you get treatment for emotional 
or psychological problems? 
 
(Circle One) 
YES  .................................................  1 
NO  ...................................................  2   
REFUSED               -1  








H. Did you need home care or personal assistance in the last six months? 
 
(Circle One) 
YES  .................................................  1 
NO  ...................................................  2   SKIP TO NEXT 
SECTION 
REFUSED               -1  SKIP TO NEXT 
SECTION  DON'T KNOW    2
  SKIP TO NEXT SECTION  
 




YES  .................................................  1 
NO  ...................................................  2   
REFUSED               -1  
DON'T KNOW             -2  
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J.  PATIENT DESCRIPTION 
 
 
RECORD TIME THIS SECTION BEGINS:________________ 
 
 
J1. What is your date of birth? 
 
  ________  / __________  / __________  
 MO DAY YR 
 
 
J2a. Which of these would you say is your main racial or ethnic group? 
READ GROUPS AND CODE ONE. 
(Circle One) 
White or Caucasian, but not Hispanic or Latino   1   SKIP TO J3 
Black or African-American, but not Hispanic or Latino   2   SKIP TO J3 
Hispanic or Latino   3   SKIP TO J3 
American Indian or Alaskan Native   4   SKIP TO J3 
Asian or Pacific Islander   5   SKIP TO J3 
MIXED RACE    6 
OTHER SINGLE RACE   7   SKIP TO J3 
WHAT?   
 
 
J2b. What groups are your main racial or ethnic groups? 
(Circle All That 
Apply) 
 WHITE OR CAUCASIAN  ..........................................................   1 
 BLACK OR AFRICAN-AMERICAN  ........................................   2 
 HISPANIC OR LATINO  .............................................................   3 
 AMERICAN INDIAN OR ALASKAN NATIVE  .......................   4 
 ASIAN OR PACIFIC ISLANDER  ..............................................   5 
 SOMETHING ELSE  ....................................................................   6 
 WHAT? _____________________________________________ 
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J3. How many years of regular school or college did you ever complete and get credit 
for?  DO NOT COUNT VOCATIONAL EDUCATION AFTER HIGH SCHOOL. 
 YEARS OF SCHOOL   
 
 
J4. What is the highest degree or diploma you have? 
 (Circle One) 
NONE/LESS THAN HIGH SCHOOL  ...............................................   1 
HIGH SCHOOL DIPLOMA OR G.E.D. ............................................   2 
A.A. OR ASSOCIATE DEGREE, JUNIOR OR 2-YEAR COLLEGE   3 
B.A., B.S., BACHELOR’S, 4-YEAR COLLEGE DEGREE  .............   4 
GRADUATE OR PROFESSIONAL DEGREE  .................................   5 
 
J5. At this time, are you: 
 CODE HIGHEST CATEGORY THAT APPLIES. 
 (Circle One) 
Working full time or part time, .......................................   1  SKIP TO J6 
With a job and on sick leave, ..........................................   2  SKIP TO J6 
With a job and not working for other reasons .................   3  SKIP TO J6 
Laid off,...........................................................................   4  SKIP TO J6 
Unemployed and looking for work, ................................   5  SKIP TO J9 
Not working or not looking for work ..............................   9  SKIP TO J9 
Disabled and not working ...............................................   6  SKIP TO J9 
Or retired and not working? ............................................   7  SKIP TOJ11 
NONE OF THE ABOVE            8 SKIP TO J9 
 
 
J6. During the last month, how many hours did you usually work for pay per week? 
 
ENTER NUMBER OF HOURS  __  
OR 
REFUSED  .....................  -1  SKIP TO J6b 
 
DON'T KNOW  .............  -2  SKIP TO J6b 
 
 J6a. CHECK: 
 (Circle One) 
Q6 = 34 HOURS OR LESS  ...............................  1  SKIP TO J7 
Q6= 35 HOURS OR MORE  ..............................  2  SKIP TO J8 
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J6b. Was it: 
  (Circle One) 
35 HOURS OR MORE     1   SKIP TO J8 
20-34 HOURS      2 
OR LESS THAN 20 HOURS PER WEEK?   3 
 
 
J7. Have health problems related to HIV kept you from working full time in the last 6 
months? 
 (Circle One) 
YES  ..............................................   1 
NO  ................................................   2 
 
J8. How many hours or days of work did you miss because of HIV-related illness or 
treatment in the last month? 
 (Circle One) 
 a. ENTER NUMBER: ________ b.CODE UNIT: HOURS  .....................  1 




J9. Have you ever been employed? 
 (Circle One) 
YES  ..............................................   1 
NO  ................................................   2  SKIP TO 
J11 
REFUSED  ....................................  -1  SKIP TO 
J11 
DON'T KNOW  .............................  -2  SKIP TO 
J11 
 
J10. On your last job were you working: 
 (Circle One) 
Full-time, or  ..................................   1 









J11. At this time, are you living alone or are there others in your household? 
 (Circle One) 
LIVING ALONE ...................................................   1  
OTHER(S) IN HOUSEHOLD ...............................   2 
NO USUAL PLACE TO LIVE, HOMELESS, 
MOVING AROUND .............................................   3  
 
 
J12. (SKIP IF 20A = 1)  What is your current legal marital status?  Are you now: 
 IF SINGLE, PROBE:  Is that divorced, widowed, or never married? 
 (Circle One) 
  Married,  .....................................................................................................  1 
Separated,  ..................................................................................................  2 
Divorced, ....................................................................................................  3 
Widowed, or  ..............................................................................................  4 
Never Married?  .........................................................................................  5 
 
 
J13. We need to ask about program participation.  Are you currently receiving Social 
Security Disability payments? 
 (Circle One) 
YES  ........................................................   1 
NO  ..........................................................   2 
 
J14. Do you currently receive assistance through the Aid to Families with Dependent 
Children program, sometimes called AFDC or ADC? 
 (Circle One) 
YES  ........................................................   1 
NO  ..........................................................   2 
 
 
J15. Are you currently receiving Supplemental Security Income or SSI? 
 (Circle One) 
YES  ........................................................   1 
NO  ..........................................................   2 
 
 




Appendix C – Study Codebook 
Construct:  Health Status/Need for Services 
Stage of Illness 
Operational 
Definition Lowest CD4 
Note 
CD4 count is a measure of a patient's immune system strength, how 
far advanced HIV has progressed, and one predictor of risk for 
complications and debilitating infections.  A CD4 below 200 
cells/mm3 is indicative of AIDS. Lowest CD4 count is an indicator of 





B2) Of all the CD4 tests you have had, what was your lowest count? 
(if DK, 3 probes). 
B3) Was your lowest CD4 count less than 500? 
B4) Was it less than 200? 




B2) Less than 50 cells/mm3, 50-200 cells/mm3, 201-500 cells/mm3, 
over 500 cells/mm3, missing data 





Definition Change in Health Status 
Note 
JHU has used F1 items to come up with appropriate combinations of 
drug categories that represent highly active antiretroviral therapy 
(HAART).  HAART is a Yes/No variable.  HAART should be 
prescribed for patients whose CD4 count is below 200 cells/mm3, but 
may be initiated at higher CD4 counts for some patients who have 
other co-morbidities. 
HIVRN Item 
Number F1, F5 
HIVRN 
Question(s) 
F1) Over the last 6 months, which of the following drugs have you 
taken?   
F5) Which of the following drugs are you supposed to be taking 
today? 
Categories Multiple drugs 
Created 
Variable/Recode 
Stable HIV Condition (No Change in HAART regimen or not on 
HAART regimen for both times because not clinically indicated), 





JHU created new HAART variable that uses F5 items (current 
antiretroviral medications).  HAART use from past 6 months (F1 
items in specific combinations) compared with current HAART use. 
A HAART change is a proxy for less stable health status.  The onus 
of "clinically indicated" is assigned to HIVRN clinicians who have 
the experience to make educated HAART decisions for their patients. 
Health-Related Quality of Life 
Operational 
Definition Patient perception of current health 




Question(s) Overall, how would you rate your current health? 





Creating cutoffs for better/worse health i.e. recoding above/below the 
mean may help with recode but would be arbitrary. Variable will be 
kept continuous. 
Illicit Drug Use 
Operational 
Definition Ever Inject 




Question(s) Have you ever used any of these substances by injection 
Categories Sedatives, amphetamines analgesics, marijuana, cocaine, inhalants, LSD, heroin 
Created 
Variable/Recode 
Created the following 3 drug use categories: no drug use history; 





Definition Patient Sex 
Note 
No transgender category.  Demographic factors can play a role in 
disease progression and in how others, including providers and others 
respond.  For example, women respond differently to HAART than 







Question(s) Interviewer notes patient sex.  This is not a self-reported variable. 








Note Providers may respond differently to people from different 
racial/ethnic groups; Other category will be deleted from bivariate 





J2a) Which of these would you say is your main racial or ethnic 
group? 
Categories White, Black, Hispanic, AI/AA, Asian Pacific Islander, Mixed Race, 
Other Single Race 
Created 
Variable/Recode 
White, Black, Hispanic, missing data 
Note to 
Committee 





Note Providers may respond differently to people from different 
racial/ethnic groups; Other category will be deleted from bivariate 







Question What is your date of birth? 
Categories Mo/Day/Year 
Created 
Variable/Recode Interview year date minus reported date of birth year 
Note to 
Committee None 
Enabling Resources: Access to Health Resources 
Operational 
Definition Health Insurance 
Note Disabled persons may be more likely to be on Medicaid. 
HIVRN Item 





D2) Are you presently covered by Medicaid? 
D5) Are you presently covered by Medicare? 
D9) Are you presently covered by any of these other public health 
programs (WIC, VA, Champus, county, other)? 
D10) Are you now covered by any private health insurance? 
D14) Have you not been covered by any private or public health 




Patients with one or more of these types of public insurance were 










Question(s) What is the highest degree or diploma you have? 
Categories None/Less than HS, HS/GED, 2 year college, 4 year college, Grad 
Created 







Employed persons may be more likely to have health insurance, but 
this is not true for all persons.  They may also be in better health.  
Not all employed persons have health insurance, particularly those 





J5) At this time are you: working full time or part time, with a job 
and on sick leave, with a job and not working for other reasons, laid 
off, unemployed and looking for work, not working or not looking 
for work, disabled and not working, or retired and not working 
Categories 
Working full time or part time, with a job and on sick leave, with a 
job and not working for other reasons, laid off, unemployed and 
looking for work, not working or not looking for work, disabled and 
not working, or retired and not working 
Created 
Variable/Recode Full-time or part-time, not working, missing 




Informal Social Support 
Operational 
Definition Living Arrangement 
Note Persons in household may provide some support, but whether this is 





At this time, are you living alone or are there others in your 
household? 
Categories Living alone, others in household, no usual place to 
live/homeless/moving around 
Created 





Formal Social Support: Scope 
Operational 
Definition Case Manager 
Note 45% of patients had 1 case manager in the last 6 months, 9.5% had 2 






In the last 6 months, how many case managers did you have?  This is 
a professional in a medical or social service agency who helps you to 
arrange for services or programs you need. 
Categories Number of case managers 
Created 
Variable/Recode 0, 1 (1 = 1 or 2 case managers) 
Note to 
Committee None 
Formal Social Support: Intensity 
Operational 
Definition Frequency of In-Person Visits across 2 case managers 
Note In HCSUS studies, patients who had at least 1 case management 
contact by phone or in person in the last 6 months had less unmet 





How many times did you see this case manager in person in the last 6 
months? 





Formal Social Support: Type of Support 
Operational 
Definition Informational 
Note Two items: Advice about HIV meds, Personal advice 
HIVRN Item 
Number I5d, I5e 
HIVRN 
Question(s) 
I5d) How did 1st case manager help in the past 6 months?  









Note Three items:  Referral to Medical Services, Referral to Social 
Services, Help with Forms/Benefits 
Look at individual types of support 
HIVRN Item 
Number I5a, I5b, I5c 
HIVRN 
Question(s) 
How did first case manager help in the past 6 months? 
Composite score of each type of formal social support 
Categories Yes/No 








Note Two items: Advice about HIV meds, Personal advice 
HIVRN Item 
Number I8d, I8e 
HIVRN 
Question(s) 
18d) How did 2nd case manager help in the past 6 months?  











Note Three  items:  Referral to Medical Services, Referral to Social 
Services, Help with Forms/Benefits 
Look at individual types of support 
Look at individual types of support across up to 2 case managers 
HIVRN Item 
Number I8a, I8b, I8c 
HIVRN 
Question(s) 
18a, I8b, I8c) How did second case manager help in the past 6 
months? 
Composite score each type of formal social support 
Categories Yes/No 
0-2 Informational, 0-3 Instrumental 





HIV/AIDS-related Outpatient Care: Clinical Care 
Operational 
Definition Number of outpatient Visits 
Note Outpatient care is categorized into rare, average and high use for 






In the past 6 months, how many times did you go to a clinic, private 
Dr's office, or HMO for medical care? 
Categories 0-1 visits (rare), 2-5 visits (average), 6+ visits (high) 
Created 
Variable/Recode 0-1 visits (rare), 2-5 visits (average), 6+ visits (high) 
Note to 
Committee 
2 visits per 6 month period is standard of routine care. Due to low 













HUMAN SUBJECT REVIEW COMMITTEE (IRB APPLICATION) for  




Highly active anti-retroviral therapy (HAART) revolutionized HIV care in 1996, 
transforming HIV from a terminal illness into a chronic disease best managed by  
coordinated care, including medication management, substance abuse and mental health 
treatment, and other ancillary services.  Patients with case managers may have less unmet 
needs, and less frequent use of costly emergency room and inpatient hospitalization.  The 
relationships among HIV/AIDS case management, ancillary services, and health care 
utilization, and previously documented sex and race/ethnic disparities impacting HIV-
related care, need further scrutiny. 
 
Data for this work will come from the HIV Research Network (HIVRN), patient 
interview survey. The Federally-funded HIVRN is a convenience sample of 19 U.S. 
clinical care sites serving about 14,500 people living with HIV/AIDS.  The goal of the 
HIVRN is to provide timely information on health services utilization by persons in HIV 
care.  In 2003, interviews were conducted with a stratified sample of approximately 950 
clients at 14 HIVRN sites to ascertain patient level information about HIV care received 
at all provider sites.  Interviews were conducted in both English and Spanish by trained 
interviewers, with prior informed consent from each patient.  All sites had IRB approval.  




In 1998, Johns Hopkins University (JHU), Baltimore, Maryland, was selected as the data 
coordinating center (DCC) for the HIVRN.  The first phase of the HIVRN focused on 
health care utilization collecting clinical, demographic, and utilization data from 18 high-
volume providers of HIV treatment.  Standardized clinical data elements are abstracted 
from medical charts and sent to JHU to be cleaned and put into a uniform database.  
 
In 2003, JHU subcontracted with Battelle, a survey research company to conduct patient 
interviews with a stratified sample of HIVRN patients.  All patients in the larger HIVRN 
clinical dataset were eligible to participate.  Each site, including JHU, received local IRB 
approval (see Appendix A). The patient interview survey was pilot tested on a sample of 
ten patients at the Johns Hopkins HIV/AIDS Clinic, Baltimore, Maryland.  Patients were 
recruited from the clinic waiting room and received $30 for their participation.  
 
Patients who were under 18 years of age, and those who were drunk or intoxicated at the 
time of interview were ineligible. Oversampling for women and Hispanics was done to 
ensure representation of these underserved groups.  The student investigator will be using 




This dissertation will be an analysis of data previously collected by JHU and its 
subcontractor, Battelle.  The data were collected following IRB approval at each HIVRN 
site and informed consent was given in writing by each patient before interviews took 
place.  JHU followed an approved protocol for collecting patient level data.  Interviews 
were conducted one-on-one with patients and answers were recorded on interview forms.  
Patients could refuse to answer any question or stop the interview at any time.  Excerpts 
of the protocol are available upon request. 
 
The present study will use a subsample of the HIVRN patient-level data to analyze 
disparities in the receipt of HIV-related health care services.  A signed confidentiality 
statement between the student investigator and JHU is on file and a copy is attached to 
this IRB application package under Appendix B. 
 
A copy of the HIVRN patient interview survey is attached to this IRB application in 
Appendix C.  Not all items will be included in this secondary data analysis.  All patient 
identifiers, including site ID, and names of health care clinics or hospitals have been 
removed from the dataset provided to the student investigator. 
 
Risks and Benefits 
 
Patient risks are minimized by the strict study protocol followed by JHU.  In the original 
data collection effort, patients were assigned unique numeric identifiers; patient names 
are not recorded anywhere on interview forms.  The student investigator is not provided 
with patient identifier or site identifier information to further protect patient 
confidentiality.   
 
There is no direct benefit to patients who participated in the HIVRN patient interviews. 
Information obtained from the HIVRN patient interviews will help investigators better 
understand why and how HIV patients seek their care at multiple provider sites.  At any 
one site, medical records may be incomplete.  More complete data regarding patients’ use 
of pharmaceuticals and ancillary services such as case management, substance abuse, and 
mental health treatment can help program planners justify the need for a comprehensive 
set of primary care services for HIV positive individuals.  The Health Resources and 
Services Administration’s (HRSA), HIV/AIDS Bureau and its partners also plan to use 




The student investigator is not provided with patient identifier or site identifier 
information to further protect patient confidentiality.  If potentially identifying 
information is discovered, the student will notify the original investigators immediately, 
remove those data, and not disclose the information learned. 
 
As previously noted, the student investigator has signed a written statement of 
confidentiality for using the HIVRN patient interview dataset.  A copy of this signed 
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statement is attached to this package and is on file with JHU. The statement clearly 
establishes guidelines for protecting the data.  Patient interview data will be kept on the 
student’s home computer during the dissertation process, which is expected to conclude 
in late 2005 or early 2006.  The student’s home computer is password protected.  As 
noted in the confidentiality statement, the data will not be shared with others not involved 
with the HIVRN study.  Persons with access to the data include Dr. Richard Conviser 
(HRSA), Dr. Kelly Gebo, (JHU co-principal investigator); Dr. Richard Moore (JHU 
principal investigator), other Federal partners at the Agency for Healthcare Research and 
Quality (John Fleishman, Ph.D.), and other HIVRN coordinating center staff at JHU.  
Upon completion of this dissertation, all HIVRN data will be removed from the student’s 
computer and destroyed, and any hard copies of analyses will be shredded.  
 
Information and Consent Forms 
 
As noted above, all HIVRN patients or any proxies who participated in an interview were 
required to sign an informed consent form.  An example of a patient consent form is 
attached under Appendix D.  Original copies of the signed consent forms are kept on file 
at JHU.  Copies of signed consent forms from each HIVRN site are kept at the respective 
sites. 
 
Conflict of Interest 
 
There is no conflict of interest associated with this study.   
 
HIPAA Compliance  
 
This research will use de-identified protected health information that does not identify an 
individual by name, geographic site, clinical care site or other identifying information.  
For further protection, a data use agreement/statement of confidentiality has been signed 
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